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DEVELOPMENT OF CORE PHARMACY ROLES WITH 
COMPETENCY/EPA ALIGNMENT AND LEVELS OF ENTRUSTMENT 
Kimberly K. Daugherty 
October 6, 2020 
The purpose of this two-phase embedded mixed-method project was to investigate the 
extent to which a consensus exists among pharmacy professionals regarding core 
practice-ready roles for graduates that align with current pharmacy competencies/EPA 
statements with entrustment levels. Current competencies/EPAs were perceived as 
mapping to the core roles developed during this study, with some missing competencies. 
Some of the EPA levels of entrustment varied depending on the role to which it was 
mapped. Some levels were different than the current recommended EPA entrustment 
level recommended to be used by schools/colleges. The development of a set of core 
roles with the mapping of pharmacy competencies and EPAs is the first step in pharmacy 
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CHAPTER 1:  INTRODUCTION 
A critical issue in pharmacy education is the production of practice-ready entry-level 
graduates equipped to engage in 21st-century healthcare (Frenck et al., 2010). Vogenberg 
and Santilli (2018) identified themes describing the current healthcare trends driving the 
US healthcare system. These themes include the use of technology (e.g., telehealth, 
telemedicine), as well as changes in (a) healthcare insurance, (b) workforce, (c) 
healthcare cost, (d) drug supply chains, and, lastly, (e) government and regulatory 
changes (e.g., Affordable Healthcare Act). Just as the healthcare world has changed, so 
has the definition of a practice-ready pharmacy graduate. As of today, a practice-ready 
entry-level graduate is a pharmacist that is not only prepared for current practice but also 
has life-long learning skills (Wolff, Pesut, & Regan, 2010). These themes and changing 
definition of practice-readiness require schools/colleges of pharmacy to prepare practice-
ready entry-level graduates for pharmacy’s place in this shifting healthcare world 
(Barnett, 2000b). To prepare practice-ready graduates, schools/colleges of pharmacy need 
to know the core roles students need to execute upon graduation. Competency statements 
and entrustable professional activities (EPAs), mapped to these core roles, could then be 
used to create the pedagogies and assessments to prepare practice-ready graduates.  
Due to continuous healthcare changes, shortages in primary care physicians, and the 
aging population, the role of the pharmacist is in the transition from a product-centered 
focus (just dispensing medication as prescribed) to a now patient-centered focus (Frenck 
et al., 2010; Isasi & Krofah, 2015). This shift to a patient-centered focus means 
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pharmacists are no longer working in a silo to dispense medications. Instead, they serve 
as an integral part of the healthcare team initiating and modifying drug therapies, 
reviewing patient mediation problems to identify issues, performing lab tests, and 
collaborating with other healthcare providers. Adding a pharmacist to a healthcare team 
can improve healthcare outcomes and decrease costs (Isasi & Krofah, 2015). For 
example, one retrospective analysis conducted in North Carolina community pharmacies 
found that medication therapy management (MTM) services (e.g., patient assessments, 
creating medication treatment plans) improved outcomes and reduced costs ($9444 
annual cost savings; Michaels, Jenkins, Pruss, Heidrick, & Ferreri, 2010). Pharmacy 
education needs to continue to adapt to better prepare students to be practice-ready for the 
new and uncertain roles occurring with this transition to a patient-centered focus. 
Establishing a set of core practice-ready roles may help ensure that all schools/colleges of 
pharmacy produce graduates with minimal knowledge, skills, and attitudes to allow the 
graduate to be successful as a practitioner.  
With this new patient-centered focus, practice-ready entry-level pharmacy 
graduates will need to mobilize knowledge, think critically to modify drug therapies, and 
collaborate with other healthcare providers on both local and global teams (e.g., 
conducting medication therapy management services; Frenk et al., 2010; Leadbeatter & 
Peck, 2017). Graduates also need soft skills such as ethics, concern for others, and 
engaging perspectives different from their own (e.g., working with physicians to modify 
patients' chronic medications; Frenk et al., 2010; Leadbeatter & Peck, 2017). Pharmacists 
need these skills to provide more intensive patient care, such as health 
improvement/wellness counseling, disease-prevention services, and even primary care 
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services (Isasi & Krofah, 2015). The job of schools/colleges of pharmacy is to ensure that 
all students meet these skills by being professionally competent. The definition of 
professional competence is “the habitual and judicious use of communication, 
knowledge, technical skills, clinical reasoning, emotions, values, and reflection in daily 
practice for the benefit of the individual and community served” (Epsetin & Hundert, 
2002, p. 226). To aid pharmacy programs in creating pedagogies and assessments that 
ensure minimum professional competence, the concepts discussed in the professional 
competency definition need to be included not just in the outcomes but also in the roles 
pharmacy graduates prepare to perform. The current lack of defined roles leads 
schools/colleges to define these practice-ready roles based on their interpretations of the 
existing pharmacy competencies, leading to students being prepared differently for 
practice. 
Pharmacy Accreditation Standards 2016 adopted the CAPE (Center for the 
Advancement of Pharmacy Education) 2013 (Medina et al., 2013) outcomes as the 
competencies that all schools/colleges of pharmacy need to teach and assess 
(Accreditation Council for Pharmacy Education [ACPE], 2015). CAPE 2013 is the fourth 
version of educational outcomes created to guide curricular and assessment discussions 
within schools/colleges of pharmacy (Medina et al., 2013). Pharmacy chose a different 
competency development path from other professional programs such as medicine. 
Medicine developed its competencies after developing a set of broad abilities (roles) that 
physicians should acquire at graduation and continue to grow throughout their career to 
meet the healthcare needs of their patients (Accreditation Council for Graduate Medical 
Education [ACGME], 2017; Frank, Snell, & Sherbion, 2015; General Medical Council, 
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2017). Pharmacy chose to update the 2004 version of the CAPE outcomes (previous 
versions in 1992 and 1998) through a pharmacy and other healthcare literature review 
instead of defining roles first (Medina et al., 2013). The final CAPE outcomes center on 
four large domains that subdivide into 15 specific subdomains (Appendix A). The four 
broad domains include Foundational Knowledge, Essentials for Practice and Care, 
Approach to Practice and Care, and Personal and Professional Development (Medina et 
al., 2013). While the CAPE outcomes divide into four broad domains, these domains are 
student learning outcomes instead of roles that student pharmacists should prepare for 
upon graduation. Schools/colleges of pharmacy are also not provided a framework for 
pedagogy and assessment of the CAPE outcomes, which leaves it up to the school/college 
how they want to implement these outcomes to meet the accreditation standards. The 
pharmacy accreditation standards only require that schools/colleges maintain a specific 
pass rate on the pharmacy licensure exam [North American Pharmacy Licensure Exam 
(NAPLEX)], which is a knowledge-based exam as opposed to holding schools/colleges to 
specific assessment standards related to the CAPE outcomes (ACPE, 2015), which is why 
each school can set their outcome attainment level. 
One way that schools/colleges might show achievement of the CAPE outcomes is by 
using EPAs (Appendix B) developed by the AACP (American Association of Colleges of 
Pharmacy) Academic Affairs Standing Committee (Jarrett, Berenbrok, Goliak, Meyer, & 
Shaughnessy, 2018). EPAs are considered “units” of professional practice designed to be 
independent, executable, observable, and measurable activities to aid in assessing 
professional competency by translating competencies into clinical practice (ten Cate, 
2013). Usage of the 15 pharmacy EPAs occurs in a variety of ways in schools/colleges of 
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pharmacy. Some schools/colleges use the EPAs to assess students' progression 
throughout the curriculum by defining different EPA entrustment levels based on a 
student’s professional year in the curriculum. Other schools/colleges use the EPAs to 
assess students during only the curriculum's experiential portions to tie the didactic 
competencies with the professional activities seen in the clinical setting (Jarrett et al., 
2018). This lack of standardization allows schools/colleges to define their level of 
entrustment required for graduation. 
Assessment of EPAs occurs using entrustment levels, which students should 
complete, like climbing rungs of a ladder (Modi, Gupta, & Singh, 2015). Level 1 
entrustment suggests a student can observe but not complete a task (e.g., a student may 
observe but not do a patient's medication history). Level 2 is execution with direct and 
proactive supervision (e.g., student will perform the medication history with the 
pharmacist in the room providing advice). Level 3 is performance with quickly available 
(reactive) supervision (e.g., the student will perform the medication history alone with the 
pharmacist in the next room should help be needed). Level 4 is execution with 
supervision from a distance or when asked for by the student (e.g., a student can be freely 
trusted to perform the history without any help). Level 5 is the ability to teach someone 
else the skill (ten Cate, 2013). The AACP Academic Affairs Standing Committee 
recommends pharmacy graduates achieve a Level 3 (reactive supervision) on each of the 
15 core EPAs upon graduation (Jarrett et al., 2018). Accreditation does not require a 
specific entrustment level, so schools/colleges are free to define their own, making it hard 
to compare student EPA achievement across programs.  
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The lack of consistency on use and understanding of the pharmacy EPAs across 
schools/colleges is seen in three studies (Moon, Lounsbery, Schweiss, & Pittenger, 2018; 
Pittenger, Gleason, Haines, Neely, & Medina, 2019; VanLangen, Meny, Bright, & 
Seiferlin, 2019). The first study by Moon et al. (2018) surveyed all pharmacy residency 
program preceptors and residents using a Likert scale and free text at the University of 
Minnesota. Moon et al. asked the preceptors and resident pharmacists to describe their 
perceptions of using the EPAs to assess performance. Results showed that 66.7% of 
residents and 78.3% of preceptors thought the EPA framework was more helpful than the 
previously used assessment model for all but three EPAs (leadership skills, 
developmental planning, and practice management skills). Resident pharmacists achieved 
an entrustment level of 4 or 5 upon completion of the program. Research needs to be 
done on the EPAs related to leadership skills, developmental planning, and practice 
management skills to determine why both resident pharmacists and preceptors found 
them hard to assess as well as on the level of entrustment that residents should achieve. 
Suppose resident pharmacists should be achieving a 4 or 5 upon completion of the 
residency year. In that case, it should make sense that student pharmacists should be 
performing at an entrustment level of less than that upon graduation. However, literature 
related to student entrustment level attainment does not seem to support this idea, making 
it hard to use EPAs to assess graduate practice-readiness (Moon et al., 2018).  
VanLangen et al. (2019) sought to examine faculty feelings on the importance of 
the current EPAs and the expected entrustment level. Faculty at one school of pharmacy 
were surveyed using a Likert scale to quantify the importance of the current EPAs and 
the anticipated level of entrustment for each EPA. VanLangen et al. found a strong 
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consensus (≥75% agreement) of importance for 13 out of the 15 EPAs. Two of the EPAs 
only had a moderate consensus (50-74.9% agreement):  appropriate use of medication in 
a population and identifying risk for prevalent diseases in a population. Faculty also 
could not come to a consensus on the appropriate level of entrustment. Only 10 of the 15 
EPAs had a moderate consensus of a level three entrustment recommended by AACP. 
The others had rates that spanned across all the entrustment levels (VanLangen et al., 
2019). VanLangen et al. is the first published article that has reviewed faculty perceptions 
of what level of entrustment students should achieve on the EPAs outside of the 
recommendation made by the standing committee at the time of EPA development. 
Further research and consensus-building need to occur around the minimum entrustment 
level that students should achieve before graduation. Without a minimum level of 
entrustment that all schools/colleges should have students achieve, it leaves it up to each 
school/college to define it for themselves. This lack of required level of entrustment 
makes it hard for schools/colleges of pharmacy to explain to students how the EPAs will 
prepare them for practice. 
Pittenger et al. (2019) studied a student’s understanding of how the EPAs and 
levels of entrustment fit into practice. Pittenger et al. surveyed student pharmacists to 
determine if students across multiple programs felt the 15 EPAs were relevant to 
pharmacy practice and if practice settings used the EPAs. Greater than 94% of students 
perceived relevance for 14 out of the 15 EPAs in practice, with the lowest agreement 
occurring on the EPA for continuous professional development (85% agreement). Greater 
than 91% of students felt that nine out of the 15 EPA statements represented activities 
performed in multiple practice settings. With the lowest level of agreement again on 
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continuous professional development (67% agreement). Another one of the lower levels 
of agreement was for the EPA to identify risk for prevalent diseases in a population (72% 
agreement), which was also seen as a problem by faculty in VanLangen et al. (2019). 
These results indicated that students do understand the usage of activities assessed with 
the EPAs in pharmacy practice. However, they see less need for the EPA around 
continuous professional development, which is an essential skill in this new healthcare 
environment as outlined in the professional oath of a pharmacist that students take upon 
graduation (American Pharmacists Association, 2020).  
Pittenger et al. (2019) also asked students to rate their level of entrustment on the 
EPAs as they moved through the pharmacy curriculum as well as areas they felt least 
prepared to do upon graduation. Students did report feeling they required less supervision 
in performing the EPAs as they progressed throughout the program with a median 
entrustment level of 2 for 13 out of the 15 EPAs for first-year students and median 
entrustment level of 3 for 10 out of the EPAs in the second year students. Third-year 
students indicated an equal split on the EPAs between entrustment levels 3 and 4. Before 
graduation, fourth-year students showed a median entrustment level of a 4 on 13 out of 
the 15 EPAs. Students felt the least prepared for EPAs involving overseeing pharmacy 
operations (57% felt prepared), developing plans for continuous professional 
development (42% felt prepared), and establishing patient-centered goals and care plans 
(32% felt prepared; Pittenger et al., 2019). The Pittenger et al. study shows gaps in 
understanding how the current EPAs assess the skills needed for practice (i.e., continuous 
professional development, establishing patient care plans, and overseeing pharmacy 
operations). Without a set of core pharmacy roles on which to map the competencies and 
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EPAs, it is hard to help students understand the big picture of how EPAs assessments will 
determine they are ready for practice upon graduation and what level of entrustment they 
should be obtaining. 
Other healthcare professions have created a core set of roles for their professions to 
define the abilities needed to care effectively for patients upon graduation and throughout 
a professional’s career. These core roles help students understand how pedagogies and 
assessments used by the school/college determine practice-readiness. For example, the 
three large medical education groups, CanMeds (Frank et al., 2015), ACGME 
(Accreditation Council for Graduate Medicine Education; ACGME, 2017), and the 
General Medical Council (General Medical Council, 2017), have all created similar sets 
of roles that describe the broad abilities physicians should acquire upon graduation. 
These roles are the same regardless of the medical discipline or stage of professional 
development. Specific competency statements and EPAs map then to each of these roles. 
The competency statements and EPAs are discipline-specific (i.e., internal medicine 
would have different competencies/EPAs compared to pediatrics), but all map back to the 
broad roles. Levels of entrustment a student/professional should be achieving for a stage 
of their career is then assigned (i.e., a medical student may be a level 3 for a competency 
while a practitioner who just graduated residency is a level 4). This level of mapping of 
competency/EPAs back to a broad set of roles is missing in pharmacy education, making 
it hard to determine if all students have the minimal skills necessary to practice regardless 
of the pharmacy discipline.  
The medical competency statements and EPAs mapped to core roles aid in the 
pedagogy and assessment of medical students (ACGME, 2017; Frank et al., 2015, & 
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General Medical Council, 2017). For example, one of the competencies mapped to the 
CanMeds Medical Expert role is: “Practice medicine within their defined scope of 
practice and expertise” (Frank, Snell, & Sherbion, 2014, p. 1). This competency indicates 
schools of medicine need to have pedagogies that discuss the knowledge and skills 
required for a physician’s scope of practice. An example EPA for this competency would 
be “Gather a history and perform a physical examination” (Englander et al., 2016, p. 
1354). Assessment of student performance on EPAs occurs using the entrustment levels 
described earlier with the goal entrustment level based on the stage of the student’s career 
(i.e., lower for medical students, higher for residents). Students are said to have met the 
competencies mapped to the specific EPA if they achieve the desired EPA level for the 
particular stage in their training (ten Cate, 2013). This alignment of roles to competency 
statements to EPAs shows a clear connection between the pedagogy and assessment used 
in colleges of medicine and the roles students will be required to participate in upon 
graduation. Pharmacy has not created a clear connection between the competencies and 
EPAs used for pedagogy and assessment and the roles students should be prepared for 
upon graduation, leaving it up to schools/colleges to determine the roles. This lack of 
consistency across programs results in schools/colleges designing pedagogies and 
assessments based on the program’s interpretation of the competencies, making it hard to 
compare pedagogies and assessments across schools/colleges. It also makes it hard for 
stakeholders to know what students should minimally be prepared for upon graduation, as 
everyone is potentially prepared differently depending on where they graduate. 
A range of academic, industry, and other stakeholders have discussed the 
competencies and entrustable activities that pharmacists should be able to do upon 
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graduation (Alston, Marsh, Castleberry, Kelley, & Boyce, 2017; American College of 
Clinical Pharmacy, 2014; Augustine et al., 2018; Chanakit, Low, Wongpoowarak, 
Moolasaran, & Anderson, 2015; Greinter & Knebel, 2003; Hester et al., 2014; Kennie-
Kaulback et al., 2012; McLaughlin et al., 2017; O’Sullivan, Sy, & Bacci, 2017; Saseen et 
al., 2017; Thompson, Nuffer, & Brown, 2012; Vlasses et al., 2013). Employers and 
student graduates agree students need to have the skills mentioned in the current CAPE 
outcomes (Alston et al., 2017; Kennie-Kaulback et al., 2012; Thompson et al., 2012). 
However, both employers and student graduates point towards the need for more skills in 
other areas (Chanakit et al., 2015; McLaughlin et al., 2017; Noble et al., 2014; Vlasses et 
al., 2013. Waite et al., 2018). Employers feel graduates need more development in human 
resource skills, including conflict resolution, management/leadership, and the regulatory 
aspects of pharmacy as well as in imagination, adaptability, and agility (Chanakit et al., 
2015; McLaughlin et al., 2017; Vlasses et al., 2013). The limited data from recent 
graduates find that graduates would recommend more emphasis on professional identity 
formation and how to handle performing services for patients in busy pharmacy practice 
situations (Noble et al., 2014; Waite et al., 2018). Employers and student graduates' data 
point to potential gaps in student training based on the current competencies. These gaps 
may be due to a lack of core roles that define what students should do upon graduation. 
Pharmacy organizations also agree the skills within the CAPE outcomes are 
needed. However, pharmacy organizations feel additional systems-based and population 
health-based outcomes such as practice-management, identifying systems-based errors, 
resolving medication-related problems, and improving transitions of care need to be 
added for practice (American College of Clinical Pharmacy, 2014; Hester et al., 2014; 
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Saseen et al., 2017). Discussions with stakeholders demonstrate that despite having a set 
of competency statements (CAPE outcomes), there are still some gaps for which 
graduates are not prepared. 
The other thing that makes it appear to stakeholders there are gaps in graduate 
preparedness is the differences in state laws required for licensure. Some states require 
students only to pass the NAPLEX and a law examination while others require students 
also to pass other competencies such as non-sterile compounding or sterile compounding 
(NABP, 2020). Confusion also occurs due to the extra credentials that pharmacists can 
achieve both before and after graduation. Credentials like additional master’s degrees and 
medication management certificates can be received before graduation, while others like 
residency training and Board Certification have to wait until after graduation (Salahudeen 
and Nishtala, 2015). The lack of defined core roles upon graduation leads stakeholders to 
determine skill students should have upon graduation for themselves, which may explain 
some of the gaps discussed in the literature.  
To aid healthcare professions in developing competencies for their curricula 
regardless of the profession, Englander et al. (2013) developed a competency template. 
The purpose of the competency template is to provide a common taxonomy for 
competency domains to ensure that all healthcare professions prepare students to practice 
in an ever-changing healthcare world. After reviewing 153 competency lists from across 
all healthcare professional education, the competency template was put together, 
including nursing, pharmacy, chiropractic, optometry, public health, physician assistants, 
dentistry, and veterinary medicine. The eight competency domains included in the final 
competency template were patient care, knowledge for practice, practice-based learning 
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and improvement, interpersonal and communication skills, professionalism, systems-
based practice, interprofessional collaboration, and personal and professional 
development (Englander et al., 2013). Comparing the pharmacy competencies to the 
Englander list shows about 80% of the competencies are within the CAPE 2013 
outcomes just under different competency headings (Englander et al., 2013). Missing 
areas in the pharmacy competencies include systems-based practice, transitions of care, 
and providing role modeling as well as specifics related to handling difficult 
conversations, uncertain situations, conflict management, and stress management. These 
missing areas may be due to a lack of mapping to a core set of roles that pharmacists 
should be prepared for upon graduation, as many of these missing areas are mentioned in 
the pharmacy stakeholder literature.  
Aligning the pharmacy competencies with those on the health professional 
competency template by Englander et al. (2013) may help ensure a common language 
between pharmacy and other health professions. This common language will help 
develop interprofessional education opportunities because all professionals will teach and 
assess common competencies. This common language will also help demonstrate where 
pharmacy fits into the broader healthcare system, which will be important as the 
profession continues to advocate for increasing roles on the healthcare team (Englander et 
al., 2013). Aligning pharmacy competencies with those of other health professionals, like 
medicine, may also help pharmacy transition to competency-based education seen in 
medicine. 
One of the biggest benefits of competency-based education is ensuring all 
students have the same baseline level of skills upon graduation due to the definition of 
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consistent competencies and milestones that all students would need to meet. The move 
to full competency-based education would also provide schools with a minimum set of 
acceptable levels of performance for all competencies, thus leading to all students having 
the same minimum level of skills upon graduation. Lastly, competency-based education 
allows students to achieve competencies at their own pace instead of relying solely on the 
passage of time (i.e., just because you move from one professional year to another 
because you passed all courses does not mean you meet all competencies). However, 
pharmacy is far from moving to full competency-based education due to multiple factors. 
One factor is assigning experiential rotations when current state laws dictate a maximum 
level of students per preceptor. Schools may not have enough preceptors available with 
the move to competency-based education, depending on how fast or slow students are 
moving through the curriculum.  
Another problem is how to handle faculty workload and assessments when the 
number of students is not consistent moving through the curriculum and how to handle 
lock-step curricula that require students to move from one course to another in a specific 
order. Lastly, opponents of competency-based education fear that this move would mean 
more emphasis on skills and less on the knowledge. This move could be a problem in a 
content-heavy profession like pharmacy, thus moving pharmacists back to the product-
centered role as oppose to the patient-centered role (Medina, 2017).    
Defining core roles from which pharmacy could derive competency and EPA 
statements needed for pedagogy and assessment is one way to help with this move to 
competency-based education. It will be important when defining the core roles for 
pharmacy graduates to consider the knowledge and skills needed for current practice and 
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the role of life-long learning, which will be necessary for a pharmacist to succeed in this 
ever-changing healthcare world (Leadbeatter & Peck, 2017). In healthcare, research 
telling pharmacists what influences patients' health conditions continuously updates, and 
a pharmacist needs to keep up with this new information and integrate it into their 
practice throughout their career (Leadbeatter & Peck, 2017). This example makes it 
essential to ensure pedagogy and assessments used by schools/colleges of pharmacy 
prepare students for the ability not just to regurgitate knowledge and skills that they have 
learned but enable students to apply knowledge and skill domains in new and different 
ways due to continuously changing practice (Barnett, 2000b). It is essential students and 
faculty understand how the competencies and EPAs used to derive program pedagogy 
and assessment link to core roles that students should prepare to execute upon graduation. 
This linkage will help schools/colleges of pharmacy better prepare students for the 
changing healthcare world. 
Theory For Role Development   
The theory of “learning in a supercomplex world” (Barnett, 2000a) represents an 
educational theory to use to define core pharmacy roles and the alignment of the 
competency/EPA statements (Leadbeatter & Peck, 2017). This theory stems from the 
undergraduate higher education literature and seeks to explain how learning changes 
based on how society perceives the world:  complex or supercomplex (Barnett, 2000a). A 
complex world is one where handling of facts, data, evidence, tasks, and arguments occur 
within a framework known by the person (Barnett, 2000a). The complexity arises when 
demands exceed the resources needed to meet them, which leads to an overload of data 
(Barnett, 2000b). For example, in a complex pharmacy world, patients' disease states 
were treated without regard to a patient’s social or cultural traits, so a pharmacist only 
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had to think within their professional knowledge scope to diagnose and treat a patient 
(Leadbeatter & Peck, 2017). For student pharmacists, this meant that they only had to fill 
the prescribed medications and only had to know information about the drug itself. The 
complex world (product-centered focus) did not require the student to learn to work with 
other healthcare disciplines nor to think much about the patient’s social or cultural 
situation before providing treatment.  
In contrast, in a supercomplex world (patient-centered focus), problems are not as 
identifiable. This lack of problem identification is because, in a supercomplex world, 
knowledge and skills are continually changing (Barnett, 2000a, 2000b). For example, 
research telling pharmacists what influences different health conditions in patients 
continuously updates, and a pharmacist needs to keep up with this new information and 
integrate it into their practice (Leadbeatter & Peck, 2017). The ability to keep up with and 
incorporate further knowledge into practice takes a different teaching and assessment 
type to prepare students to learn in this type of ever-changing world. Student pharmacists 
now must work in interprofessional teams, learn new information continuously, and 
apply old data in new ways. The knowledge/skills that one develops in school will 
become irrelevant over time, which requires continuous learning skills (Barnett, 2000b; 
Bengtsen, 2017). Continuous learning skills are an area that needs better emphasized to 
students as, according to the study by Pittenger et al. (2019), students felt the least 
prepared for continuous learning and did not see this EPA as relevant to pharmacy 
practice.  
To help students learn to function in a supercomplex world, pharmacy roles need 
to take on three components:  knowing, action/skills, and self-identity/attitude (Barnett, 
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2000a; Bengtsen, 2017). While the current CAPE Outcomes (Appendix A) contain 
knowledge (Domain 1), skills (Domains 2 and 3), and attitudes (Domain 4; ACPE, 2015), 
the problem becomes that many times, the concepts are looked at in silos as opposed to 
teaching and assessing things holistically. The other problem is that because pharmacist’s 
roles upon graduation have not been precisely defined, schools/colleges are left to 
determine the knowledge, skills, and attitudes that students should be taught and assessed 
for themselves as long as they align with the current pharmacy outcomes.  
Pharmacy created competencies and EPAs to mirror medicine to help define and 
assess the knowledge, skills, and attitudes needed by students upon graduation 
(Englander et al., 2016). While the CAPE Outcomes are required to be used by 
schools/colleges for accreditation, EPAs are not. EPAs also do not have an accreditation 
required defined level of entrustment, allowing programs to set this for themselves. This 
lack of standardization means that students may be prepared differently for practice 
depending on where they graduate and may lead to graduates not being as prepared for 
safe and effective practice as seen in other professions (Frank, Snell, Englander, & 
Holmboe, 2017; Josiah Macy Jr. Foundation, 2017). Having a defined set of pharmacy 
roles with competency and EPA mapping and a set level of entrustment based on 
progression through a professional’s career may be one way to help ensure minimal 
preparation for all graduates. The purpose of this project is to investigate the extent to 
which a consensus exists, if any, among pharmacy professionals regarding core practice-
ready roles for graduates that then align to current pharmacy competencies and EPA 
statements, with levels of entrustment. The creation of a core set of roles with 
competencies/EPAs that align with them and a standardized level of EPA entrustment 
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would help ensure consistency of student knowledge, skills, and attitudes upon 
graduation. It would also allow schools/colleges of pharmacy to work together to develop 
pedagogies and assessments that would ensure all students are practice-ready upon 
graduation. Achievement of consensus may occur for pharmacists' roles, and no 
agreement may be found on the competency/EPA mapping and/or the entrustment 
attainment levels. The lack of consensus on the competency/EPA mapping or the 
entrustment attainment level would signal the need for more research on the 
competencies/EPAs and levels of entrustment.   
Research Questions 
This project will answer the following research questions: 
1. What are the core professional roles pharmacy programs believe students should 
be able to demonstrate competency in upon graduation?  
2. What is the alignment of the current pharmacy competencies and entrustable 
professional activities (EPAs) to the core professional roles?    
3. What level of entrustment should pharmacy graduates be expected to achieve for 
each EPA?     
Methodology 
This project will be conducted in two phases, using an embedded mixed-method 
design for each phase (Creswell & Clark, 2011). Different consensus development 
techniques will be used to collect data during each phase (Delbecq, van de Ven, & 
Gustafsen, 1975). The use of two different consensus development techniques is 
preferred for this study. All three research questions require a combination of subjective 
judgments from multiple people to form one agreed-upon answer and require different 
data types, group sizes, and anonymity (Delbecq et al., 1975).  
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The first phase will address Research Question One, developing a set of core roles 
that define what student pharmacists should prepare to do upon graduation. In Phase One, 
qualitative data collection occurs via a nominal group technique on the strengths and 
modifications needed on a core role proposal (discussed in Chapter 3) provided to the 
study participants. Quantitative data is supportive because the nominal group participants 
rate the importance of the strengths and modifications discussed (Creswell & Clark, 
2011). Conduction of the Nominal Group Technique (NGT) for the proposal review 
process occurs in four key stages. It typically occurs during a single scheduled meeting: 
silent generation, round-robin, clarification, and voting (Delbecq et al., 1975). The use of 
the NGT review process via an internet conference call with an outside facilitator will 
allow 6-7 experts to provide input into the core roles and ensures no one person 
dominates the conversation as each group member provides input one at a time. This 
process will also allow the experts to react to each other’s ideas, leading to better quality 
and quantity of ideas, which is essential when developing a set of core roles for pharmacy 
practice (Linstone & Turoff, 1975). By the end of the conference call, a set of core roles 
that define what student pharmacists should prepare to do upon graduation will occur. 
Phase Two will use the final core roles created in Phase One to answer Research 
Questions Two (alignment of competencies and EPAs) and Three (setting the level of 
entrustment) with simultaneous quantitative and qualitative data collection occurring 
using a cross-sectional survey via the Delphi technique. In this phase, the qualitative data 
(constructed-response questions) are supportive of the quantitative data (selected-
response questions; Creswell & Clark, 2011). For example, if one of the core roles were 
Patient Care skills, panelists would be asked their level of agreement regarding the 
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competency “Provide-patient-centered care as the medication expert” (Medina et al., 
2013, p. 3-4) mapped to this role. A larger, more diverse group of pharmacists (i.e., 
around 40-to 50 with multiple different types of pharmacy practice & different times 
since graduation) is needed for consensus on the competency/EPA mapping (Research 
Question Two) and levels of entrustment (Research Question Three) to ensure as many 
areas of pharmacy have a chance to review the mappings and levels of entrustment. The 
anonymity provided by the Delphi survey process is crucial as it allows everyone to 
provide their opinion regarding the mapping and levels of entrustment without feeling 
pressured to give a particular answer as the surveys are conducted individually with no 
discussion among the participants (Linstone & Turoff, 1975). The lack of pressure to 
provide a specific answer is essential, given the lack of consensus currently related to 
levels of entrustment (VanLangen et al., 2019). By the end of the three-round Delphi 
process, an exploratory mapping of the current pharmacy competencies and EPAs to the 
roles defined in Research Question One, along with a level of entrustment for each EPA, 
will have occurred. After completing Phases One and Two, the data to all three research 
questions will tie to the broad objective of exploring the development of graduate core 
practice-ready roles aligned to competencies and EPAs with entrustment levels.  
Limitations/Reducing Bias 
There are several limitations to a multi-phase mixed methods study, including the 
number of resources needed, time, and lack of meaningful connection between phases 
(Creswell & Clark, 2011). Resources will not be an issue with this study as it will be 
conducted via video conference call for Phase One and via an electronic survey for the 
second phase. The only resources needed are available free through the University:  the 
conference call platform and access to Microsoft® Word and Forms. The amount of time 
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required to complete both phases may be an issue. Still, mitigation will occur using the 
NGT process, which requires only one scheduled meeting and only conducting a 
maximum of three rounds of the Delphi process. The lack of meaningful connections 
between the phases can occur in some studies; for example, it may not be clear how the 
data collected in Phase One is used for the next phase of the project (Creswell & Clark, 
2011). A meaningful connection will not be a problem in this project as Phase Two 
(alignment of competencies/EPAs to the core roles) cannot be completed without Phase 
One (creation of the core roles).  
Disadvantages of the consensus development techniques for Phase Two need 
considering as well, such as organizing a meeting time, the domination of the 
conversation by one participant or group of participants, and lack of inter-rater reliability 
(Delbecq et al., 1975; McMillan et al., 2016). The video conference call should allow for 
the organization of a meeting time that will suit everyone. Mitigation of one person or 
group of people (people from one school of pharmacy) dominating the conversation 
occurs by choice of the NGT method of this project over a focus group methodology. 
NGT protocol is set-up so that every member of the group gets the opportunity to express 
their thoughts one at a time in an organized order, thus allowing everyone the chance to 
express their ideas. The researchers chosen for this project by the Deans will be well-
versed in the literature related to this study's topic. They will not be inclined to defer to 
others’ opinions on the subject if they disagree. Once everyone has responded to the 
question once, the process starts again until no new ideas generate. Another potential area 
of bias would be having the researcher who developed the proposal lead the NGT 
process. Mitigation of researcher bias will occur through the use of a facilitator who did 
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not participate in the development of the proposal but is well known in the field of 
pharmacy and assessment, so those on the NGT panel will respect her ability to lead the 
discussion (Delbecq et al., 1975). 
Some of the Delphi method's disadvantages include the time it takes to do the 
process (it can take weeks or months) and the potential for a low response rate to the 
surveys (McMillan et al., 2016). The time it takes to do the Delphi method will be one 
big negative to this process, but by combining Research Questions Two and Three into 
one Delphi survey, it will help limit some of the timetable. The potential for a low 
response rate will need monitoring and reminders sent to help improve the results. The 
last drawback is the researcher's potential for bias who is reviewing and combining the 
results (McMillan et al., 2016). Mitigation of the risk of bias will occur by providing the 
original and the changed mappings and levels of entrustment in each round of the Delphi 
process, thus allowing Delphi participants to serve as reviewers. 
Besides the limitations of the consensus processes chosen for this study, threats to 
internal and external validity also need to be considered (Campbell & Stanley, 1963). The 
risks for external validity that need consideration in this study are sample bias and 
reactive effects of arrangements (Campbell & Stanley, 1963). Reactive effects of 
arrangements refer to the inability to generalize to non-experimental settings because the 
experimental setting is artificial. Reactive effects of arrangements could potentially be a 
problem in this study since no actual testing of the alignments and levels of entrustment 
will be happening, and results are from practitioners’ thoughts about the appropriate 
alignments and achievement levels of entrustment. Future studies would need to be 
conducted in real-world educational settings to determine if this process's entrustment 
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levels are correct. There is less of an issue with this validity threat as the consensus 
participants are active practitioners with various experiences. They should be capable of 
accurately determining what graduates need to perform as an entry-level pharmacist. 
Sample bias is the other threat to external validity. Sample bias occurs when there is a 
chance that the sample chosen for the study may not represent the population of interest. 
Sample bias is a potential threat in this study, given only a small number of pharmacists 
will be used for the consensus development process. One way this will be mitigated is to 
use a non-randomized sample to ensure that the sample chosen consists of a diverse mix 
of pharmacy practice types and levels of experience (Campbell & Stanley, 1963). 
The following threats to internal validity also need to be considered: (a) history, 
(b) maturation, (c) testing, and (d) experimenter bias (Campbell & Stanley, 1963). 
History is when events occur during the study that may impact the results, which could be 
an issue between the Delphi rounds if participants were to change jobs or learn different 
information that may alter the way they think about the alignments and levels of 
entrustments between the rounds. Maturation could be a problem as processes with the 
participants (aging, experience) could impact the outcomes. History and maturation will 
be mitigated by keeping the time between the rounds to no more than two-three weeks. 
Another potential internal threat is testing itself. Results are affected when participants do 
multiple rounds of “testing.”  Testing will be mitigated by only using two to three rounds 
of the Delphi process. The last threat to internal validity is experimenter bias. This bias is 
when the experimenter’s expectations of the results may consciously or unconsciously 
affect the results. The experimenter’s expectations will be mitigated through the design of 
the NGT process for research question one and then through the use of the participants 
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from the NGT process to review the results of the Delphi process (Campbell & Stanley, 
1963). 
Significance of the Study 
The lack of clarity on pharmacists' roles leads to schools/colleges of pharmacy 
defining these for themselves, thus leading to differences in curricula and assessment. 
Secondly, currently, EPAs are not required to be used or assessed per 2016 ACPE 
Accreditation Standards, and the standards do not provide a level of obtainment needed 
upon graduation (Medina, 2017). Without this standardized set of roles with the EPAs 
aligned to them and an agreed-upon level of entrustment, it may mean that not all 
students are graduating with the same minimal expectations potentially to practice.  
The development of pharmacists’ roles for practice-readiness will impact 
pharmacy education and practice in several ways. For pharmacy education the roles, 
competency alignment, and EPA entrustment levels should help to ensure that all 
graduates possess the same minimal level of competence in knowledge, skills, and 
attitudes upon graduation that are needed to function in both today’s healthcare 
environment and the future (ACGME, 2017; Frank et al., 2015, & General Medical 
Council, 2017). Creating a standard set of roles should help move the pharmacy 
profession forward and expand its role in the healthcare team (Isasi & Krofah, 2015). 
Having minimal EPA entrustment levels that are consistently agreed upon by the 
profession will also allow schools/colleges of pharmacy to specialize in areas requiring 
higher EPA attainment levels before graduation or additional specialty EPAs that are 
program-specific. 
Results from this study will also impact pharmacy research in multiple areas. The first 
area is the types of assessments that will be useful to determine students have met the 
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appropriate level of EPAs as well as other assessments that may be required to ensure 
that students are meeting the full definition of each role. Pharmacy will need to look for 
ways to ensure that assessments are holistic and review students across the curriculum 
and not just at one point in time. Arising will also be a need to develop pedagogies 
appropriate to teach students how to achieve the competencies and EPAs associated with 
each role.  
Definitions/Terminology 
 Multiple terms and abbreviations need defining to aid in the reading of this 
dissertation.  
1. AACP:  American Association of Colleges of Pharmacy; This national pharmacy 
organization represents pharmacy education in the United States with a mission to 
advance pharmacy education, scholarship, practice, and service to improve the 
health of society through partnerships with its members (AACP, 2019a). 
2. ACGME:  Accreditation Council for Graduate Medical Education; This national 
medical organization sets and monitors the professional educational standards for 
physician preparation to ensure delivery of safe, high-quality medical care to all 
people living in the United States (ACGME, 2019). 
3. ACPE:  Accreditation Council for Pharmacy Education; The US Department of 
Education recognizes this national pharmacy organization as the governmental 
agency for professional degree accreditation in pharmacy. Its mission is to set the 
pharmacy education standards for schools/colleges of pharmacy to prepare 
students for the delivery of pharmacists-provided patient care (ACPE, 2019). 
4. CanMEDS:  This is a physician training framework developed by the Royal 
College to define competencies for all medical practice areas to provide a medical 
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education and practice foundation in Canada. This framework was developed 
based on empirical research, educational principles, and broad consultation of 
stakeholders. The framework was initially adopted in 1996 and has undergone 
two revisions since 2005 and 2015 (CanMeds, 2019). 
5. CAPE:  Center for the Advancement of Pharmacy Education; This is a group of 
educators and practitioners nominated by practitioner organizations to create 
outcomes that pharmacy curriculum should aim for students to achieve. CAPE 
2013 is the fourth iteration of these outcomes (1992, 1998, and 2004; AACP, 
2019b). 
6. Competency:  Competency is the ability of a health professional to integrate and 
apply the multiple components of knowledge, skills, attitudes, and values (Frenck 
et al., 2010; Orgill & Simpson, 2014). 
7. Complex world:  This is a world where clearly and fundamentally identifiable 
problems occur even if a clear solution is not immediately seen (Bengtsen, 2017).  
8. Delphi process:  This approach used self-completed questionnaires instead of 
face-to-face communication to develop consensus from large groups of 
participants (Linstone & Turoff, 1975).  
9. Embedded mixed methods:  In an embedded mixed methods design, one type of 
data collection is predominant with quantitative and qualitative data collection 
occurring simultaneously (Subedi, 2016).  
10. Entrustable professional activities (EPAs):  EPAs are considered “units” of 
professional practice that define the tasks and/or responsibilities that a trainee 
should be entrusted to perform have he/she has attained sufficient competence in 
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an area. EPAs are independent, executable, observable, and measurable activities 
that aid in assessing competencies by translating competencies into clinical 
practice (ten Cate, 2013). 
11. Entrustment:  Determination of entrustment occurs by assessing the level an 
individual can trust someone to complete the tasks. Level 1 is the student can 
observe but not do, level 2 is execution with direct and proactive supervision, 
level 3 is the performance with reactive supervision (quickly available), level 4 is 
execution with supervision from a distance or when asked for, and level 5 is the 
ability to teach someone else the skill (ten Cate, 2013). 
12. Nominal group technique:  This technique allows for the collection of qualitative 
data through semi-structured interview questions. Four key stages comprise NGT: 
silent generation, round-robin, clarification, and voting (usually done by ranking 
or rating) (Delbecq et al., 1975).  
13. Practice-ready:  This is a complex, commonly used term that as many meanings 
depending on the context to which it occurs. In this paper, the word will be used 
to mean practitioners prepared for current practice, but that also have the life-long 
learning skills needed to function in this ever-changing healthcare environment 
(Wolff et al., 2010). 
14. Professional competency:  Professional competency is “the habitual and judicious 
use of communication, knowledge, technical skills, clinical reasoning, emotions, 
values, and reflection in daily practice for the benefit of the individual and 
community served” (Epsetin & Hundert, 2002, p. 226).  
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15. Supercomplex world: In a supercomplex world, overloads of data are not 
manageable by merely adding more resources, and problems are not as 
identifiable (Barnett, 2000a, 2000b).   
Outline of the Dissertation 
 The remainder of the dissertation will have four chapters. Chapter 2 provides a 
thorough literature review on the current state of pharmacy and medical education, 
discusses why changes are occurring and needs to continue to occur in healthcare 
education, and describes the areas currently missing in pharmacy education that make the 
need to define practice-ready roles so important. Chapter 3 provides the step by step 
methods for how the research questions are answered in this project. It discusses the 
sampling methodology used for the Phase One NGT process and the Delphi process used 
for Phase Two. It also explains data collection and analysis for each method as well as 
the timelines for each procedure. It also explains how the two phases of this project are 
intertwined. Chapter 4 provides the empirical findings that answer each research 
question. Finally, Chapter 5 will interpret the findings from Chapter 4, explain how the 
Chapter 4 findings contribute to the body of research in this area and how the results may 




CHAPTER 2:  LITERATURE REVIEW       
A critical issue in pharmacy education is the production of practice-ready entry-
level graduates equipped to engage in 21st-century healthcare (Frenck et al., 2010). The 
healthcare world is transforming with the use of technology (e.g., telemedicine) and 
changes in healthcare insurance, the workforce, and regulations (e.g., Affordable 
Healthcare Act; Vogenberg & Santilli, 2018). The definition of a practice-ready 
pharmacy graduate has also transitioned to include preparation for current practice and 
the development of life-long learning skills (Wolff et al., 2010). The job of 
schools/colleges of pharmacy is to ensure that students are practice-ready, and they 
possess and can demonstrate the key professional competencies required to meet the 
needs of an increasingly diverse population. The definition of professional competence is 
“the habitual and judicious use of communication, knowledge, technical skills, clinical 
reasoning, emotions, values, and reflection in daily practice for the benefit of the 
individual and community served” (Epsetin & Hundert, 2002, p. 226). Preparation of 
practice-ready, professionally competent graduates is a requirement that must be met for 
schools/colleges of pharmacy to receive accreditation. However, accreditation standards 
do not provide a true definition of entry-level practice-readiness (ACPE, 2015). To 
prepare practice-ready graduates, pharmacy needs to define the core roles students need 
to do upon graduation. The current pharmacy competency statements and entrustable 
professional activities (EPAs), mapped to these core roles, could then be 
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used to drive pedagogies and assessments used by schools/colleges to prepare practice-
ready graduates.  
Schools/colleges of pharmacy use the current pharmacy competencies (Appendix 
A; Medina et al., 2013) and EPAs (Appendix B; Jarrett et al., 2018) in various ways 
depending on the pharmacy's program mission and goals. For example, some 
schools/colleges use the EPAs to assess student’s progression throughout the curriculum 
by defining different levels of EPA entrustment based on a student’s professional year in 
the curriculum. Other schools/colleges use the EPAs to assess students during only the 
curriculum's experiential portions to tie the didactic competencies with the professional 
activities seen in the clinical setting (Jarrett et al., 2018). These different usages may 
mean that students are prepared differently for practice depending on where they 
graduate. These different uses of the competencies and EPAs also make it hard for 
schools/colleges to share pedagogies and assessment methods. The purpose of this project 
is to investigate the extent to which a consensus exists among pharmacy professionals 
regarding core practice-ready roles for graduates that then align to pharmacy 
competencies and EPA statements, with levels of entrustment. The creation of a core set 
of roles with competencies/EPAs that align to them and a standardized level of EPA 
entrustment would help ensure students' minimal competency upon graduation. Still, it 
would allow schools/colleges of pharmacy to develop pedagogies and assessments that 
could be compared across programs to ensure all students are practice-ready upon 
graduation.  
The development of pharmacists’ roles for practice-readiness will impact pharmacy 
education and practice in several ways. For pharmacy education, development of a set of 
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core pharmacy roles as proposed in this project that then align with the current pharmacy 
competencies and EPAs (including a standardized level of entrustment for assessment) 
may help to ensure all pharmacy school graduates possess the same minimal knowledge, 
skills, and attitudes upon graduation (ACGME, 2017; Frank et al., 2015; General Medical 
Council, 2017). A standardized level of entrustment is necessary as EPA assessment 
occurs using five levels of entrustment (described in detail later) that assess increased 
independence in skill conduction as the level increases (ten Cate, 2013). Still, currently, 
the pharmacy accreditation standards do not require the use of the EPAs, nor do they 
define a set level of EPA attainment upon graduation.  This lack of required usage and a 
set level of minimal entrustment makes it hard to compare pharmacy graduate skill 
attainment across different schools/colleges. Creating core roles upon which the 
pharmacy competencies, EPAs, and levels of entrustment align may aid schools/colleges 
in developing shared pedagogies and assessments. This alignment may also provide 
stakeholders with the ability to compare students' knowledge, skills, and attitudes upon 
graduation across programs since all schools/colleges would be ensuring all students 
meet the same minimum standards. Having minimum EPA levels may also allow 
schools/colleges of pharmacy to specialize (prepare students for residencies or 
fellowships, prepare students for specific disciplines such as pediatrics) as they can 
require higher EPA attainment levels before graduation or add additional specialty EPAs 
that are program-specific without compromising minimal competency. The creation of a 
core set of pharmacy roles may also help to move the pharmacy profession forward as the 
profession continues to expand its role on the healthcare team (Isasi & Krofah, 2015) as 
the core roles will provide a clear definition to other healthcare professions of what 
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pharmacists can do (knowledge, skills, and attitudes). Lastly, establishing a set of core 
roles from which all competencies and EPAs evolve will provide a firm basis from which 
to start the move to full competency-based education, as seen in other healthcare 
professions (Medina, 2017).  
The development of pharmacists’ roles for practice-readiness will impact pharmacy 
research in multiple areas as well. The first research area is the types of assessments that 
will help determine students have met the appropriate EPA entrustment level as currently 
there is a lack of data related to the assessment of the EPAs (discussed in detail later). 
Pharmacy will need to look for ways to ensure that assessments are holistic and review 
students across the curriculum and not just at one point in time. For example, creating 
assessments that would assess a student’s communication skills at the beginning, middle, 
and end of the program to ensure skills improved as the student moved through the 
program. Arising will also be a need to develop pedagogies appropriate to teach students 
how to achieve the competencies and EPAs associated with each role. For example, in 
medicine, one of the competencies mapped to the CanMeds Medical Expert role is: 
“Practice medicine within their defined scope of practice and expertise” (Frank et al., 
2014, p. 1). This competency indicates schools of medicine need to have pedagogies that 
discuss the knowledge and skills required for a physician’s scope of practice. An example 
EPA for this competency would be “Gather a history and perform a physical 
examination” (Englander et al., 2016, p. 1354). Assessment of student performance on 
the EPA occurs using the entrustment levels described later with the goal entrustment 
level based on the stage of the student’s career (i.e., lower for medical students, higher 
for residents). Pharmacy has not created such a concrete mapping that aligns core 
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pharmacy roles, competencies, and EPAs with entrustment levels. This lack of alignment 
means schools/colleges are left to determine alignment independently, which may lead to 
different student preparation for practice depending on where they graduate. Suppose a 
consensus is not reached during this study on mapping the competencies/EPAs and/or on 
entrustment attainment levels. In that case, there will be a need for more research on the 
viability of the current competencies/EPAs and entrustment levels. 
The subsequent chapter is organized into five sections. Section 1 reviews 
healthcare and the role of pharmacy education. The second and third sections review 
pharmacy and medical education. The fourth section discusses the elements missing from 
pharmacy education. The last section discusses the theory of learning in a supercomplex 
world and how this might be used along with the current pharmacy competencies and 
EPAs to develop pharmacist’s roles. This review will then explain the study's purpose 
and how it will impact pharmacy education and future research areas. 
Healthcare and the Role of Pharmacy Education  
Vogenberg and Santilli (2018) recently identified multiple themes describing the 
current healthcare trends driving the US healthcare system's transformation. These 
themes include changes in (a) technology (e.g., telehealth, telemedicine), (b) healthcare 
insurance (move to high deductible plans), (c) workforce, (d) drug supply chains, and, 
lastly, (e) regulatory (Affordable Health Care Act; Vogenberg & Santilli, 2018). 
Pharmacy needs to consider these healthcare trends when developing core roles that 
students should be prepared for upon graduation so schools/colleges can design curricula 




One of the themes driving today’s healthcare system involves increasing technology 
use to improve healthcare (Vogenberg & Santilli, 2018). Healthcare needs to use more 
technology to reach rural populations and integrate care for larger populations due to the 
shift to more primary preventive services. Technology is one way to deal with the current 
rate of rural hospital closures. One in three rural hospitals is at financial risk due to the 
decline (loss of 200,000 people between 2010-2016) in people living in rural counties 
(Vogenberg & Santilli, 2018). Technologies, including telehealth and telemedicine, allow 
rural hospitals to provide specialty services (e.g., post-operate care) to patients without 
having to have the service in the town itself (Vogenberg & Santilli, 2018). Telehealth and 
telemedicine would allow a rural hospital to take advantage of the cost-savings that have 
been found by having a pharmacist on a healthcare team without having the pharmacist 
actual on-site. De Rijdt, Williems, and Simoens (2008) conducted a literature review of 
the economic evaluations of clinical pharmacy interventions in a hospital setting between 
1996-2007. To be included, studies had to be in hospital pharmacies, compare the 
provision of clinical pharmacy services versus no clinical pharmacy services, and 
compare both costs and outcomes. De Rijdt et al. found when pharmacists participated in 
multidisciplinary teams, there was more intensive and direct care of patients, which 
reduced preventable adverse drug events and prescribing errors, thus leading to decreased 
costs. Without a core set of pharmacy roles that define what pharmacists should do upon 
graduation, there is no way to ensure student preparation for this move to telehealth 
practice. 
The move to a more primary preventive focus will require a better way for patients to 
monitor and communicate with pharmacists from their own homes. Technologies such as 
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consumer wearables or smartphones allow patients to monitor blood pressure and blood 
sugar at home and send this information electronically to healthcare providers who can 
make changes in the patient’s care without needing to see the patient (Vogenberg & 
Santilli, 2018). These new technologies will allow pharmacists to provide medication 
therapy management (MTM) as well as other primary care services (e.g., diabetes 
medication adjustment), which improve healthcare outcomes and decrease costs (Isasi & 
Krofah, 2015). Michaels et al. (2010) conducted a retrospective analysis in North 
Carolina community pharmacies to determine the economic impact of a Medicaid MTM 
program and assess pharmacist recommendations' acceptance and implementation. 
Ninety-two pharmacies from one pharmacy chain in North Carolina from August 2006-
July 2007 were used for this retrospective review. Medicaid recipients who had received 
at least 12 prescriptions each month and who completed four quarterly medication 
reviews by the pharmacists were eligible for the retrospective review. A review of 88 
recipients occurred to assess the rate of acceptance of pharmacist recommendations and 
the overall impact of changing from brand-name medications to more cost-effective 
alternatives. There was a 62-86% acceptance rate of the pharmacists’ recommendations 
during one year of the research, and this resulted in an average cost savings of $107 per 
Medicaid beneficiary. The pharmacists’ recommendations led to a total of $9444 in 
annual cost savings during the study (Michaels et al., 2010). These technologies will lead 
to the need for tech-savvy pharmacists and will create potential new career options for 
pharmacists trained to take advantage of these new areas of practice. One way to 
potentially ensure students are ready for changing practice is to develop a core set of 
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pharmacy roles that all graduates should prepare for regardless of the type of pharmacy 
the student chooses to practice.  
Another trend is the changes in healthcare insurance, which has led to consumerism 
in healthcare. This consumerism is due to the increasing cost of employee healthcare 
benefits (move to high deductible insurance plans meaning the employee pays more out 
of pocket before benefits start), cost of physician and hospital visits, and the cost of 
pharmaceutical medication, especially with the rise of specialty drugs (Vogenberg & 
Santilli, 2018). The millennial generation will need to share more of the burden of the 
cost of healthcare. This increase in cost-sharing leads to consumers being more engaged 
in ensuring they receive the most value for their money. The cost-sharing is also leading 
to more transparency in healthcare costs, including the cost of prescription medications 
(Vogenberg & Santilli, 2018). This change will require pharmacists to be more involved 
in finding cost-effective therapies for patients and educating patients so they receive the 
best benefit from the therapies they are using and will require pharmacists to be an 
integral part of interprofessional teams (Frenck et al., 2010). Defining core roles for 
pharmacists that align with the roles seen in medicine will show other professions what 
pharmacists can do. Aligning pharmacy competencies and EPAs to these roles will help 
schools/colleges ensure that all graduates are minimally competent to practice on 
interprofessional teams. 
Another theme involves changes in the current general workforce (Vogenberg & 
Santilli, 2018). The current workforce is more diverse and has more education than ever 
before (Pew Research Center, 2016). According to a Pew Research Center report (2016), 
occupations that require average (associate degree or one-two years of job experience) to 
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above-average education (college-degree plus additional years of experience or training) 
has increased from 49 million in 1980 to 83 million (68%) in 2015. The gender 
demographics are also changing as 47% of the workforce in 2015 were women, 
increasing over previous years. The age groups that make up the workforce are also 
changing, with less than half of 16-24-year-olds being employed in 2015 compared to 
57% in 2000. Older adults are also staying longer in the workforce, with approximately 
62% still working (Pew Research Center, 2016). This make-up requires better 
communication and different employee benefits then previous generations as healthcare 
benefits needed by older adults look different than those required for younger adults. The 
ability to communicate with multiple different entities (patients, caregivers, providers, 
insurance companies) will be an essential skill to ensure is incorporated into core role 
development as this is a skill that goes across all pharmacy disciplines.  
The last set of themes center around the changes in drug supply chains and 
government/regulatory changes. Over the last year or two, several new entities have 
emerged into the drug delivery system. While these new entities provide more options to 
patients to receive medications at lower costs, they do challenge the healthcare system to 
have access to all the patient’s accurate medical records as patients could receive care and 
medications through multiple places. The lack of accurate patient medical records makes 
it even more critical that pharmacists have excellent communication skills, the ability to 
mobilize knowledge from various sources to formulate a patient’s treatment plan, think 
critically to modify drug therapies, and collaborate with other healthcare providers on 
both local and global teams (Frenk et al., 2010; Leadbeatter & Peck, 2017). These 
38 
 
knowledge and skills need consideration when developing the core roles for pharmacists 
as they are essential regardless of the type of pharmacy a student chooses to practice.  
The uncertainty of the status of the Affordable Care Act and the withdrawal of many 
insurance plans from the Affordable Care Act exchanges is also affecting the way 
patients are seeking care and how healthcare workers are getting paid for providing care 
(Vogenberg & Santilli, 2018). The change in the way people seek care may open new 
opportunities for pharmacists in primary care areas since pharmacists are easily 
accessible. Pharmacists will need soft skills such as ethics and concern for others and be 
able to engage with perspectives different from their own to participate in these new areas 
(Frenk et al., 2010; Isasi & Krofah, 2015; Leadbeatter & Peck, 2017).  These attitudes 
will be important to consider when designing the core roles for pharmacy as they are just 
as important as knowledge and skills regardless of the type of pharmacy practice. 
To function as a productive member of a healthcare team based on these themes, a 
pharmacist will need the ability to imagine entirely new roles for the profession (Barnett, 
2000b). Historically, the pharmacist’s role was only to dispense medication and devices 
prescribed by the physician, which tied the pharmacist to the product (medicine). 
However, today, the role of the pharmacist is in the transition from a product-centered to 
a patient-centered focus with the pharmacist no longer working in a silo to dispense 
medication but instead as an integral part of the healthcare team initiating and modifying 
drug therapies, performing lab tests, and collaborating with other health care providers. 
These changes in practicing pharmacists' responsibilities and the knowledge, skills, and 
attitudes needed to execute them have important implications for pharmacy education 
programs (Barnett, 2000b; Epsetin & Hundert, 2002).  
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Pharmacy Education     
Pharmacy has created a set of professional competency and EPA statements to 
help schools/colleges of pharmacy educate students. However, the derivation of the 
professional competency statements did not occur from a defined set of core roles, 
indicating what graduates should perform. This lack of defined roles leads 
schools/colleges to define these practice-ready roles based on their interpretations of the 
competencies. The lack of standardization could lead to students being prepared 
differently for practice depending on the school/college they choose to attend. The 
pharmacy education section of this paper will review the current competencies used in 
pharmacy education, review pharmacy’s current use of the EPAs, and discuss knowledge 
and skills that stakeholders feel need to be taught and assessed to prepare future 
graduates. 
Pharmacy Accreditation Standards 2016 adopted the CAPE 2013 outcomes as the 
competencies that all schools/colleges of pharmacy need to teach and assess (ACPE, 
2015). CAPE 2013 is the fourth version of educational outcomes created to guide 
curricular and assessment discussions within pharmacy schools/colleges. The CAPE 
committee for the revision included seven members from the central pharmacy educator 
organization (American Association of Colleges of Pharmacy [AACP]) and eight 
members from the Joint Commission Pharmacy Practitioners (JCPP). Rather than starting 
the development of outcomes based on a set of core roles that students should prepare for 
upon graduation, the CAPE committee chose to update a previous version of the CAPE 
outcomes after conducting a literature review from pharmacy and other health 
professions (Medina et al., 2013). The 15 CAPE outcomes, with one-word descriptors 
(Appendix A), center around four large domains:  Foundational Knowledge, Essentials 
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for Practice and Care, Approach to Practice and Care, and Personal and Professional 
Development (Medina et al., 2013). While the CAPE outcomes do roll-up into four broad 
domains, these domains are student learning outcomes as opposed to roles that student 
pharmacists should prepare for upon graduation, as is seen with medicine (ACGME, 
2017; Frank et al., 2015; General Medical Council, 2017). Secondly, schools/colleges of 
pharmacy are not provided a framework for pedagogy and assessment for the CAPE 
outcomes, which leaves it up to the school/college of pharmacy how they want to 
implement these outcomes to meet the accreditation standards. 
Running alongside the CAPE outcomes is the JCPP patient care process, which 
better defines CAPE outcome 2.1 (Caregiver). The development of the patient care 
process occurred through a review of several resources on pharmaceutical care and 
medication therapy management. The method was adopted in May of 2014 as a process 
to set clear expectations for a patient-pharmacist visit and is a required component of the 
2016 Accreditation standards (ACPE, 2015; Bennett, Kilethermes, Derr, & Irwin, 2015). 
This five-step process is a foundational framework designed to promote students’ 
professional competence in working with other healthcare providers to provide optimum 
medication use and improved patient outcomes (Kolar, Hager, & Losinski, 2017). It 
includes:  collect, assess, plan, implement, and monitor/evaluate. Collection involves the 
initial collecting of data from various sources to determine the focus and intensity of the 
service. Assessment is the use of the data collected to determine the patient’s needs as 
well as reviewing the appropriateness, safety, efficacy, and adherence to the patient’s 
current and anticipated medication therapy. The plan is creating a patient-specific 
treatment plan in collaboration with the full health care team, patient, and caregivers. 
41 
 
Addressing of medication problems and goals of treatment occur in this step. The 
implement step is where the plan starts, and patient/caregiver education about the plan's 
specifics happens. The last step of monitor and evaluate is where the patient is followed 
over time to monitor for relevant parameters (e.g., lab tests, blood pressure, blood sugar) 
of care, and when needed, new data are collected to restart the process (Bennett et al., 
2015). This process's steps provide a roadmap for pedagogies and assessments for 
schools/colleges of pharmacy, but it does not stand alone. It is one of the foundations of 
patient care (CAPE Domain 2) related to other pieces of knowledge, skills, and attitudes 
(Boyce, 2017). Without a core set of roles defining what graduates should prepare for 
upon graduation, it is hard to determine what other pieces of knowledge, skills, and 
attitudes students would need to go along with the patient care process. 
A lack of core roles agreed upon by all schools/colleges leaves it up to each school to 
define these roles for themselves. The lack of core roles also allows each school/college 
to establish its assessments to determine student preparation for these goals and 
achievement of the CAPE outcomes as the pharmacy accreditation standards only require 
that schools/colleges maintain a specific passing rate on the pharmacy licensure exam 
[North American Pharmacy Licensure Exam (NAPLEX)] which is a knowledge-based 
exam. Schools/colleges are not held to specific assessment standards related to the CAPE 
outcomes, making it hard to compare the assessment of the outcomes between programs 
(ACPE, 2015). One of the problems with assessing competencies like the CAPE 
outcomes is no assessment method to date can reliably measure competencies separately 
from one another as independent constructs (Ginsburg, Mcllory, Oulanova, Eva, & 
Reghr, 2010). The EPAs are used by pharmacy and medicine to separate competencies 
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into measurable units assessable over time and provide a consistent assessment method 
for comparison across all schools/colleges. 
The profession of pharmacy created a set of EPAs to describe what pharmacists 
do as well as to set expectations and guide future actions in practice. The creation of 
EPAs occurred because patients, practitioners, and policymakers more easily understand 
EPAs as opposed to competencies (outcomes) since EPAs assess workplace activities. 
EPA creation for pharmacy started in 2015-16 with the Academic Affairs Standing 
Committee of AACP. The AACP president charged this committee to identify EPAs for 
pharmacy graduates as they transition from completion of their advanced pharmacy 
practice experiences into professional practice and other postgraduate opportunities. 
Work continued with the 2016-17 Academic Affairs committee, which compiled 
comments and input from stakeholders regarding the draft EPAs and completed the final 
edits (Haines et al., 2017). A list of the fifteen pharmacy EPAs is in Appendix B. 
After EPA creation, it was essential to demonstrate the EPAs were valid for 
schools/colleges to use as an assessment tool. Haines, Pittenger, Gleason, Medina, & 
Neely (2018) conducted a face validity study on the fifteen core EPAs using a 28-item 
questionnaire sent to experience pharmacy practitioners affiliated with four 
schools/colleges of pharmacy. Participants had to be pharmacy practitioners with at least 
five years of experience that oversaw and graded at least six student pharmacists on 
experiential rotations in the previous 24 months. Of the participants involved, 89% said 
the patient care provider domain was where they spent most (61%) of their time, 
followed by being an interprofessional team member. Seventy-one usable surveys were 
returned (52% response rate). Participants agreed, with ≥ 75% agreement, that the current 
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15 EPA statements describe activities pertinent to pharmacy practice and that pharmacists 
should perform. A consistent level of agreement occurred regardless of the preceptor’s 
employment, board certification status, or postgraduate training completion. Overall, the 
survey shows that the EPAs developed and vetted by AACP have face validity (Haines et 
al., 2018). 
EPAs are measured using entrustability scales. An entrustability scale is a 
behaviorally anchored ordinal scale from progression to competence (Rekman, Gofton, 
Dudeck, Gofton, & Hamstra, 2016). Pharmacy uses the same definition for the five levels 
of EPA entrustment as the field of medicine (ten Cate, 2013). Level 1 entrustment 
suggests a student can observe but not complete a particular task. For example, a student 
may observe the pharmacist do a patient's medication history, but the student is not yet 
ready to do the history themselves. Level 2 is execution with direct and proactive 
supervision. For this level, the student will perform the medication history, but the 
pharmacist is in the room and can provide advice or add in missing pieces to the history if 
needed. Level 3 is performance with reactive supervision (quickly available). At this 
level, the student will perform the medication history alone with the pharmacist in the 
next room quickly available should help be needed. Level 4 is execution with supervision 
from a distance or when asked for by the student. For this level, the student is performing 
the medication history without a pharmacist in the nearby room or even building. The 
student can be freely trusted to perform the history without any help unless he/she asks 
for it. Level 5 is the ability to teach someone else the skill (ten Cate, 2013). The AACP 
Academic Affairs Standing Committee recommends that pharmacy graduates achieve a 
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Level 3 (reactive supervision) on each of the 15 core EPAs upon graduation (Jarrett et al., 
2018).  
Assessment of the EPAs needs to use levels of entrustment, not scores, 
percentages, or letter grades, which is one of the hard parts in pharmacy education 
implementation since many pharmacy schools/colleges still provide letter grades for 
experiential rotations. Like medicine, there is also a lack of remediation plans for those 
who are not satisfactorily meeting the required level of supervision (Jarrett et al., 2018). 
The lack of standardization on grading and way to remediate makes it hard to determine 
the appropriate use of EPAs in pharmacy education to assess student competency upon 
graduation.  
Pharmacy programs use EPA entrustment levels for two specific purposes. One 
way is to link individual competencies and overall professional responsibilities (e.g., 
students would need to master each competency related to dispensing a medication before 
being able to complete the EPA of fulfilling a medication order without supervision). The 
other way is as a mechanism for faculty to assess the level of supervision for a student 
(e.g., can a student be trusted to perform this activity alone or does the faculty need to be 
in the room [no tie to a particular competency]; Jarrett et al., 2018). 
Determination of entrustment occurs through assessment of the level one can trust 
someone to complete the tasks. Determination of a trainee’s competence is by not only 
their knowledge and skills but also their ability to recognize their limitations, their 
willingness to seek help, and their conscientiousness. Other things that go into 
entrustability are the context and culture of the workplace, the task complexity and 
familiarity, and the relationship between the supervisor and trainee. Trust begins to 
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develop as soon as a supervisor starts working with a student or resident, and judgments 
of trust usually occur within hours or days based on direct clinical care and team 
leadership observations. Often, decisions that students make in the clinical setting hold 
real consequences such as improvement in a patient's health status or even death if a 
mistake occurs. Because of these consequences, entrustment choices are not easy for 
supervisors (Damodaran, Shulruf, & Jones, 2017; Hauer et al., 2015). For example, in 
pharmacy, if a student is entrusted to counsel a patient on medication at a level 3 
(pharmacist does not have to be present) and the student makes an error, it is the 
pharmacist who is ultimately liable for the mistake because they allowed the student to 
complete the task unsupervised. The consequences of entrustment decisions are one of 
the negatives to EPA usage. The consequences also make it hard sometimes to get 
everyone to agree on a specific level of attainment for a given EPA.  
While EPAs help define a universal language of assessment for the pharmacy 
competencies (Haines et al., 2017), there are multiple negatives to EPA usage. One 
negative is that some see EPAs as just another mandate that schools/colleges of pharmacy 
need to assimilate into their curricula and assess student progression. Another negative is 
that some pharmacy educators do not feel that the EPAs reflect all specialized practice 
areas. Lastly, others have difficulty seeing how the EPAs reflect the content they teach 
(Haines et al., 2017).  
To help schools/colleges understand how EPAs can aid pedagogy and assessment, 
mapping the EPAs to the CAPE outcomes and JCPP Patient Care Process occurred. 
Mapping to CAPE and the Patient Care Process occurred because both processes are 
requirements for assessment in all schools/colleges per accreditation standards (ACPE, 
46 
 
2015; Pittegner et al., 2017). Table 1 shows how the EPAs integrate with the CAPE 
outcomes and the Patient Care Process. This mapping helps to demonstrated which 
competencies and portions of the Patient Care Process, a student would be competent in 
should they achieve the required level of entrustment (ten Cate, 2013). 
Table 1 
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Notes. Adapted from “Report of the 2016-2017 Academic Affairs Standing Committee:  
entrustable professional activities implementation roadmap,” by A. L., Pittenger, et al., 
2017, American Journal of Pharmaceutical Education, 81(5), Article S4, p. 9. 
To date, there is limited information on the extent to which pharmacy programs’ 
use of EPAs has driven our understanding of graduating student competency. Conduction 
of one study occurred in a pharmacy residency program (Moon et al., 2018), another in 
pharmacy faculty (VanLangen et al., 2019), and another in student pharmacists (Pittenger 
et al., 2019). A pharmacy residency study conducted by Moon et al. (2018) surveyed all 
pharmacy residency program preceptors and residents using a Likert scale and free text at 
the University of Minnesota asking them to describe their perceptions of using the EPAs 
to assess performance. Results showed that 66.7% of residents and 78.3% of preceptors 
thought the EPA framework was more helpful than the previously used progressions 
rating model for all but three of the EPAs with residents achieving an entrustment level 
of 4 or 5 upon completion of the program. Moon et al. found that leadership skills, 
developmental planning, and practice management skills were not as easy to assess with 
the EPAs compared to the old residency progression model. EPAs were useful for 
assessment in residents with an entrustment level of 4 or 5 being the goal. More research 
needs to be done on the EPAs related to leadership skills, developmental planning, and 
practice management skills to determine why residents and preceptors found them hard to 
assess. The other area that needs more research is the level of entrustment attainment 
because if residents should be achieving a 4 or 5 upon completion of their resident year, 
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then it should make sense that student pharmacists should be performing an entrustment 
level of less than that upon graduation as is recommended by the committee that created 
the EPAs. However, literature related to student entrustment level attainment does not 
support this idea. This lack of entrustment attainment standardization makes it hard to use 
EPAs as an assessment for graduate practice-readiness.  
A study by VanLangen et al. (2019) asked faculty to quantify the importance of 
the current EPAs and their corresponding levels of entrustment. VanLangen et al. found a 
strong consensus (≥75% agreement) of importance for 13 out of the 15 EPAs. Two of the 
EPAs only had a moderate consensus (50-74.9% agreement):  appropriate use of 
medication in a population and identifying risk for prevalent diseases in a population. 
Faculty also could not come to a consensus on the appropriate level of entrustment. Only 
10 of the 15 EPAs had a moderate consensus of a level three entrustment recommended 
by AACP. The others had rates that spanned across all the entrustment levels 
(VanLangen et al., 2019). VanLangen et al. is the first published article that has reviewed 
faculty perceptions of what level of entrustment students should achieve on the EPAs 
outside of the recommendation made by the standing committee at the time of EPA 
development. Further research and consensus-building are needed around the minimum 
entrustment level that students should achieve before graduation. Without a minimum 
level of entrustment that all schools/colleges should have students achieve, it makes it 
hard to determine if all graduating students are practice-ready upon graduation as the 
level of preparedness would depend upon where a student graduated. 
Pittenger et al. (2019) studied students' understanding of how the EPAs and levels 
of entrustment fit into practice. Pittenger et al. surveyed student pharmacists to determine 
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if students across multiple programs felt the 15 EPAs were relevant to pharmacy practice 
and if practice settings used the EPAs. Greater than 94% of students perceived relevance 
for 14 out of the 15 EPAs in practice, with the lowest level of agreement occurring on the 
EPA for continuous professional development (85% agreement). Greater than 91% of 
students felt that nine out of the 15 EPA statements represented activities performed in 
multiple practice settings. With the lowest level of agreement again on continuous 
professional development (67% agreement). Another one of the lower levels of 
agreement was for the EPA to identify risk for prevalent diseases in a population (72% 
agreement), which was also seen as a problem by faculty in VanLangen et al. (2019). 
These results indicated that students do understand the activities assessed with the EPAs 
are used in pharmacy practice. However, they see less need for the EPA around 
continuous professional development, which is essential in this new healthcare 
environment.  
Pittenger et al. (2019) also asked students to rate their level of entrustment on the 
EPAs as they moved through the pharmacy curriculum as well as areas they felt least 
prepared to do upon graduation. Students did report feeling they required less supervision 
in performing the EPAs as they progressed throughout the program with a median 
entrustment level of 2 for 13 out of the 15 EPAs for first-year students and median 
entrustment level of 3 for ten out of the EPAs in the second year students. Third-year 
students indicated an equal split on the EPAs between entrustment levels 3 and 4. Before 
graduation, fourth-year students showed a median entrustment level of a 4 on 13 out of 
the 15 EPAs. Students felt the least prepared for EPAs involving overseeing pharmacy 
operations (57% felt prepared), developing plans for continuous professional 
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development (42% felt prepared), and establishing patient-centered goals and care plans 
(32% felt prepared; Pittenger et al., 2019). The Pittenger et al. study shows gaps in 
understanding how the current EPAs assess the skills needed for practice (i.e., continuous 
professional development, establishing patient care plans, and overseeing pharmacy 
operations). Without a set of core pharmacy roles on which to map the competencies and 
EPAs to it is hard to help students understand the big picture of how the assessments they 
are doing will determine they are ready for practice upon graduation and what level of 
entrustment they should be obtaining.  
There is limited data on the use of EPAs, especially in student pharmacists, which is 
not surprising given that the adoption of EPAs just occurred in 2017. Many of the 
concerns mentioned regarding the use of the EPAs in their early adoption are similar to 
the fears seen in the medical literature, especially regarding the EPAs not assessing all 
the skills needed for professional practice (Krupat, 2018). The core EPAs developed by 
AACP help move the new pharmacy identity from the traditional dispensing role to the 
medication-related cognitive services roles. Currently, the EPAs are not required to be 
used as an assessment tool by accreditation, however. The lack of standardization on the 
use of EPAs and the level of entrustment needed upon graduation makes it hard for 
schools/colleges of pharmacy to work together on creating assessments as currently, each 
school/college establishes its assessments based on their interpretations of the 
competencies and EPAs. The lack of standardization also makes it hard for stakeholders 
to know what to expect from students upon graduation. 
Several stakeholders have discussed the competencies and EPAs that pharmacists 
should be able to do upon graduation, including employers, specialty practice groups, and 
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student graduates. Overall, stakeholders support the current CAPE outcomes but discuss 
additional areas that need adding, as will be discussed in detail in this section. (Alston, et 
al., 2017; American College of Clinical Pharmacy, 2014; Augustine et al., 2018; 
Chanakit et al., 2015; Greinter & Knebel, 2003; Hester et al., 2014; Kennie-Kaulbach et 
al., 2012; McLaughlin et al., 2017; O’Sullivan et al., 2017; Saseen et al., 2017; 
Thompson et al., 2012; Vlasses et al., 2013). It is important that stakeholders are 
considered in the formation of the core roles, competency/EPA mapping, and levels of 
entrustment as the stakeholders are the ones that will be hiring graduates. Most pharmacy 
graduates are employed immediately upon graduation, unlike medical students who are 
required to complete a residency where additional training occurs. 
Employers and pharmacy organizations. In 2017 the Hiring Intent Reasoning 
Examination (HIRE) study was conducted to explore the utility of the 2013 CAPE 
outcomes from the perspective of practicing pharmacists, examining how each attribute 
influences hiring and identifying which attributes are the most and least valuable (Alston 
et al., 2017). An electronic questionnaire was developed and distributed to licensed 
pharmacists in four states (Arkansas, California, Ohio, and North Carolina). Respondents 
ranked their thoughts about the CAPE outcomes and five other business-related attributes 
(marketer/sale builder, business manager, producer, team builder, and business operator). 
A total of 3723 pharmacists responded (10% response rate). Of the fifteen CAPE 
outcomes and five-plus attributes, ten ranked as being necessary for most or all 
pharmacist jobs by more than 80% of respondents with the following characteristics have 
the highest rankings:  professional, communicator, problem solver, learner, self-aware, 
patient advocate, and team builder. These were also areas in which 90% or higher of 
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employers said had a higher impact on hiring decisions. Areas that were considered less 
important and were less likely to disqualify a person from employment were:  innovator, 
medication system-manager, business manager, business operator, and marketer/sales. 
(Alston et al., 2017). Alston et al. (2017) provide information on attributes, based on the 
CAPE outcomes that practicing pharmacists feel are essential when hiring graduates. This 
information will be helpful when creating the core roles student pharmacists should be 
prepared for as it provides information regarding skills employers feel are essential for a 
practicing pharmacist.  
The results of the HIRE study mirror results found in Kennie-Kaulbach et al. 
(2012) and Thompson et al. (2012). Kennie-Kaulbach et al. was a modified Delphi 
process to develop and validate primary healthcare pharmacists' competencies in Canada. 
Core primary health care competencies for pharmacists were drafted based on innovative 
pharmacy practice, existing entry-level competencies/education outcomes, and a 
literature review. The competency formatting used the CanMeds template for medicine 
(Frank et al., 2015). Validation of the competencies occurred by ten pharmacists (leaders 
in patient care, education, and research in primary care). Once validated, first and second 
round surveys were sent to 87 pharmacists identified as proficient or expert in primary 
care. Sixteen pharmacists responded to the first Delphi round, and 33 pharmacists replied 
to the survey's second round. Pharmacists confirmed the most important primary care 
responsibilities as being related to direct patient care, including communication, 
collaboration, and professionalism (Kennie-Kaulbach et al., 2012), all of which are part 
of the current pharmacy competencies.  
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Thompson et al. (2012) also discussed the need for skills found in the current 
competency statements. Thompson et al. conducted a study to determine the most valued 
characteristics when hiring a new pharmacist using a survey sent to Colorado 
pharmacists. Pharmacists selected and prioritized the top five characteristics out of 20 
that were considered the most important in hiring a new pharmacy graduate. Responses 
were then reviewed by the practice site (retail vs. hospital) and by role (manager vs. 
staff). Three hundred eighteen surveys were received, with communication skills be 
characterized as the highest priority in all groups. Professional behavior and adaptability 
were also highly ranked in all groups. Critical thinking was considered more important in 
hospital pharmacy over retail versus efficiency, ranked higher in retail than in a hospital 
(Thompson et al., 2012). Similar to Kennie-Kaulbach et al. (2012), Thompson et al. 
found the skills that were most important for pharmacists to have were communication, 
collaboration, and professionalism, as well as adaptability with critical thinking being 
essential, depending on the position (Kennie-Kaulbach et al., 2012; Thompson et al., 
2012). These skills echo in the pharmacy organization literature; however, the pharmacy 
organizations due discuss some gaps.  
Many pharmacy organizations agree with the stated competencies in HIRE 
(Alston et al., 2017) for graduates entering clinical practice. Pharmacy organizations 
discuss the need for additional competencies in systems-based and population health and 
continuing professional development (American College of Clinical Pharmacy, 2014; 
Hester et al., 2014; Saseen et al., 2017). Overall, most stakeholders agree that the current 
pharmacy competencies based on CAPE are an excellent start to train pharmacy 
graduates, but some studies show potential gaps.  
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In contrast to the HIRE (Alston et al., 2017) study, Augustine et al. (2018) and 
O’Sullivan at al. (2017) used semi-structured interviews or focus groups to look at the 
critical business, management, and human resource skills needed by pharmacy graduates 
since many graduates assume management positions shortly after graduation. Augustine 
et al. conducted a focus group study to identify key business, management, and human 
resource skills needed by pharmacy graduates. Recruitment of twenty-seven preceptors 
with management positions and 10.5 years of experience from one college of pharmacy 
in Arizona occurred to participate in the focus groups. Augustine et al. found seven 
themes related to pharmacy graduates' skills, including communication, time 
management, conflict resolution, and leadership. O’Sullivan et al. conducted semi-
structured interviews with community pharmacy practitioners to design and sequence 
experiential curricula to prepare students for community practice. Fourth-two individuals 
were interviewed (11 individually and 31 in focus groups). Upon reviewing the interview 
data, participants identified the outcomes from CAPE and outcomes related to 
organizational competence, relationship-building, adaptability, and having a provider 
mentality (O’Sullivan et al., 2017). Skills such as time management, conflict resolution, 
adaptability, and organization competence are not clearly outlined in the pharmacy 
competencies.  
Another study by Chanakit et al. (2015) echoed similar gaps, as seen in Augustine 
et al. (2018) and O’Sullivan at al. (2017). Chanakit et al. conducted a cross-sectional 
survey in 180 hospital pharmacists in Thailand to explore whether students graduating 
with PharmD degrees were prepared for practice in a hospital pharmacy. Ninety-eight 
surveys were received (55.6% response rate), and the majority of pharmacists (76.5%) 
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felt PharmD graduates were prepared for practices. Hospital pharmacists, however, did 
think that graduates are currently competent in-patient care services and readiness for 
work but could use more training in health promotion and human relations skills 
(Chanakit et al., 2015). According to stakeholders, the CAPE outcomes do cover most of 
the skills needed by students upon graduation. However, there is a need for more 
competencies in the area of human relation skills (e.g., communication, relationship-
building, and management skills (e.g., adaptability, management, conflict resolution). 
Human relations and management need consideration as some of the core roles that 
students need preparing for according to stakeholders. 
A study by McLaughlin et al. (2017) discusses yet other potential competency 
gaps. McLaughlin et al. conducted facilitated group discussions to identify core 
competencies and skills that pharmacists need in today’s healthcare environment. Six 
discussion groups of 15-20 preceptors, pharmacists, and other North Carolina College of 
Pharmacy partners described the competencies and skills they thought graduating 
students needed. Identification of eight themes occurred from the discussions, including 
skills related to initiative, curiosity, imagination, and analyzing information.  
The other thing that makes it hard for stakeholders to know what entry-level skills 
students should have upon graduation is the differences in state laws regulating licensure 
requirements. Some states require students only to pass the NAPLEX and a law 
examination, while others require students to pass other competencies such as 
compounding or medication safety (NABP, 2020). Confusion also occurs due to the extra 
credentials that pharmacists can achieve both before and after graduation. Credentials like 
additional master’s degrees and medication management certificates can be received 
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before graduation, while others like residency training and Board Certification have to 
wait until after graduation (Salahudeen & Nishtala, 2015). It is essential to consider all 
the skills mentioned by employers and pharmacy organizations needed for employment 
when considering activities that students should be able to do upon graduation. 
Employer/pharmacy organization data should then be triangulated with student graduate 
perception data to help determine the roles that students need to prepare for upon 
graduation since the employers are the ones who will be hiring students upon graduation.  
Student perceptions. Noble et al. (2014) and Waite et al. (2018) reviewed student 
perceptions of their practice readiness after graduation. Noble et al. examined the 
formation of professional identities by Australian student pharmacists using focus groups. 
Eighty-two students from all levels of a four-year Australian undergraduate pharmacy 
course were asked questions related to their perceptions of their curricular experiences 
and how these experiences influenced the development of their professional identities. 
Many students did not come into pharmacy school with a firm idea of what pharmacy 
was, making the transition into school difficult. Noble et al. concluded that identity 
formation needs to be taught from the beginning of the degree program throughout the 
curriculum, especially for students who may not be thoroughly familiar with all the 
aspects of pharmaceutical education (Noble et al., 2014). Professional identity formation 
is essential to know in developing student pharmacists, but it is hard to teach professional 
identity when the profession has not identified its core roles. 
A more recent study by Waite et al. (2018) in Canada examined how recent PharmD 
graduates feel about providing full-scope pharmacy services using a cross-sectional 
survey. Recent graduates from two pharmacy schools who worked in community 
57 
 
pharmacy settings in Ontario, Canada, were asked to complete a survey regarding how 
they felt about performing 14 full-scope pharmacist services (less/more able and 
less/more sure about completing the task). Many recent graduates said their practice site 
was “busy” and that they participated in direct patient care 26-50% of the time. For every 
one-year increase in age, there was an increased chance of the new graduate feeling they 
were able to perform four services:  prescribe or renew prescriptions until a physician 
visit, prescribe or renew appropriate therapy for three months supply or more, conduct 
medication reviews, and administer a flu vaccine. Every unit increase in the busyness of a 
recent graduate’s practice setting, the likelihood of the graduate feeling able to provide a 
pharmaceutical opinion decreased, and to conduct a medication review increased. Every 
unit of increase in age was also associated with the likelihood of recent graduates feeling 
2.17 times more sure of providing a pharmaceutical opinion and 2.57 times more sure 
about administering flu vaccines. New graduates had high levels of feeling sure about 
providing services as long as it is a standard service. Overall, they felt that pharmacy 
school prepared them for the full scope of their pharmacy practice. Feelings of being sure 
were affected by age, the busyness of the practice, and the frequency of service 
performance (Waite et al., 2018). Despite the lack of data in U.S. students, the studies by 
Nobel el al. (2014) and Waite et al. (2018) show the need for professional development 
and time management skills in graduating students.  
Employes, graduates, and pharmacy organizations all have essential ideas of what 
roles pharmacists should engage in and the competencies and EPAs that align with these 
roles. Data from these groups show students need to have CAPE outcomes and human 
relation skills (e.g., communication, relationship-building) and management skills (e.g., 
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adaptability, management, conflict resolution, time-management). Students also need 
innovation, curiosity, and professionalism. It will be necessary to use a diverse set of 
stakeholders to form a consensus on the roles and competencies/EPAs created in this 
project to ensure students' preparedness as generalists upon graduation. Medical 
education as more recently completed a process of creating broad roles for physicians 
that then map to competencies and EPAs, which are used for pedagogy and assessment 
for medical schools and residency programs.  
Medical Education 
It is essential to remember that both medicine and pharmacy seek to develop 
professional competence in their students. Professional competence dimensions break 
down into cognitive, technical, integrative, relational, and affective/moral constructs. The 
cognitive dimension includes the core knowledge and skills needed to problem-solve 
(e.g., Learner domain in the pharmacy CAPE Outcomes). The technical dimension 
consists of those skills that are hands-on and required for a specific type of physician or 
pharmacy practice (i.e., medication history taking, blood pressure taking). Integration 
includes linking basic and clinical knowledge to other disciplines and managing 
uncertainty within the defined clinical setting and place in the physicians’ or pharmacist’s 
career. The relationship domain includes the communication skills, teamwork, and 
conflict-management skills needed to form relationships within the healthcare domain as 
well as the patient and their families. The affective/moral domain includes emotional 
intelligence and ethics, consisting of the physicians’ and pharmacists’ ability to observe 
their emotional intelligence, curiosity, and willingness to acknowledge and correct errors. 
These domains all work together to produce a physician and pharmacist capable of 
functioning in the ever-changing healthcare world to manage ambiguous problems, 
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tolerate uncertainty, and make decisions with sometimes limited knowledge (Epstein & 
Hundert, 2002).  
The Royal College of Physicians and Surgeons of Canada (CanMEDS), General 
Medical Council (GMC) in the United Kingdom, and the Accreditation Council for 
Graduate Medical Education (ACGME) have created roles that all medical school 
graduates should be competent in upon graduation. These roles center around the 
cognitive, technical, integrative, relational, and affective/moral dimensions of 
professional competency. While pharmacy education has started the move towards 
professional competence and has developed competencies, there is no clear set of roles 
centered around the concepts that define what graduates should be competent in upon 
graduation. This lack of standardization makes it hard to determine if all students are 
minimally prepared to be professionally competent upon graduation regardless of the 
school/college from which they graduate. This section will discuss the current medical 
roles that all medical graduates should prepare for upon graduation and how they can 
formulate the pharmacy roles. Then it will review how medicine built their competencies 
and EPAs are around these roles. 
The medical graduate roles created by CanMEDS, GMC, and ACGME develop a 
consistent education approach that embeds outcomes and content across all medical 
curricula and defines the abilities needed for all domains of medical practice regardless of 
discipline. These frameworks can serve as a template for pharmacy in developing our 
core roles, as was done in Kennie-Kaulbach et al. (2012) with the creation of roles and 
competencies for primary care pharmacists in Canada. The CanMEDs’ definition of a 
medical expert is a good summary of all three organizations’ definitions of a practice-
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ready physician: “physicians integrate all of the roles, applying medical knowledge, 
clinical skills, and professional values in their provision of high-quality and safe patient-
centered care. Medical Expert is the central physician role and defines the physician’s 
clinical scope of practice” (Frank et al., 2015, p. 3). All three definitions have roles that 
fit into the cognitive, technical, integrative, relational, and affective/moral dimensions 
needed for professional competence (Epstein & Hundert, 2002). Table 2 summarizes the 
broad roles that represent a practice-ready physician according to the three physician 
organizations (ACGME, 2017; Frank et al., 2015; General Medical Council, 2017). The 
table lists the roles that all physicians should be prepared for upon graduation and beyond 
broken down into the five professional competency areas. These three organizational sets 
of roles are a good starting place for pharmacy when developing pharmacists’ roles since 
pharmacists participate in many of the same functions as physicians in healthcare practice 
with just more of medication focus. 
Table 2 
Medical Practitioner Roles Upon Graduation 
CanMEDs 2015 ACGME General Medical Council 
Cognitive 
 




Health Advocate Patient care and 
procedural skills 
Professional Skills 
   
Integrative 
Manager Systems-based practice Health promotion and illness 
prevention 
Scholar  Patient Safety and quality 
improvement 
Education and Training 
Research and Scholarship 
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 Affective/Moral  
Professional Professionalism Professional Values/behaviors 
 Practice-based learning 
and improvement 
 
Notes. Adapted from. “ACGME common program Requirements [Web page],” by 
Accreditation Council for Graduate Medical Education., 2017,  Retrieved from 
https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_2017-07-
01.pdf; “CanMeds 2015 Physician Competency Framework”, by J. R. Frank et al., 2015, 
Ottawa:  Royal College of Physicians and Surgeons of Canada; “Generic professional 
capabilities framework,” by General Medical Council, 2017, Retrieved from  www.gmc-
uk.org. 
 
The cognitive dimension includes the core knowledge and skills needed to problem-
solve. It includes the roles of Medical Expert in CanMeds 2015 (Frank et al., 2015), 
Medical Knowledge in ACGME (ACGME, 2017), and Professional knowledge in GMC 
(General Medical Council, 2017). The CanMed 2015 role of Medical Expert is not as 
explicit as the other two in defining cognitive knowledge. Still, the concept of needing to 
know foundational knowledge before learning technical, integrative, relational, and 
affective/moral skills and attitudes is a thread that runs through the Medical Expert 
definition and the other six CanMeds domains (Frank et al., 2015). Both ACGME and the 
GMC discuss the need for students to learn foundational knowledge before learning the 
other concepts, and they have specific roles related to knowledge (Medical Knowledge 
[ACGME] and Professional Knowledge [GMC]). Pharmacy has already created a 
foundational knowledge competency (CAPE Outcome 1.1 [Learner]), so creating a role 
around this would not be difficult.  
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The technical dimension consists of those skills that are hands-on and required for a 
specific type of physician or pharmacy practice (i.e., medication history taking, blood 
pressure taking). CanMeds titles the role that fits into this dimension as Health Advocate, 
which means a professional that adds their expertise and influence in the community to 
improve population health (Frank et al., 2015). ACGME and GMC are a little more 
descriptive in the title of their roles for this dimension: Patient care and procedural skills 
(ACGME) and Professional skills (GMC). ACGME defines patient care and procedural 
skills as the ability to provide compassionate, appropriate, and effective care for the 
treatment of health problems and health promotion (ACGME, 2017). The GMC 
definition of professional skills is practical skills, communication and interpersonal skills, 
abilities needed to deal with complexity and uncertainty, and clinical skills (General 
Medical Council, 2017). Pharmacy has competencies that also fit into this dimension 
(Appendix A CAPE Outcomes 2.1, 2.3, 2.4, 3.2, 3.3, 4.2), but they cross several of the 
CAPE outcome domains and do not concretely link to one professional role as is seen in 
the medicine roles. 
Integration includes linking basic and clinical knowledge to other disciplines and 
managing uncertainty within the defined clinical setting and place in the physician’s or 
pharmacist’s career. This dimension occurs in CanMEDS Manager and Scholar roles 
(Frank et al., 2015), ACGME’s systems-based practice role (ACGME, 2017), and GMC’s 
health promotion/illness prevention and patient safety/quality improvement roles 
(General Medical Council, 2017). A CanMEDs Manager is a leader who engages with 
others to contribute to a vision of a high-quality healthcare system and takes 
responsibility for delivering excellent patient care through all activities. A scholar 
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demonstrates a life-long commitment to excellence in practice through continuous 
learning and teaching of others and contributions to scholarship (Frank et al., 2015). 
GMC also has a role related to research and scholarship defined in the same way but also 
adds a role related to education/training (General Medical Council, 2017). The definition 
of systems-based practice in the ACGME roles is the awareness of and responsiveness to 
a broader context and system of health care to provide optimal health care (ACGME, 
2017). In the GMC roles, health promotion and illness prevention related to health 
inequalities and social determinants of health such as income and social status, education, 
healthy behaviors, and access to health services and patient safety and quality 
improvement in compass capabilities of leadership/teamwork. Pharmacy does have 
competencies related to management and leadership (CAPE Outcomes 2.2 and 4.2) and 
competencies related to health promotion and patient safety (CAPE Outcomes 2.2 and 
2.3). Once again, the pharmacy competencies related to these roles cross outcome 
domains and do not concretely link to a specific pharmacist role. Pharmacy also does not 
have competencies that explicitly describe scholarship and systems-based practice, which 
are areas of weakness discussed in the pharmacy stakeholder literature. 
The relationship domain includes the communication skills, teamwork, and conflict-
management skills needed to form relationships within the healthcare domain as well as 
the patient and their families. CanMEDS has two roles related to this domain, 
communicator and collaborator (Frank et al., 2015). ACGME and GMC only have one 
role associated with this dimension interpersonal and communication skills and 
safeguarding vulnerable groups (ACGME, 2017; General Medical Council, 2017). The 
CanMEDS definition of a communicator is forming relationships with patients and their 
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families that allow the gathering and sharing of essential information needed for adequate 
health care. A collaborator is a physician that works effectively with other healthcare 
professionals to provide high-quality patient-centered care (Frank et al., 2015). 
ACGME’s domain, interpersonal, and communication skills are defined as skills that lead 
to the effective exchange of information with patients, families, and other healthcare 
professionals (ACGME, 2017). The GMC role is to safeguard vulnerable groups related 
to mental health, disabilities, human trafficking, and child and elder abuse (General 
Medical Council, 2017). Pharmacy does have a CAPE Outcome (3.6) related to 
communications and one related to interprofessional education (3.4) but does not have 
one explicated related to safeguarding vulnerable groups.  
The last dimension needed for professional competency is related to concepts around 
affective/moral attitudes, including emotional intelligence and ethics, consisting of the 
physicians’ and pharmacists’ ability to observe their emotional intelligence, curiosity, and 
willingness to acknowledge and correct errors. All three medical groups have roles 
related to professionalism or professional values, and ACGME adds a role related to 
practice-based learning and improvement (ACGME, 2017; Frank et al., 2015; General 
Medical Council, 2017). All three organizations define a professional similarly as one 
who is committed to the health and well-being of individuals and society through ethical 
practice, high personal standards of behavior, accountability to the profession, and 
maintenance of personal health (ACGME, 2017; Frank et al., 2015; General Medical 
Council, 2017). Pharmacy also has a similar competency (CAPE Outcome 4.4). The 
definition of ACGME’s role related to practice-based learning and improvement is 
evaluating the care of their patients, using scientific evidence, and improving patient care 
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based on constant self-evaluation and life-long learning. This role is covered in the 
pharmacy competencies as well under Outcome 4.1. 
These derived medical roles play an important part in the development of the 
medicine competencies statements used to drive pedagogy and assessment for medical 
education. All three of the medical organizations have developed competencies for each 
of the physician roles in their frameworks. A person achieving all the competencies for a 
given role is said to be “competent” in that area. For example, CanMeds defines five key 
competencies for the medical expert role. One of these competencies is “practice 
medicine within their defined scope of practice and expertise” (Frank et al., 2014, p. 10). 
The creation of assessments occurs from the enabling competencies that are under each 
of the five broader competencies. For example, under the competency just mentioned, 
there are six enabling competencies with one being “Integrate the CanMEDS Intrinsic 
Roles into their practice of medicine” (Frank et al., 2014, p. 10). Pharmacy has developed 
the competency statements similar to the three medical organizations but has never 
mapped these to a set of roles to ensure coverage of all roles that pharmacists should be 
competent in before graduation. This mapping of competencies to core roles would help 
ensure that all students are prepared for the same core roles upon graduation regardless of 
the school/college of pharmacy from which they graduated and would also allow the 
development of assessments to share among schools/colleges pharmacy. 
Assessment planning is a critical step to determine if students are practice-ready. 
It is crucial when setting up assessments to remember that competencies are 
developmental (Modi et al., 2015). Assessments also require appropriate comprehensive 
periodic reviews, use of multiple assessors, avoidance of assessment fatigue (both student 
66 
 
and faculty), and optimization of relationships between givers and receivers of formative 
feedback (Holmboe, Sherbion, Long, Swing, & Frank, 2010; Loackyer et al., 2017). The 
analogy used many times to describe competency assessment is a ladder where each rung 
is a level of competency (Modi et al., 2015). Medicine has defined the “ladder rungs” 
based on a student’s stage in their medical education (medical school, discipline-specific 
residency, and learning practice). The competency levels in medical school are medical 
school fundamentals and early clinical activity. Competency levels for residency are 
transitions to discipline, foundations of the discipline, and core of the discipline. Lastly, 
competency levels for learning in practice are transitions to practice and continuing 
professional development (Frank et al., 2014). While pharmacy has created 
competencies, it has not defined entrustment levels based on students' progress through 
their careers. It is hard to develop these assessments when pharmacy has not determined 
the core roles students should prepare for upon graduation as these are the starting point 
for a practitioner's growth.  
Just as discussed in the pharmacy education section, EPAs are a way to link 
competencies to clinical practice and determine if a student is ready for practice (Rekman 
et al., 2016). EPAs assess multiple competencies at one time in a holistic manner as they 
mimic actual physician and pharmacy practice. The EPAs also help link competencies to 
clinical practice because the EPAs are the tasks/activities that need accomplishment and 
competencies are the knowledge and skills required to do the EPA (Englander et al., 
2016; Rekman et al., 2016). Some examples of the 13 EPAs from medicine include 
gathering a history and performing a physical examination, prioritizing a differential 
diagnosis following a clinical encounter, and recommending and interpreting standard 
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diagnostic and screening tests. For performance activities like entrustable professional 
activities to be useful, one needs to map the EPA's competencies and set the entrustment 
level required for each stage of training (Modi et al., 2015). Medicine has created such a 
mapping with their roles mapped to EPAs competencies with defined entrustment levels 
for a particular time in a student’s learning career (medical school, residency). Pharmacy 
has developed a set of EPAs (Appendix B), which map to the CAPE Outcomes (Table 1, 
p.46). However, pharmacy has not created agreed-upon levels of entrustment for each 
EPA, making it hard to share assessment data between programs. 
 The core EPAs developed in medicine were designed to be minimum standards 
for schools/colleges, and then schools/colleges could add on to them as needed for their 
specific programs. The Association of the American Medical Colleges initially drafted 
the EPAs for residency, but medical schools are being encouraged to use them. There are 
several arguments for not using EPAs in undergraduate medical education. One argument 
is whether workplace activities are an appropriate framework for medical school 
outcomes and does entrustment apply to students. Another argument is that pre-clerkship 
learning is knowledge-focused, and workplace assessments such as EPAs do not fit. The 
case for the use of EPAs during medical school is that schools need to incorporate 
workplace learning and assessment earlier in the curricula to help students develop their 
professional identity. Clinical curricula with early clinical experiences vertically 
integrated and having increased clinical responsibilities over time help improve the 
clinical abilities of graduates (Chen, van den Broek, & ten Cate, 2015). The literature 
suggests that medical students should reach the level of indirect supervision (EPA level 
3=without a supervisor's physical presence but quickly available) upon graduation from 
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medical school. Medical schools feel that there must be a defined body of evidence to 
support the entrustment decisions, and workplace-based evidence is essential. 
Assessment tools are still lacking in this area. The pilot schools did feel the core EPAs 
were an excellent framework. However, work is still needed on assessment development 
and having space for authentic student work-place participation such as clinical 
experiences while working on didactic portions of the curriculum in medical school 
(Lomis et al., 2017). Pharmacy is having the same discussion about using the EPAs 
during pharmacy school, but the same thoughts apply to the need to incorporate clinical 
experiences earlier in the curricula as is required in the accreditation standards (ACPE, 
2015).  
Despite the widespread use of medical EPAs, there are some concerns about their 
use. Criticisms of the medical EPAs include:  not being real discrete, being single-
encounter based medical tasks, and sounding more like objectives than tasks. Some feel 
that the EPAs push professionalism, communicating with patients, and delivering quality 
patient care to the background, and they do not do enough to interconnect the capabilities 
to be a physician. There is also a fear that the EPA-based system has not increased 
medical educators' capacity to make reliable ratings or valid judgments. EPAs still direct 
too much attention to ordinary and technical skills. There are several recommendations to 
address some of these issues. One proposal is to create a hybrid model that combines the 
EPAs and competencies. Another suggestion is to develop a single set of descriptors 
covering the full range from beginner to master long-term practitioner. EPAs are an area 
of continued debate and research as the EPAs' usage is just starting in undergraduate 
medical education (Krupat, 2018).  
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EPA usage in pharmacy education is a newer concept, yet many of the same 
discussions in medicine are occurring in pharmacy. The most significant debate in 
pharmacy currently is the level of entrustment that students should be achieving and the 
best methods of assessments for EPAs (VanLangen, 2019). Solutions to these debates 
will be hard to determine until pharmacy has a core set of roles that all students need 
preparing for upon graduation. Mapping of competencies and EPAs to these roles is one 
way to help schools/colleges better define assessments and levels of entrustment to 
ensure students are practice-ready upon graduation. The other thing that mapping to a 
core set of roles would do would be to help identify gaps (if any) in the current pharmacy 
competencies and EPAs.  
Elements Missing From Pharmacy Education Outcomes and Assessments 
Pharmacy has created competencies and EPAs like medicine (Haines et al., 2017; 
Medina et al., 2013), but because there is no defined set of core roles that pharmacists 
should be able to do, there is no way to ensure all the competencies and EPAs needed to 
ensure student practice-readiness upon graduation as listed. The inability to know if the 
current competency/EPA list is all-inclusive limits pharmacy's ability to begin the move 
to full competency-based education, as seen in other health professions. One of the 
biggest benefits of competency-based education is the ability to ensure all students have 
the same baseline level of skills upon graduation due to the definition of consistent 
competencies and assessment milestones that all students would need to meet before 
graduation. Competency-based education allows students to achieve competencies at 
their own pace as opposed to relying solely on the passage of time (i.e., just because you 
move from one professional year to another because you passed all courses does not 
mean you meet all competencies). However, pharmacy is far from moving to full 
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competency-based education due to multiple factors. One factor is assigning experiential 
rotations when current state laws dictate a maximum level of students per preceptor. 
Schools may not have enough preceptors available with the move to full competency-
based education, depending on how fast or slow students are moving through the 
curriculum (Medina, 2017). 
Another problem is how to handle faculty workload and assessments when the 
number of students is not consistent moving through the curriculum and how to handle 
lock-step curricula that require students to move from one course to another in a specific 
order. Lastly, opponents of competency-based education fear that this move would mean 
more emphasis on skills and less on the knowledge. This emphasis on skills could be a 
problem in a content-heavy profession like pharmacy, thus moving pharmacists back to 
the product-centered role as oppose to the patient-centered role (Medina, 2017). One way 
to ensure pharmacy is developing competencies that would allow pharmacists to continue 
to focus on patients instead of the product is to build competencies similar to other 
healthcare professions.  
Englander et al. (2013) conducted a review of the different competence domains 
developed for any health care professional to extract a standard set of competencies for 
use by all health professions to aid in interprofessional education. The ACGME list of six 
domains and 36 competencies was the starting reference list for the comparison. After 
reviewing other professions, the addition of two different domains occurred along with 
12 additional competencies. Comparison of the list of 48 competencies to the 153 
competency lists from across all medical education, including nursing, pharmacy, 
chiropractic, optometry, public health, physician assistants, dentistry, and veterinary 
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medicine, occurred. Englander et al. resulted in a final set of 8 domains of competency 
that could serve as a template for any health profession’s development of a competency 
list. 
The eight competency domains include patient care, knowledge for practice, practice-
based learning and improvement, interpersonal and communication skills, 
professionalism, systems-based practice, interprofessional collaboration, and personal 
and professional development. Comparing the pharmacy competencies to the Englander 
list shows most of the competencies are within the CAPE 2013 outcomes just under 
different competency headings (Englander et al., 2013). There are, however, some areas 
missing in the pharmacy competencies, including transitions of care and providing role 
modeling as well as specifics related to handling difficult conversations, uncertain 
situations, conflict management, and stress management. The broad competency domain 
of “systems-based practice” is not as well developed in the pharmacy competencies 
either. The “systems-based practice” is one area that pharmacy needs to make more 
explicit in the competencies and EPAs as there are only one competency and one broad 
EPA dedicated to this area (Englander et al., 2013).  
 Pharmacy used a consensus process to develop the pharmacy EPAs and 
conducted a face validity study, but the face validity study occurred with preceptors that 
were mainly involved in patient care (Haines et al., 2018). However, to date, no one has 
done studies looking at the EPAs' face validity using non-preceptors and nonpatient care 
providers. The survey only asked about the currently written EPAs; it did not ask if they 
thought any components of the pharmacist role were missing. Only one published study 
conducted to date has looked at the use of the EPAs in practice, and this study found that 
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the EPAs were not good at measuring leadership skills, developmental planning, and 
practice management skills (Moon et al., 2018). The EPAs need reviewing to determine if 
there is a need for additional EPAs in these areas as they are critical areas for the 
pharmacist's role given many student pharmacists practice in community settings where 
they will manage pharmacies and lead people. There have also been no studies to date 
that have tried to define the roles that student pharmacists should prepare for upon 
graduation. Without a standard set of roles, similar to medicine, how does pharmacy 
know that the current competencies and EPAs created are complete and prepare students 
for 21st-century practice and beyond? 
Theory of Learning In a Supercomplex World 
The theory of learning in a supercomplex world is one theory to use to transform 
pharmacy education (Barnett, 2000a). This theory stems from the undergraduate higher 
education literature and seeks to explain how learning changes based on how society 
perceives the world:  complex or supercomplex (Barnett, 2000a). A complex world is one 
where handling of facts, data, evidence, tasks, and arguments occur within a framework 
known by the person (Barnett, 2000a). The complexity arises when demands exceed the 
resources needed to meet them, which leads to an overload of data. These situations can 
lead to stress and challenges, but the circumstances are manageable with added resources 
such as additional people or additional ways to manage data (Barnett, 2000b). In a 
complex world, clearly and fundamentally identifiable problems occur even if a clear 
solution is not immediately seen (Bengtsen, 2017). For example, in a complex healthcare 
world, patients' disease states were treated without regard to a patient’s social or cultural 
traits, so a healthcare professional only had to think within their professional knowledge 
scope to diagnose and treat a patient (Leadbeatter & Peck, 2017).  
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 In contrast, in a supercomplex world, data overload is not manageable by merely 
adding more resources, and problems are not as identifiable. This lack of manageability 
and problem identification is because a supercomplex world leads to challenges in our 
known frameworks due to knowledge and skills continually changing (Barnett, 2000a, 
2000b). This conceptual overload leads to challengability, uncertainty, and 
unpredictability (Barnett, 2000b). One needs to continually learn new knowledge and/or 
adapt to evolving environments. For example, research telling practitioners what 
influences different health conditions in patients continuously updates, and a practitioner 
needs to be able to keep up with this new information and integrate it into their practice 
(Leadbeatter & Peck, 2017). The ability to keep up with and incorporate further 
knowledge into practice takes a different teaching and assessment type to prepare 
students to learn in this type of ever-changing world. 
It is important to remember that in a supercomplex world, the knowledge/skills 
that one develops in school will become irrelevant over time and need to be transportable 
from one situation to another, so one needs to create continuous learning skills (Barnett, 
2000b; Bengtsen, 2017). To help students develop these skills, learners need to discover 
how they learn, what to do when they encounter strange things, how to engage others, 
control their learning, manage their personal growth, and listen. Educators must be 
willing to stretch students out of their comfort zones (force students to face perspectives 
different from their own), place students in situations of cognitive and experiential 
complexity, and encourage students to engage each other in different points of view to 
help them develop these necessary skills (Barnett, 2011; Bengtsen, 2017). Curricula also 
need to take on three components:  knowing, action/skills, and self-identity/attitude 
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(Barnett, 2000a). These ideas are essential for creating pedagogies in healthcare 
education that help a student become more self-aware and develop good professional 
attitudes and the knowledge/skills needed for their profession (Bengtsen, 2017). A more 
standardized definition of pharmacy roles upon graduation with competencies and 
assessment EPAs aligned to them would help ensure that all students meet the same 
minimal standards to be ready for supercomplex healthcare practice regardless of the 
pharmacy program. 
Study Purpose and Potential Implications to Practice and Research 
Unlike medicine, pharmacy has not created a minimum set of roles that all 
pharmacists should be competent in regardless of practice setting. This lack of roles 
makes it hard to determine a set of competencies and EPA statements to ensure that all 
students are ready for pharmacy practice as a generalist upon graduation. Currently, 
schools/colleges of pharmacy use the current competency and EPA statements in various 
ways depending on the pharmacy program's mission and goals. These different usages 
mean that students are prepared differently for practice depending on where they 
graduate. These differences also make it hard for schools/colleges to compare pedagogies 
and methods of assessment. Answering the research questions for this study will provide 
a minimal set of roles that students should be competent in upon graduation. This 
research will also help to align the current competencies and EPAs along with levels of 
entrustment that can be used by all schools/colleges of pharmacy.  
This research will have an impact on pharmacy education and pharmacy practice in 
several ways. Development of pharmacists’ roles for practice-readiness will help ensure 
that all pharmacy school graduates possess the same minimal level of competence in 
knowledge, skills, and attitudes upon graduation needed to function in both today’s 
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healthcare environment and the future. Creating a standard set of roles and definitions of 
these roles will help move the pharmacy profession forward as the profession continues 
to expand its role on the healthcare team as the defined roles will help identify what the 
profession can do. Pharmacy, however, will need to be careful setting up these roles as 
they may intrude on other professional jurisdictions such as medicine and nursing.  
Professional jurisdiction is the link between a profession and its work, which can be 
attacked by other professions. Jurisdiction occurs when a profession takes control of a 
problem. Most of the time, professions do not have full control of a problem but may split 
control (i.e., law and accounting over tax practices in the US). One profession may also 
be subordinate to the other and have a limited sphere of control over the problem (i.e., 
physician assistants and physicians). Other professions have advisory jurisdiction where a 
profession offers advice or partial services to clients of other professions (i.e., pharmacy 
and medicine). Still, others have limited jurisdiction where the profession cannot provide 
full control but does have control over a piece of the problem (i.e., psychiatry in 
medicine). Pharmacy is currently seeking to change its jurisdiction into more of a limited 
jurisdiction model as opposed to an advisory model (Abbott, 1986). Driving this change 
in jurisdiction is the change in healthcare discussed earlier. Pharmacy needs to be aware 
of the jurisdictional lines that may need to be adjusted when the roles are created and 
ensure there is buy-in for these roles, not just from within the profession but also outside. 
To have these conversations, pharmacy needs to first decide on what roles it wants to 
undertake.  
Having minimal EPA levels that are consistently agreed upon by the profession 
may also affect pharmacy education. It would allow schools/colleges of pharmacy to 
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specialize by requiring higher EPA attainment levels before graduation or adding 
additional specialty EPAs that are program-specific. The concept of having competencies 
with minimum requirements of attainment for all programs that still allows schools to 
specialize is not new. This concept is consistent with the concepts discussed in the degree 
qualifications profile by the Lumina Foundation. This profile defines what degree 
recipients should minimally be able to do at each degree level in non-professional schools 
independent of the field of study. The profile allows proficiencies to be weighted and 
shaped differently according to an institution or program’s mission and priorities (termed 
spider webbing). The key is that each spider web contains all proficiencies, just maybe a 
different degree of focus or emphasis in one area over another. The profile also allows 
schools to add proficiencies as needed (Lumina Foundation, 2014). Creating a set of roles 
for pharmacy students would work similarly in schools/colleges as the Degree Profile. 
Schools/colleges could emphasize areas differently or add competencies/EPAs following 
their mission/goals as long as the minimum roles' achievement still occurs.  
Results from this study will also have an impact on pharmacy research. One area of 
research is the types of assessments that will be useful to determine students have met the 
appropriate level of EPAs as well as other assessments that may be required to ensure 
that students are meeting the full definition of each role. Pharmacy will need to look for 
ways to ensure that assessments are holistic and review students across the curriculum 
and not just at one point in time. Arising will also be a need to develop pedagogies 
appropriate to teach students how to achieve the competencies and EPAs associated with 
each role. Lastly, more research may be needed on the current competencies/EPAs or the 
way pharmacy assesses entrustment, especially if a consensus is achieved on pharmacists' 
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roles but not on the competency/EPA mapping and/or the entrustment attainment levels. 
The lack of agreement would signal the need for more research on the 
competencies/EPAs and levels of entrustment.  
Currently, pharmacy has developed a set of competencies and EPAs with the EPAs 
being a new addition to pharmacy. Schools/colleges are currently working to find ways to 
incorporate EPAs into their assessment plans. However, with this lack of role definition, 
how the competencies and EPAs are incorporated, and the level of EPA attainment is 
different across programs. This lack of standardization may lead to students being 
prepared differently for practice depending on where they choose to attend school and 




CHAPTER 3:  METHODS         
The purpose of this project is to investigate the extent to which a consensus exists 
among pharmacy professionals regarding core practice-ready roles for graduates that 
align with pharmacy competencies and EPA statements, with levels of entrustment. A 
multiphase mixed-methods experimental design with two phases (Creswell & Clark, 
2011) is selected for the study methodology. A multiphase mixed-methods design uses a 
series of sequentially aligned studies (data building from one study to another) that 
require collecting a combination of quantitative and qualitative data. A multiphase mixed 
methods design works well for the research questions in this study as the three questions 
are all centered around the same broad objective: Exploring the development of graduate 
core practice-ready roles aligned to competencies and EPAs with levels of entrustment. 
Empirical findings have the potential to contribute to the development of school/college 
pedagogies and assessments to ensure all students are practice-ready upon graduation. 
This project will use an embedded mixed-method design for both phases. The 
difference in the two phases will be which data type is dominant and supporting 
(Creswell & Clark, 2011). The first phase will address Research Question One, 
developing a set of core roles that define what student pharmacists should prepare to do 
upon graduation. In Phase One, the qualitative data collection occurs via a nominal group 
technique on the strengths and modifications needed on a core role proposal (discussed in 
detail later) provided to the study participants. Quantitative data is supportive because the
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nominal group participants rate the importance of the strengths and modifications 
discussed (Creswell & Clark, 2011). Phase Two will use the final core roles created in 
Phase One to answer Research Questions Two (alignment of competencies and EPAs) 
and Three (setting the level of entrustment) with simultaneous quantitative and 
qualitative data collection occurring using a cross-sectional survey. In this phase, the 
qualitative data (constructed-response questions) are supportive of the quantitative data 
(selected-response questions; Creswell & Clark, 2011). For example, if one of the core 
roles were Patient Care skills, panelists would be asked their level of agreement regarding 
the competency “Provide-patient-centered care as the medication expert” (Medina et al., 
2013, p. 3-4) maps to this role. After completing Phases One and Two, the data to all 
three research questions will tie to the broad objective of exploring the development of 
graduate core practice-ready roles aligned to competencies and EPAs with levels of 
entrustment.  
There are multiple advantages to using a multiphase mixed-method design in this 
study. First, the design offers the ability to address interconnected research questions that 
require the collection of both qualitative and quantitative data to answer, such as the ones 
proposed in this study. Research Question One will provide the roles for which the 
pharmacy competencies and EPAs align in Research Questions Two and Three. Another 
advantage is the ability to collect rich and comprehensive data since both phases will 
collect quantitative and qualitative data. Using both data types allows for the collection of 
participants' thoughts and feelings regarding the topics while still providing numeric 
values that can be mathematically analyzed (Creswell & Clark, 2011). Another advantage 
is the ability to analyze and report Phase One findings while completing Phase Two of 
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the study due to the phases' autonomous nature and methodologies (Creswell & Clark, 
2011). This project's studies loosely connect as the answers to the three research 
questions are needed to fully explore the development of practice roles aligned to 
competencies and EPAs with levels of entrustment to ensure that pharmacy graduates are 
practice-ready.  
Research Questions 
This project will answer the following research questions: 
1. What are the core professional roles that pharmacy programs feel should be 
demonstrated by graduating student pharmacists?  
2. According to pharmacy practitioners, what is the alignment of the current 
pharmacy competencies and entrustable professional activities (EPAs) to the core 
professional roles?    
3. According to pharmacy practitioners, what level of entrustment should pharmacy 
graduates be expected to achieve for each EPA?     
General Methodology 
This two-phase mixed methods study will use a different consensus development 
technique for each phase (two in total; Delbecq et al., 1975). The use of consensus 
development techniques is preferred for this study, given the research questions' 
subjective nature. All three research questions require a combination of subjective 
judgments from multiple people to form one agreed-upon answer (Delbecq et al., 1975). 
The choice of two different consensus techniques for this study was due to the types of 
data, group sizes, and anonymity needed for the various research questions. Phase One 
(Research Question One) will use the nominal group technique (NGT), which allows for 
the collection of qualitative data as the primary data type using quantitative data to 
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support the final group decision. Phase Two (Research Questions Two and Three) will 
use the Delphi technique, which allows for surveys to collect quantitative data with 
qualitative data as explanations for why specific ratings were selected (Delbecq et al., 
1975). A more detailed discussion follows for each methodology used for the research 
questions. 
Research Question One 
The first research question is: What are the core professional roles that pharmacy 
programs feel should be demonstrated by graduating student pharmacists?  Research 
Question One will use the NGT for proposal review process developed by Delbecq et al. 
(1975). This NGT method offers a framework for gathering stakeholder data on topics 
that are complex and call for aggregation of individual judgments, such as the 
development of a set of core roles that define what student pharmacists should prepare to 
do upon graduation (Research Question One; Delbecq et al., 1975). The NGT proposal 
review process allows a group of 6-7 experts to review a set of proposed core roles that 
student pharmacists should prepare to do upon graduation (core role proposal) to provide 
a group consensus on the strengths and modifications needed to improve the core roles 
(Delbecq et al., 1975). With the complexity and amount of background literature for 
review regarding the creation of the proposed core roles, it made sense to provide a group 
of experts with a draft copy of the core roles derived from the existing pharmacy 
competencies/EPAs and medical literature to stimulate the constructive formation of a 
final set of core roles.  
The NGT for proposal review process is conducted in four key stages and 
typically occurs during a single scheduled meeting: silent generation, round-robin, 
clarification, and voting (usually done by ranking or rating; Delbecq et al., 1975). The use 
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of the NGT review process via an internet conference call with an outside facilitator 
(someone not involved in the research project) will ensure all experts can provide input 
into the core roles and ensures no one person dominates the conversation as each group 
member provides input one at a time. This process will also allow experts to react to each 
other’s ideas, leading to better quality and quantity of ideas, which is essential when 
developing a set of core roles for pharmacy practice (Linstone & Turoff, 1975). The 
group's ideas regarding the core pharmacy roles will be written down and voted on by the 
participants per the NGT proposal review process rules. By the end of the conference, 
call a set of core roles that define what student pharmacists should prepare to do upon 
graduation will occur. 
NGT has been used in multiple disciplines (e.g., social sciences) to conduct 
exploratory research (i.e., to help develop questions for survey and interview field 
research), allow citizen participation in decisions (i.e., collect information on the design 
of new products or services), allow multidisciplinary experts to participate in decision 
making (i.e., to provide solutions to complex problems), and to review proposals (i.e., 
new policies and procedures; Delbecq et al., 1975). The usage of this method also occurs 
in pharmacy. It is most often used to generate evidence-based guidelines, inform practice 
changes, and identify attributes to include when interviewing student pharmacists 
(Johnson & Traynor, 2018; Kennie-Kaulbach et al., 2012; McMillan et al., 2016). The 
NGT process is best for Phase One of this project as it will allow aggregation of 
individual expert judgments on the development of a set of core roles that define what 
student pharmacists should prepare to do upon graduation (Research Question One) 
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through the four phases of the process:  silent generation, round-robin, clarification, and 
voting (Delbecq et al., 1975). 
A purposeful sampling of 6-7 pharmacy faculty and administrators that have 
researched the areas of practice-readiness, pharmacy competencies, and EPAs will form 
the expert panel of participants for the NGT process. The sample size for NGT is usually 
between 2-14, with a maximum of seven being recommended (McMillan et al., 2016). 
The use of purposeful sampling is due to the need to select faculty/administrators that 
have done work in practice-readiness to ensure the panel had the necessary knowledge to 
form the roles. Deans of four pharmacy programs, three large-research intensive four-
year pharmacy programs, and one smaller three-year teaching-intensive pharmacy 
program will select the panelists. These programs will participate as they have faculty 
who have done extensive research in pharmacy competencies and EPAs.  
Silent generation. The purpose of silent generation, the first step in the NGT process, 
is to provide adequate time for panelists to reflect on the core role proposal with no 
interruptions (Delbecq et al., 1975). During this part of the process, panelists write down 
strengths and potential modifications of the core role proposal without editing their 
thoughts (stream of thought). Usually, the silent generation process occurs in the first part 
of the live NGT meeting, but due to the complexity of the core role proposal to answer 
Research Question One, a slight modification has occurred in this part of the process. 
Rather than silent generation occurring at the start of the live meeting, panelists will 
receive the proposal (core pharmacy roles and role definitions), an explanation of 
proposal creation, the purpose of the proposal review, and worksheets on which to take 
notes regarding the strengths and modifications needed on the proposed core roles and 
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their definitions a day or two before the scheduled meeting. Before starting the NGT 
proposal review process, I will write a proposed set of core roles and role definitions 
based on published medical roles, literature review, and current pharmacy competencies 
from Chapter 2 (Appendices A and B). The ability to complete the silent generation 
process before the initial meeting will allow panelists in this study to more thoroughly 
review the core roles/definitions and carefully think through strengths and modifications 
given the proposal’s complexity as there would be less of a time constraint (Delbecq et 
al., 1975).  
Round-robin. The second stage of the NGT proposal review process is a two-part 
round-robin and will be the first stage conducted during the live conference call. The 
purpose of this 30-45-minute session is to record the strengths and modifications that 
each panelist generated for the core role proposal during the silent generation step. For 
this study, the round-robin will occur via video conference due to panelists' locations 
throughout the country. In the NGT proposal review process, the round-robin occurs in 
two parts: a review of the proposal strengths and then a discussion of proposed 
modifications to strengthen the proposal (Delbecq et al., 1975). During the round-robin, 
each panelist provides their thoughts about the strengths or proposal modifications one at 
a time in an organized fashion. A MS Word document, visible to the panelists through the 
video conferencing system, will be used to write down the proposed strengths and 
modifications generated during the robin-round process (Delbecq et al., 1975).  
In Part One, panelists will provide ideas related to the proposed core roles and 
role definitions' strengths. There are several benefits to this approach, such as allowing 
for equal participation of all members, depersonalizing the strengths (separating ideas 
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from the person who provided them since the strengths are written down and shared as a 
whole), and encouraging members to build off strengths already presented. Starting with 
a discussion of the strengths of the core role proposal, it avoids the usual problem seen in 
proposal reviews of focusing strictly on the proposal's negative aspects. Starting with the 
strengths also helps determine if modifications provided later during the modification 
discussion will lower the core role proposal's power. Identifying the strengths will also 
help ensure core roles are not removed, which would weaken the final proposed set of 
core roles. Panelists continue to give strengths one at a time until all panelists have 
exhausted their ideas (seen when all members have “passed” when it is their turn). This 
portion of the process is a free flow of ideas to ensure the generation of all proposal 
strengths for the clarification and voting steps (Delbecq et al., 1975).  
During Part Two, panelists will provide ideas related to modifications to improve 
the proposed core roles and role definitions. The same benefits from the strengths apply 
to the modifications, such as allowing for equal participation, depersonalizing the 
modifications, and encouraging members to build off modifications already presented. 
Panelists continue to give modifications one at a time until all panelists have exhausted 
their ideas. This portion of the process is once again a free flow of ideas to ensure the 
generation of all modifications of the core role proposal for the clarification and voting 
steps (Delbecq et al., 1975). These modifications will occur to make changes in the final 
set of core roles and their definitions. The purpose of the discussion is to point out 
criticism of the core role proposal and provide solutions for the critiques (different roles, 
different role definitions), thus making the proposal stronger. The NGT proposal review 
process, as described starting with defining the strengths of the draft core roles and then 
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moving on to changes, will help to ensure a collegial discussion when discussing the core 
roles and role definitions. The round-robin step provides the data for the next step, 
clarification.  
Clarification. The clarification stage elicits clarity on each strength and modification. 
During the clarification stage of the conference call (about 30 minutes), discussion of the 
core role proposal’s strengths and modifications developed during the round-robin phase 
occurs to clarify any statements, allow questions about any of the statements, and/or 
provide (dis)agreements for any of the statements. During this section, panelists can 
convey the logic behind any strength or modification added to the list, as well as reasons 
they felt the item was essential to add. During this section, it will be necessary to ensure a 
balanced amount of time spent reviewing each strength and modification to ensure that a 
review of all strengths and modifications occurs (Delbecq et al., 1975). Once the 
discussion of both the strength and modifications lists occurs, the group is ready for the 
preliminary voting stage to determine which proposal strengths and modifications are the 
most important to the panelists. 
Voting. The purpose of the preliminary voting stage is to determine how strongly 
each panelist feels about a strength or modification of the core role proposal from the 
clarification phase using a numeric rating method. Aggregation of the individual 
panelists’ numeric ratings occurs to determine a final single rating for a core role 
proposal strength or core role proposal modification. For example, if there were three 
panelists and they rated the role proposal strength of “covers all pharmacy roles” on a 
scale of 0-100 as 50, 70, and 90, the final importance rating for this strength would be 70 
(average of all three). Panelists will first rank all items on the core role proposal strength 
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list from the clarification stage then the core role proposal modification list. This stage 
will take place on the conference call immediately after the clarification phase and last 
about 15 minutes (Delbecq et al., 1975).  
For this study, a rating procedure will be used for voting since panelists will be 
participating via video conference call. Panelists will first rate the items via a Microsoft 
Form, on the core role proposal strength list from the clarification step via a scale of 0-
100, then on the role proposal modification list on the same scale. A rating of zero would 
be assigned to items the panelist feels is the weakest of the strengths (e.g., the panelist 
may feel that have six roles is not as strong of strength as the roles covering all areas of 
practice)  or the lowest priority modification, and 100 would be the item the panelist feels 
is the most robust strength or the highest priority modification. I will average the 
individual panelist’s ratings for each strength while the group works on rating the list of 
modifications on a separate Microsoft Form. After panelists have completed their role 
modification ratings, computation of an average rating score will occur for each 
modification like the strengths. Once the preliminary voting finishes, there will be two 
lists. One list will contain the average ratings for all the core role proposal strengths, and 
one list will be the average ratings for all the potential modifications for the core roles. 
After the preliminary voting finishes, the facilitator will have the panelists take 
about 20 minutes to review the average ratings for the core role proposal strengths and 
core role proposal modifications. The purpose of the discussion is to review any strengths 
or modifications that receive ratings that are outliers (e.g., if the averages on five out of 
the six strengths are 50-70 and the six strengths is a 10, discussion of this strength would 
occur). The purpose of this discussion is to ensure that all panelists understand why the 
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strength or modification discussed was added to the list and what it means before a final 
vote occurs. The discussion is to ensure no misunderstandings of the strengths or 
modifications that could influence the voting. This discussion is shorter than the initial 
clarification section. It may not be needed if the ratings for the strengths and 
modifications during the preliminary voting do not have any outliers. For this study, the 
group will not only review the results of the voting but will also set the cut-off limit to 
make modifications to the preliminary core role proposal (i.e., changes in the roles will 
only occur for modifications with a rating of >60 points) before the final voting.  
Once the preliminary strength and modification voting and a discussion occur, the 
list of core role proposal strengths and core role proposal modifications will be once 
again sent to the panelists via email for a final vote. The use of the same rating method 
from the preliminary vote occurs where each panelist will once again rate their feelings 
regarding the importance of each core role proposal strength and core role proposal 
modification on a scale of 0-100 via Microsoft Forms (Delbecq et al., 1975). Once 
complete, the final mean ratings for each core role proposal strength and each core role 
proposal modification will occur with the group and take no more than 10 minutes. I will 
use the final list of core role proposal strengths and core role proposal modifications to 
create the final set of core roles that student pharmacists should prepare to do upon 
graduation (Research Question One). This set of roles will form the basis for the survey 
used in Phase Two (Research Questions Two and Three). 
Research Questions Two and Three 
Research Questions Two and Three are:   
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• According to pharmacy practitioners, what is the alignment of the current 
pharmacy competencies and entrustable professional activities (EPAs) to 
the core professional roles?;  
• According to pharmacy practitioners, what level of entrustment should 
pharmacy graduates be expected to achieve for each EPA?  
These two research questions will occur using the Delphi technique to collect quantitative 
and qualitative data simultaneously (Delbecq et al., 1975). Like the NGT process, the 
Delphi technique offers a framework for gathering stakeholder data on topics that call for 
aggregation of individual judgments such as Research Questions Two and Three. One big 
difference between the NGT process and the Delphi technique is that the Delphi allows 
for the collection of data via multiple rounds of surveys instead of a live discussion. The 
Rand Corporation developed the Delphi approach in 1953 during the Cold War to 
forecast the impact of technology on warfare. Since then, the technique has expanded to 
forecasting and policymaking and guideline development (Linstone & Turoff, 1975). The 
Delphi technique has been used in pharmacy to forecast the future of hospital pharmacy 
and to gain consensus on indicators for prescribing appropriateness, criteria for safety 
features, clinically significant interactions, and different aspects of student education 
(Johnson & Traynor, 2018; Kennie-Kaulbach et al., 2012; McMillan et al., 2016). The 
Delphi approach's general method is a multistage self-completed survey (Delbecq et al., 
1975). The Delphi method is useful for this study as it a way to aggregate the judgments 
of numerous (40-50) individuals to gather consensus around the mapping of 
competencies and EPAs to the core roles (Research Question Two) and the assignment of 
levels of EPA entrustment (Research Question Three; Delbecq et al., 1975).  
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Research Questions Two and Three seek to examine if there is a broad consensus 
from different pharmacy practices on the competency/EPAs (Research Question Two) 
mapped to the core roles developed in Research Question One and assign levels of 
entrustment to each EPA (Research Question Three). A larger, more diverse group of 
pharmacists (i.e., around 40-to 50 with multiple different types of pharmacy practice, 
different times since graduation, various interactions with student pharmacists) is needed 
for this consensus to ensure as many areas of pharmacy have a chance to review the 
mappings and levels of entrustment. The anonymity provided by the Delphi survey 
process is also crucial as it allows everyone to provide their opinion regarding the 
mapping and levels of entrustment without feeling pressured to give a particular answer 
as the surveys are conducted individually with no discussion among the participants 
(Linstone & Turoff, 1975). The lack of pressure to provide a specific answer is essential, 
given the lack of consensus currently related to levels of entrustment (VanLangen et al., 
2019). By the end of the Delphi process, an exploratory mapping of the current pharmacy 
competencies and EPAs to the roles defined in Research Question One, along with a level 
of entrustment for each EPA, will have occurred.  
Within this study, a panel of 40-50 pharmacists from a variety of different 
pharmacy disciplines, including, for example, community, institution, clinical, and 
academia, will review the proposed mappings and levels of entrustment. The suggested 
panelist size for a Delphi process is seven, but sizes can range from 4-3000 depending on 
the project's needs. The size needs to be determined by the qualities required on the panel 
more than size. (Linstone, 1978). A purposeful, non-randomized sample procedure will 
occur to select participants in the Delphi panel to ensure consensus from as many 
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pharmacy practice areas and years in practice (minimum of one year). Panelists from the 
NGT group in Research Question One will provide a list of 5-10 people via a Microsoft 
form. The form will collect the Delphi participant's name, pharmacy degree, practice site, 
year of graduation from pharmacy school, and email. NGT participants need to ensure 
that participants chosen come from a variety of different pharmacy disciplines (ensure at 
least three disciplines are covered in the list) and from different years of experience (at 
least one participant in each time-frame since graduation [1-5 years, 6-10, 11-15, >15]). 
A non-randomized sample is best to use in this study as participants in the Delphi process 
need to be from various pharmacy disciplines and years of experience to ensure 
representation from as many areas of pharmacy practice in the sample as possible. There 
is potential for bias and for not including all potential views given the study's non-
random nature. Minimization of this bias occurs through the use of various 
schools/colleges of pharmacy and different regions of the country to draw the sample.  
This approach's general method is a multistage self-completed survey (ies; Delbecq et 
al., 1975). Data previously gathered in Phase One will be used to develop the survey 
instrument in this investigation. Specifically, I will map the current pharmacy 
competencies/EPAs to the set of core roles created during the NGT process (Research 
Question One) and assign a level of entrustment for each EPA. The mapped 
competencies/EPAs and levels of entrustment will form the individual survey questions 
for the Delphi process, where participants will rate their level of agreement with the 
mapping as well as the level of entrustment on a 4-point Likert scale. Participants will 
receive a constructed-response box for each question to explain if they disagreed with a 
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mapping or level of entrustment. A more formal description of the survey questions 
follows in the Round 1 discussion. 
Surveys for all rounds will be sent out based on the Tailored Survey Design process 
(Dillman, Smyth, & Christian., 2014). For each Delphi round in this study, sending an 
initial email will occur with the instructions and the survey link. A reminder email will be 
sent weekly for a total of three emails (each round will be open for a total of 3 weeks). 
Emails will be sent before the start of the workday as studies have shown that people are 
more likely to respond to surveys sent early in their workday before their day gets too 
busy (Dillman et al., 2014). 
Round 1. In round 1, the Delphi questionaries will comprise selected- and 
constructed-response questions to gather data on stakeholders’ consensus on the 
competency/EPA mappings and levels of entrustment. Each Delphi participant (panelist) 
will rate their level of agreement with each competency and EPA role aligned to the roles 
from Research Question One using a 4-point Likert scale from 1 (Strongly Disagree) to 4 
(Strongly Agree). For example, if one of the roles were Patient Care skills, panelists 
would be asked if they agree or disagree that the competency “Provide-patient-centered 
care as the medication expert” (Medina et al., 2013, p. 3-4) and its associated EPAs map 
to this role. Panelists will also be asked in a separate question to rate their agreement with 
the level of entrustment before graduation they feel a student should achieve for the 
specific mapped EPA using the same Likert scale. Entrustment is defined as the level one 
can trust someone to complete a task (e.g., take a patient’s medication history). Level 1 
entrustment suggests a student can observe but not complete a particular task. For 
example, a student may observe the pharmacist do a patient's medication history, but the 
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student is not yet ready to do the history themselves. Level 2 is execution with direct and 
proactive supervision. For this level, the student will perform the medication history, but 
the pharmacist is in the room and can provide advice or add in missing pieces to the 
history if needed. Level 3 is performance with reactive supervision (quickly available). 
At this level, the student will perform the medication history alone with the pharmacist in 
the next room quickly available should help be needed. Level 4 is execution with 
supervision from a distance or when asked for by the student. For this level, the student is 
performing the medication history without a pharmacist in the nearby room or even 
building. The student can be freely trusted to perform the history without any help unless 
he/she asks for it. Level 5 is the ability to teach someone else the skill (ten Cate, 2013). 
Panelists will be provided an open-ended comment box after each question to give 
suggestions for rewording the competency/EPA, change in the alignment, or change in 
entrustment level.  
Results from the selected-response (Likert scale) questions will be aggregated into 
two categories:  Category 1 - Strongly Agree/Agree and Category 2 – Disagree/ Strongly 
Disagree from each panelist’s response. Computation of the percent number of responses 
for each category will then occur for each question. For example, if 50 participants 
completed the survey with 30 indicating Strongly Agree and 10 indicating Agree for a 
question, then the percent response for Category 1 (Strongly Agree/Agree) would be 80%. 
For there to be consensus on the competency/EPA alignment or the level of entrustment 
question, there must be a category score of 80% Strongly Agree/Agree for the question. 
Data from the literature states that cut-offs for consensus can range from 51-80% 
(Hasson, Keeney, & McKenna, 2000). A cut-off of ≥ 80%  was chosen for this study to 
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be conservative and in line with other pharmacy Delphi studies (Johnson & Traynor, 
2018). Once a competency mapping, EPA mapping, or level of entrustment question has 
reached an agreement level of 80%, it will not be included in the subsequent rounds.  
A review of constructed-response comments occurs for any question that did not 
achieve consensus (80% agreement) using structural coding via NiViVo software 
(NiViVo qualitative data analysis software, 2019). In structural coding, a content-based 
or conceptual phrase is assigned a segment of data based on the survey question being 
asked to develop themes around the survey question. For example, in this study, 
constructed-responses may be left regarding a change in the entrustment level assigned to 
a particular EPA. A review of each comment will occur to determine the themes for why 
the entrustment level should be changed (e.g., themes might include students will not be 
able to practice this EPA enough in school to achieve more than a level 3) and what the 
suggested levels are. The themes generated for both the mapping to the core roles and 
EPA levels will be used to make changes in the survey questions for Round 2 (Saldaña, 
2016). For example, suppose the comment themes suggest mapping a particular 
competency or EPA to a different role. In that case, the Round 2 survey question will 
indicate this new mapping and ask for the level of agreement. For example, if panelists 
suggested the competency “Provide-patient-centered care as the medication expert” 
(Medina et al., 2013, p. 3-4) needed mapping to another role besides Patient Care Skills 
like maybe Medicine Exert, the Round 2 question would then ask for the level of 
agreement on mapping to this new role. Panelists will receive the themes for the 




Round 2. In Round 2, panelists will receive a summary document and a new survey. 
The summary document will be a quantitative summary for all survey questions and a 
qualitative summary of questions that did not reach consensus for each competency/EPA 
statement and level of entrustment. This summary will include the total percent Strongly 
Agree/Agree and Disagree/Strongly Disagree of all panelists on the question and themes 
developed from any open-ended comments provided (if the question did not reach 
consensus). The new survey will gather data on the updated competency/EPA mappings 
and any updated entrustment levels after review of the quantitative and qualitative data 
from Round 1. The survey will contain new questions constructed based on changes 
made to the questions from Round 1 that did not reach consensus. Removal of 
competencies/EPAs and entrustment levels that achieved 80% agreement during Round 1 
will occur for the Round 2 survey. 
The new Round 2 survey questions will be constructed and analyzed in the same 
manner as Round 1. The Delphi questionaries will comprise selected- and constructed-
response questions to gather data on stakeholders’ consensus on the updated 
competency/EPA mappings and levels of entrustment that were created based on the data 
from Round 1. Each panelist will rate their level of agreement with each new competency 
and EPA role alignment or level of entrustment using the same 4-point Likert scale from 
Round 1: 1 (Strongly Disagree) to 4 (Strongly Agree). Panelists will also have 
constructed-response boxes to provide comments if needed. Results from the selected-
response (Likert scale) questions will once again be aggregated into two categories:  
Category 1 - Strongly Agree/Agree and Category 2 – Disagree/ Strongly Disagree for 
each panelist’s response. Computation of each category's percent number will then occur 
96 
 
for each question like in Round 1. For there to be consensus on the competency/EPA 
alignment or the level of entrustment, there must be a category score of 80% 
agree/strongly for the question. Once a competency mapping, EPA mapping, or level of 
entrustment has reached an agreement level of 80%, it will not be included in the 
subsequent rounds.  
A review of constructed-response comments occurs again for any question that 
did not achieve consensus (80% agreement) using structural coding via NiViVo software 
(NiViVo qualitative data analysis software, 2019) just as in Round 1. Just as discussed 
for Round 1, the themes generated for the mapping to the core roles and EPA levels will 
be used to make changes in the survey questions for Round 3 (Saldaña, 2016). Panelists 
will receive the themes for the comments that suggested the change in mapping, so they 
understand why the change occurred.  
Round 3. Round 3 will only need conducting if all competency/EPA alignments and 
levels of entrustment have not met the 80% consensus level after Rounds 1 and 2. Round 
3 will follow the same procedure from Round 2, where panelists will receive a summary 
document and a new survey. The summary document will be a quantitative summary for 
all survey questions and a qualitative summary of questions that did not reach consensus 
for each competency/EPA statement and level of entrustment from Round 2. This 
summary will include the total percent Strongly Agree/Agree and Disagree/Strongly 
Disagree of all panelists on the question and themes developed from any open-ended 
comments provided (if the question did not reach consensus). The new survey will gather 
data on the updated competency/EPA mappings and any updated entrustment levels after 
review of the quantitative and qualitative data from Round 2. The survey will contain 
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new questions constructed based on changes made to the questions from Round 1 that did 
not reach consensus. Removal of competencies/EPAs and entrustment levels that 
achieved 80% agreement during Round 2 will occur for the Round 3 survey. 
The new Round 3 survey questions will be constructed and analyzed in the same 
manner as Round 1. The Delphi questionaries will comprise selected- and constructed-
response questions to gather data on stakeholders’ consensus on the updated 
competency/EPA mappings and levels of entrustment created after Round 2. Each Delphi 
participant (panelist) rate their level of agreement with each new competency and EPA 
role alignment or level of entrustment using the same 4-point Likert scale from Round 1: 
1 (Strongly Disagree) to 4 (Strongly Agree). Panelists will also have constructed-response 
boxes to provide comments if needed. Results from the selected-response (Likert scale) 
questions will once again be aggregated into two categories:  Category 1 - Strongly 
Agree/Agree and Category 2 – Disagree/ Strongly Disagree for each panelist’s response. 
Computation of the percent number of responses for each category will then occur for 
each question like the previous rounds. For there to be consensus on the competency/EPA 
alignment or the level of entrustment, there must be a category score of 80% 
agree/strongly for the question. Competency/EPA mappings or entrustment levels will 
not be included in the final mapping document if they have not reached the 80% level of 
agreement after Round 3. Completion of all Delphi rounds will answer Research 
Questions Two and Three. Formulation of a final set of competencies and EPAs that 
align with Research Question One's roles will occur along with a setting of a level of 
entrustment for each EPA. Each panelist will receive the final structure of 
roles/definitions, competency/EPA alignment, and entrustment levels.  
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Once both Phases (One and Two) of this research project conclude, all three 
research questions will have an answer:   
1. What are the core professional roles that pharmacy programs feel should be 
demonstrated by graduating student pharmacists?  
2. According to pharmacy practitioners, what is the alignment of the current 
pharmacy competencies and entrustable professional activities (EPAs) to the core 
professional roles?    
3. According to pharmacy practitioners, what level of entrustment should pharmacy 
graduates be expected to achieve for each EPA?     
The Phase One NGT process answers Research Question One by defining the core 
professional roles that graduating student pharmacists should demonstrate upon 
graduation. This process also defines these roles to allow for easier alignment of the 
current pharmacy competencies and EPAs to these roles. The Phase Two Delphi process 
answers Research Questions Two and Three, as this process provides a consensus 
agreement of the alignment of the current pharmacy competencies and EPAs to the roles 
from Phase One. This process then provides a consensus on the level of entrustment that 
pharmacy graduates should expect to achieve for each EPA mapped to the roles. 
Limitations 
Despite the advantages of a multiphase mixed methods study, there are still 
several limitations that need addressing. One limitation is the number of resources and 
time required to complete these types of studies (Creswell & Clark, 2011). Resources will 
not be an issue with this study as the study will be conducted via video conference call 
for Phase One and via email and electronic survey for the second phase. Another 
limitation is the lack of meaningful connection that can occur between the phases. For 
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example, in some studies, it may not be clear how the data collected in Phase One is 
being used for the next phase of the project (Creswell & Clark, 2011), which is not a 
problem in this study as Phase Two requires the results from Phase One. Phase One 
results will provide the roles, definitions, and alignments needed to complete the Delphi 
process in Phase Two.  
Disadvantages need considering for the consensus development techniques 
chosen for Phase Two of this study. One downside of NGT is that it may be challenging 
to organize the meeting at a time that suits everyone, which will be overcome via the 
video conference call. This method has been used in the past for the consortium group 
and works well. Another problem with any group meeting is the potential for one or more 
participants to dominate the conversation or push their views, thus making some 
participants feel uncomfortable expressing their thoughts (McMillan et al., 2016). 
Mitigation of the problem of one person or group of people (people from one school over 
the others) dominating the conversation occurs by choice of the NGT method of this 
project over a focus group methodology. NGT protocol is set-up so that every member of 
the group gets the opportunity to express their thoughts one at a time in an organized 
order. The NGT process will allow everyone to express their strengths and modifications 
of the proposal and control one person dominating the conversation. The mitigation of the 
conversation domination will occur by requiring each person to respond to the discussion 
question before the next person answers. Once everyone has responded to the question 
once, the process starts again until no new generation of strengths and modifications 
occurs. Also, the researchers chosen for this project by the Deans will be well-versed in 
the literature related to this study's topic. They will not be inclined to defer to other’s 
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opinions on the topic if they disagree. Another potential area of bias would be having the 
researcher who developed the proposal lead the NGT process. Mitigation of researcher 
bias is through the use of a facilitator who did not participate in the development of the 
proposal but is well known in the field of pharmacy and assessment, so those on the NGT 
panel will respect her ability to lead the discussion (Delbecq et al., 1975).  
Some of the Delphi method's disadvantages include the time it takes to do the 
process (it can take weeks or months) and is the potential for a low response rate to the 
surveys (McMillan et al., 2016). The time it takes to do the Delphi method will be one 
big negative to this process, but by combining the research questions into one Delphi 
survey, it will help limit some of the timetable. The potential for a low response rate will 
need monitoring and reminders sent to help improve the results. The last drawback is the 
researcher's potential for bias who is reviewing and combining the results (McMillan et 
al., 2016). Mitigation of the risk of bias will occur by providing both the original and the 
changed mappings and levels of entrustment in each round of the Delphi process, thus 
allowing Delphi participants to serve as reviewers.  
Besides the limitations of the consensus processes chosen for this study, threats to 
internal and external validity also need to be considered (Campbell & Stanley, 1963). 
There are four threats to external validity to consider: (a) sample bias, (b) reactive effects 
of testing, (c) reactive effects of arrangements, and (d) multiple treatment interference 
(Campbell & Stanley, 1963). Reactive effects of testing and multiple treatment 
interference will not be a problem in this study. Reactive effects of testing occur when the 
giving of a pretest may affect the experimental testing results, and no pretest will happen 
with this study. Multiple treatment interference occurs when numerous treatments occur 
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in an experiment differently than in the real-world, thus making the results hard to 
replicate. Multiple treatment interference will not be a problem in this study, as no 
interventions occur. Reactive effects of arrangements refer to the inability to generalize to 
non-experimental settings because the experimental setting is artificial. Reactive effects 
of arrangements could potentially be a problem in this study since no actual testing of the 
alignments and levels of entrustment will be happening; instead, results are from 
practitioners’ thoughts about the appropriate alignments and entrustment levels 
achievement. Future studies would need to be conducted in real-world educational 
settings to determine if the entrustment levels are correct. There is less of an issue with 
this validity threat as the consensus participants are active practitioners with various 
practice experience. They should be capable of accurately determining what graduates 
need to perform upon graduation. Sample bias is the last threat to external bias. Sample 
bias occurs when there is a chance that the sample chosen for the study may not represent 
the population of interest. Sample bias is a potential threat in this study, given only a 
small number of pharmacists will participate in the consensus development process, 
which may lead to a lack of diversity (i.e., race, age, rural/urban practice sites). One way 
mitigation will occur is to use a non-randomized sample chosen by the NGT process 
members to ensure that the sample selected is a diverse mix of pharmacy practice types 
and levels of experience (Campbell & Stanley, 1963). The NGT process participants will 
select participants with different races, different lengths in practice, from different areas 
of the state (rural vs. urban), and at least one from the required ACPE practice sites that 
all students need exposure to upon graduation (ACPE, 2015). 
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Threats to internal validity also need to be considered. Internal validity threats 
include (a) history, (b) maturation, (c) testing, (d) instrumentation, (e) statistical 
regression, (f) selection, (g) mortality, (h) placebo, (i) contamination effect, (j) 
Hawthrone effect, (k) experimenter bias, and  (l) interaction effects (Campbell & Stanley, 
1963). Many of these threats are not a problem in this study, as it is not an experimental 
model with a treatment group. Statistical regression, selection, mortality, placebo, 
contamination, Hawthorne effect, and interaction effects are not internal threats to this 
study as the study does not place people into groups, nor is there an intervention or 
treatment provided or compared between groups. Instrumentation will not be an issue as 
the use of the same survey occurs throughout the study. While the survey stems may 
change between the Delphi rounds based on the participants' open-ended comments, the 
rating scale will remain the same. History, maturation, testing, and experimenter bias are 
potential threats to internal validity that need consideration. History is when events occur 
during the study that may impact the results, which could be an issue between the Delphi 
rounds if participants were to change jobs or learn different information that may change 
the way they think about the alignments and levels of entrustments in between the 
rounds. Maturation could be a problem as processes with the participants (aging, 
experience) could impact the outcomes. History and maturation will be mitigated by 
keeping the time between the rounds to no more than 2-3 weeks. Another potential 
internal threat is testing itself as results are affected when participants do multiple rounds 
of “testing.”  Testing will be mitigated by only using two to three rounds of the Delphi 
process. The last threat to internal validity is experimenter bias, which occurs when the 
experimenter’s expectations of the results may consciously or unconsciously affect the 
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results. The experimenter’s expectations will be mitigated through the design of the NGT 
process for Research Question One and then through providing both the original as well 
as the changed mappings and levels of entrustment in each round of the Delphi process, 
thus allowing Delphi participants to serve as reviewers to ensure researcher bias is 
mitigated (Campbell & Stanley, 1963).  
Summary/Statement of Significance   
Pharmacy has implemented competency statements and EPA concepts from 
medicine, but it has not established a consensus set of roles that define a practice-ready 
pharmacist. The lack of clarity leads to schools/colleges of pharmacy defining this for 
themselves. There is also some debate on the entrustment level that needs assigning to the 
EPAs (VanLangen et al., 2019). Without this standardized set of roles with the EPAs 
aligned to them and an agreed-upon level of attaining the EPA, it may mean that not all 
students are leaving with the same minimal expectations potentially to practice. A 
standard set of roles with competencies and EPAs aligned to them, as would be created 
by answering the research questions in this study, would ensure that all schools/colleges 
of pharmacy are providing students with the minimum level of training necessary to be a 
practice-ready pharmacist upon graduation and be able to move into any pharmacy or 
post-graduate training. These standard roles and aligned competencies and EPAs with 
levels of entrustment will allow schools/colleges of pharmacy to collaborate on 







CHAPTER 4:  RESULTS                   
Introduction 
A multiphase mixed-methods experimental design with two phases (Creswell & 
Clark, 2011) was used for the study methodology. The multiphase mixed-methods model 
used a series of sequentially aligned studies (data building from one study to another) that 
required the collection of a combination of quantitative and qualitative data. A 
multiphase mixed methods design worked well for the research questions in this study as 
the three questions were all centered around the same broad objective: Exploring the 
development of graduate core practice-ready roles aligned to competencies and EPAs 
with levels of entrustment. Empirical findings have the potential to contribute to the 
development of school/college pedagogies and assessments to ensure all students are 
practice-ready upon graduation. The following research questions answered the broad 
objective of this study: 
1. What are the core professional roles pharmacy programs believe students should 
be able to demonstrate competency in upon graduation?  
2. What is the alignment of the current pharmacy competencies and entrustable 
professional activities (EPAs) to the core professional roles?    
3. What level of entrustment should pharmacy graduates be expected to achieve for 
each EPA?    
The two-phase mixed methods included using different consensus development 
techniques for each phase (two in total; Delbecq et al., 1975). The use of consensus 
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development techniques was preferred for this study, given the subjective nature of the 
research questions asked. All three research questions required a combination of 
subjective judgments from multiple people to form one agreed-upon answer (Delbecq et 
al., 1975). The choice of two different consensus techniques for this study was due to the 
types of data, group sizes, and anonymity needed for the various research questions. 
Phase One (Research Question One) used the nominal group technique (NGT), which 
allowed for the collection of qualitative data as the primary data type using quantitative 
data to support the final group decision. Phase Two (Research Questions Two and Three) 
used the Delphi technique, which allowed for surveys to collect quantitative data with 
qualitative data as explanations for why specific ratings were selected (Delbecq et al., 
1975). This chapter discusses the results of the NGT and Delphi processes used to answer 
each particular research question. 
Research Question One     
Research Question One answered the question: What are the core professional 
roles pharmacy programs believe students should be able to demonstrate competency in 
upon graduation?  The NGT for proposal review census development technique was used 
to answer this question. An initial set of proposed core roles (Appendix C) that student 
pharmacists should prepare to do upon graduation (core role proposal) was provided to an 
expert group to gather consensus on the strengths and modifications needed to improve 
the core roles (Delbecq et al., 1975). With the complexity and amount of background 
literature for review regarding the creation of the proposed core roles, it made sense to 
provide the group with a draft copy of the core roles derived from the existing pharmacy 
competencies/EPAs and medical literature to stimulate the constructive formation of a 
final set of core roles.  
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Five people from four different colleges/schools of pharmacy participated in the 
NGT process plus a non-participating facilitator. The facilitator for the NGT process was 
from a college/school of pharmacy not affiliated with the project and had experience 
conducting focus groups. Purposeful sampling was used to select the NGT participants 
due to the need to select faculty/administrators that had done work in practice-readiness 
to ensure the panel had the necessary knowledge to discuss the roles. Deans of four 
pharmacy programs, three large-research intensive four-year pharmacy programs and one 
smaller three-year teaching-intensive pharmacy program selected the panelists. The 
programs selected to provide participants had faculty who have done extensive research 
in pharmacy competencies and EPAs. Each program provided at least one NGT 
participant. Four of the NGT participants were from research-intensive, four-year 
pharmacy programs, and one participant was from a three-year, teaching-intensive 
program. All participants had earned Doctor of Pharmacy degrees. The participants' 
average number of years of academic experience was 11.6 years (8.5 SD), with a range of 
academic experience from 2 to 20 years. All participants had experience in the areas of 
pharmacy school assessment, experiential education, or teacher development.  
The NGT proposal review process took place via an internet conference call system. 
The total call lasted a little under two hours. The first 10 minutes of the call was a general 
overview of each part of the proposal review process. The review of the strengths of the 
proposal occurred over four rounds lasting 30 minutes. A discussion on potential 
modifications for the proposal occurred over seven rounds and lasted 45 minutes. 
Preliminary voting for both rounds took about 10 minutes each and the final voting about 
the same amount of time.  
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The initial core role proposal that participants started with had a pharmacotherapeutic 
expert as the central role. The central role defined a pharmacotherapeutic expert as one 
who integrates all the core roles such as knowledge, appropriate patient care skills, and 
professionalism to provide high-quality and safe patient-centered care. Being a 
pharmacotherapeutics expert was considered the central role of a pharmacist and defined 
the pharmacist's scope of practice. Seven core roles were then initially proposed to define 
further a pharmacotherapeutic expert:  knowledge, patient care skills, professional, 
scholar, systems-based practice/manager, collaborator, and advocate/health promoter. 
The full initial core role proposal is in Appendix C. 
The strengths' round-robin and clarification stages of the NGT process identified 
sixteen strengths of the initial core role proposal. A rating procedure was used for the 
preliminary voting stage since panelists were participating via video conference call. 
Panelists first rated the strengths via an on-line Microsoft Form on a scale of 0-100. 
Panelists assigned a rating of zero to items they felt were extremely weak strengths, and 
100 for items the panelist felt were the strongest strengths. Averaging of individual 
panelist's ratings for each strength then occurred. Before voting, the group also set an 
average rating cut-off to indicate strengths that needed further clarification before the 
final voting. The cut-off selected was determined through a consensus voice vote of the 
group. A cut-off of an average rating score of 60 or below identified items that needed 
further clarification. Four of the five NGT participants voted on the strengths during the 
preliminary voting stage. 
During the round-robin and clarification phase, one strength identified was 
participants "liked [that] added knowledge and patient care skills" were included in the 
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roles. The average rating score on this role was 69, with a range of 45-80. Despite having 
one rating below 45, all participants' average rating was above 60; thus, this strength did 
not need further clarification before the final voting. Another strength identified was 
"alignment with and overlap between this and other resources – CAPE and other 
standards – helps with external validity." This strength had an average rating of 76, with a 
range of 40-90. Again, despite having one rating below 60, the average participant rating 
was above 60; thus, this strength did not need further clarification before the final voting. 
Table 3 reports the full list of strengths generated during the initial NGT process, along 
with the results of the initial vote.  
Table 3 
Initial Core Pharmacist's Role Proposal NGT Strength Results 
Initial Strengths Participant 1 Participant 2 Participant 3 Participant 4 M 
Central tenet is about 
being a 
pharmacotherapy 
expert (not just a drug 
expert) 95 85 100 50 83 
      
Liked added 
knowledge and 
patient care skills 70 80 80 45 69 
      
Broad, good mix of 
different topics/roles 
that any pharmacy 
graduate should be 
able to perform upon 
graduation 75 95 100 60 83 
      
Clear interplay 
between components 
– all tie together 90 60 50 100 75 
      
Alignment with and 
overlap between this 85 90 90 40 76 
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and other resources – 
CAPE and other 
standards – helps with 
external validity 
      
Evidence-based and 
patient centered terms 
were included 80 75 80 35 68 
      
Scholarship – liked 
blend/listing of 
variety of different 
ways that scholarship 
could be included 60 60 10 55 46 
      
Different components 
such as advocate and 
systems/based 
manager – adds layer 
of complexity to 
being a pharmacist 
was we are taking on 
more in the healthcare 
system 60 80 90 65 74 
      
Personal wellness (of 
pharmacist) was 
highlighted 80 70 80 80 78 
      
Most of the 
components of the 
PCPP were included 
throughout 60 80 100 90 83 
      
Advocate/Health 
promoters – liked 
ways different roles 
were laid out and 
were specific 80 60 80 10 58 
      
Thread of patient-
centered care 
throughout all of the 
areas 75 70 90 85 80 




promoter – population 
health was included 
here 70 60 70 20 55 
      
Collaborator – 
included other 
providers but also 
included the patient 85 75 80 75 79 
      
Professionalism – 
included society as a 
whole 90 50 70 70 70 
      
Systems-
based/manager – 
health care insurance 
and health care 
economics             80 85 40 30 59 
 
Upon reviewing the full results after the initial round of voting on the proposal 
strengths, four strengths were identified as having an average rating score of less than 60. 
Outliers were discussed with the group to determine the rewording of the strengths, if 
needed, before the final vote. The purpose of the clarification step was to ensure the 
group members understood the intent of the statement before the final voting. Statements 
either had words added or changed to ensure everyone understood the purpose of the 
statement. Only the final strength, "Systems-based/manager – health care insurance and 
health care economics," was reworded before the final vote. The strength was reworded 
to "Systems-based/manager – health care insurance and health care economics were 
specifically highlighted as these are often left out for pharmacists."  
The final voting stage used the same rating procedure as the preliminary voting 
stage. Panelists rated the strengths via an on-line Microsoft Form on a scale of 0-100. 
Once again, panelists assigned a rating of zero to items they felt were the weakest of the 
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strengths, and 100 to items they felt were strong strengths. Averaging of the individual 
panelist's ratings for each strength then occurred. The group used the same average rating 
cut-off as the preliminary voting stage of >60 to identify items that were strong enough 
strengths to ensure they remained as part of the final core roles after modifications were 
made. Once again, four of the five NGT participants rated the strengths during the final 
voting stage. 
The final vote found all strengths were above the cut-off score, meaning that all 
the areas listed were strengths of the proposal. For example, one of the strengths was the 
"central tenet is about being a pharmacotherapy expert (not just a drug expert)." This 
strength had an average rating of 87 with a range of 50-100. This strength means the 
participants felt it was essential to ensure the pharmacotherapy expert idea did not get 
removed during the modification stage. Another strength was "Evidence-based and 
patient-centered terms were included." The average rating for this strength was 84, with a 
range of 75-95. Once again, because the average was greater than 60, the group felt it was 
essential to ensure inclusion of the terms "evidence-based" and "patient-centered" in the 
final version of the proposal. Once the modification round was completed, and changes 
made in the proposal, it was essential to review this table of final strengths to ensure the 
inclusion of all the concepts listed in the final proposal. If one of the strengths was 
removed based on a modification, it was added back since the participants felt all of these 
strengths were vital to include in the final proposal. Table 4 contains the final list of 
strengths, along with the results of the final voting. 
Table 4 
Final Core Pharmacist's Role Proposal NGT Strength Results 
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Final Strengths   Part 1 Part 2 Part 3 Part 4 Part 5 M 
Central tenet is 
about being a 
pharmaco-
therapy expert 
(not just a drug 
expert)   
100 95 90 50 100 87 




skills   
90 70 80 80 50 74 
        





be able to 
perform upon 
graduation   
90 80 95 90 92 89 




all tie together   
80 90 60 90 60 76 
        
Alignment with 
and overlap 
between this and 
other resources 
– CAPE and 
other standards 
– helps with 
external validity   
90 85 90 80 35 76 




were included   
80 80 75 90 95 84 





different ways   






        
Different 
components 
such as advocate 
and 
systems/based 





we are taking on 
more in the 
healthcare 
system   




highlighted   
90 80 70 70 70 76 
        
Most of the 
components of 
the PCPP were 
included 
throughout   
80 75 90 80 80 81 





were laid out 
and were 
specific   
80 80 60 80 20 64 




all of the areas   
80 75 80 80 75 78 
        
Advocate/health 
promoter – 










the patient   80 85 80 90 85 84 
        
Professionalism 
– included 
society as a 
whole   70 90 60 75 90 77 









these are often 
left out for 
pharmacist    60 80 90 90 40 72 
 
The modifications round-robin and clarification stages of the NGT process identified 
seventeen potential modifications for the initial core role proposal. The same rating 
procedure as the strengths portion was used again for the modification preliminary voting 
stage. Panelists first rated the modifications via an on-line Microsoft Form on a scale of 
0-100. Panelists assigned a rating of zero to items they felt were unnecessary 
modifications, and 100 for items they felt were vital modifications. An average of the 
individual panelist's ratings for each modification then occurred. Before voting, the group 
also set an average rating cut-off to identify modifications that needed further 
clarification before the final voting. The cut-off selected was determined through a 
consensus voice vote of the group. A cut-off of an average rating score of 60 or below 
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indicated items that needed further clarification. All five NGT participants voted on the 
modifications during the preliminary voting stage. 
One potential modification was "Pharmacotherapeutics expert:  Should include all the 
other tenets – focus of the two bullets are clinical – systems-based practice/manager is 
missing – double check all other tenets are covered there." The average rating for this 
modification was 82, with a range of 40-100. Despite having one rating of <60, the 
average was above the cut-off to potentially be included in the final list of modifications 
to make on the proposal. Another potential modification was "Pharmacotherapeutics 
expert – central tenet – seems to have a very heavy clinical tenet – is there another term 
that can be used – maybe change to medication expert." The average rating for this 
modification was 58, with a range of 20-80. As written, this modification was currently 
below the cut-off of 60, meaning the modification would not be made in the final 
proposal if the average rating remains this low after the final vote. The full list of 
potential modifications generated during the initial NGT modification process with the 
initial vote results is in Table 5.  
Table 5 
Initial Core Pharmacist's Role Proposal NGT Modification Results 
Initial Modifications Part 1 Part 2 Part 3 Part 4 Part 5 M 
Knowledge – bullet 
1:  psychological is 
not usually part of the 
pharmacist role so 
what level of 
knowledge would be 
expected there 
75 30 80 30 70 57 
       
Pharmacotherapeutics 
expert:  Should 
include all the other 
tenets – focus of the 
100 100 70 40 100 82 
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missing – double 
check all other tenets 
are covered there 
Drug information 
seeking is missing 
(using resources to 
find and provide 
information) 
0 90 70 100 90 70 
       
Pharmacotherapeutics 
expert: is expert the 
right word – consider 
another word 
80 30 40 50 60 52 
       
Patient care skills – 
first bullet:  steps 
through domains of 
PCPP but 
implementation is not 
concretely there 
100 100 60 90 90 88 
       
Pharmacotherapeutics 
expert:  second bullet 
– monitor/follow-up 
is missing there 
100 95 80 90 90 91 
       
Patient care skills – 
role of PCPP is there 
but needs to be more 
on the relationship 
with the patient 
(empathy, other 
emotions) 
90 30 50 75 70 63 
       
Scholarship – likes 
examples but makes 
it seem that a 
pharmacist needs to 
all of these things – 
needs to be more of 
an example list 
100 40 30 80 90 68 
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Scholarship – use of 
data needs to be here 
(health informatics) 
  
0 90 70 50 80 58 
       
Scholarship – 




future roles for 
pharmacists 
100 70 80 60 90 80 
       
Systems-based 
Practice – first bullet 
– population 
health/public health 
50 80 60 80 80 70 
       
Quality care 
mentioned in several 
places but quality 
improvement is not 
explicated stated 
100 85 70 80 60 79 
       
Collaborator – bullet 
2 – "safe, high 
quality, and effective 
patient care" – comes 
through in several 
places – be consistent 
in document 
80 40 60 80 90 70 
       
Should "evidence-
based be included" – 
bullet 1 on 
collaborator maybe to 
replace "high quality" 
0 80 50 80 80 58 
       
Collaborator – bullet 
2 – "Must understand 
role of others on the 
team" – pharmacists 
need to be able to 
articulate their role 
on the team 
100 90 65 80 60 79 
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Missing from CAPE:  
Innovator seems to be 
missing 
100 80 70 80 80 82 
       
Pharmacotherapeutics 
expert – central tenet 
– seems to have a 
very heavy clinical 
tenet – is there 
another term that can 
be used – maybe 
change to medication 
expert 
80 70 70 50 20 58 
 
After the preliminary round of voting for the modifications, a review of results 
occurred to determine items that met the cut-off selected through a consensus voice vote 
of the group to be outliers. A cut-off of an average rating score of 60 or below indicated 
items that needed further clarification. There were five outliers identified to have an 
average of <60. The group discussed the five outliers, and clarification of all five 
statements occurred. The purpose of the clarification stage was to ensure the group 
members understood the intent of the statement before the final voting. Statements either 
had words added or changed to ensure everyone understood the purpose of the statement. 
There were five outliers discussed with clarifications made. The first outlier discussed 
was  "Knowledge -  bullet 1". Participants felt that psychological is not usually part of the 
pharmacist role, so they were confused about what level of knowledge would be expected 
for this bullet. Rewording of "Knowledge bullet 1" occurred to "psychological is not 
usually part of the pharmacist role, so what level of knowledge would be expected there – 
change is psychosocial." The second outlier discussed was "Pharmacotherapeutics 
expert." The participants discussed whether expert was the right word and suggested 
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considering another word. "Pharmacotherapeutics expert" was reworded to 
"Pharmacotherapeutics expert:  is expert the right word – consider "optimizer."  
Another outlier discussed was under Scholarship. Participants discussed the need 
to have the use of data mentioned here, specifically the use of the term health informatics. 
Rewording of this bullet occurred to "Use/Analysis of outcomes data needs to be 
included (health informatics/quality improvement)." Another outlier was under bullet one 
in collaborator. Participants thought evidence-based should maybe replace the term high 
quality. This bullet was reworded to "Should evidence-based be added to bullet one on 
collaborator." The last outlier discussed was the central tenet of "Pharmacotherapeutics 
expert." Participants felt this term had a very heavy clinical tenet, so they wondered if 
another term was available. Rewording of the Pharmacotherapeutics expert statement 
occurred to "Pharmacotherapeutics expert – central tenet – seems to have a very clinical 
tenet – is there another term that can be used – maybe change to pharmacy expert."   
The final voting stage used the same rating procedure as the modification 
preliminary voting stage. Panelists rated the modifications once again via an on-line 
Microsoft Form on a scale of 0-100. Panelists assigned a rating of zero to items they felt 
were the weakest of the modifications, and 100 to items they felt were the strongest 
modifications. An average of the individual panelist's ratings for each modification then 
occurred. The group used the same average rating cut-off of >60 (as determined during 
the preliminary voting stage) to identify modifications needed before finalizing the core 
role proposal. Once again, all five NGT participants rated the modifications during the 
final voting stage. 
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The final vote found that sixteen out of the seventeen modifications were above 
the cut-off of > 60. These results meant the panelist felt strongly these sixteen 
modifications were necessary to clarify the proposed core roles’ central tenet, core role 
definitions, and to ensure all core pharmacists' roles that pharmacists should be prepared 
to do throughout their careers were in the proposal. For example, one modification was 
"Drug information seeking is missing (using resources to find and provide information)." 
The average rating for this modification was 76, with a range of 30-100. Despite having 
one rating of below 60, the average was still above the cut-off for inclusion in the 
modifications. The proposal was modified to ensure the inclusion of drug information in 
describing one of the core roles. Another modification made before finalizing the core 
roles was "Pharmacotherapeutics expert – central tenet – seems to have a very heavy 
clinical tenet – is there another term that can be used – maybe change to pharmacy 
expert." The average rating for this modification was 68, with a range of 0-100. Again, 
even though there was a rating of <60, the overall average was high enough to make this 
modification. Based on this modification, the name of the central tenet was changed. 
Another modification that was voting on was "Pharmacotherapeutics expert:  is expert the 
right word – consider "optimizer." The average rating for this modification was 34, with a 
range of 0-60. This modification did not meet the score of >60, meaning the inclusion of 
this modification did not occur in the core role proposal. The final list of potential 
modifications, along with the results of the final voting, is in Table 6.  
Table 6 
Final Core Pharmacist's Role Proposal NGT Modification Results 
Final Modifications Part 1 Part 2 Part 3 Part 4 Part 5 M 
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Knowledge – bullet 
1:  psychological is 
not usually part of the 
pharmacist role so 
what level of 
knowledge would be 
expected there - 
change is 
psychosocial  
100 80 90 80 80 86 
       
Pharmacotherapeutics 
expert:  Should 
include all the other 
tenets – focus of the 
two bullet is clinical 
– systems-based 
practice/manager are 
missing – double 
check all other tenets 
are covered there 
100 70 100 90 50 82 
       
Drug information 
seeking is missing 
(using resources to 
find and provide 
information) 
100 70 90 90 30 76 
       
Pharmacotherapeutics 
expert:  is expert the 
right word – consider 
"optimizer"  
60 40 10 0 60 34 
       
Patient care skills – 
first bullet:  steps 
through domains of 
PCPP but 
implementation is not 
concretely there 
100 70 100 90 100 92 
       
Pharmacotherapeutics 
expert:  second bullet 
– monitor/follow-up 
is missing there 
100 80 95 90 100 93 
       
Patient care skills – 
role of PCPP is there 
70 50 50 70 90 66 
122 
 
but needs to be more 
on the relationship 
with the patient 
(empathy, other 
emotions) 
       
Scholarship – likes 
examples but makes 
it seem that a 
pharmacist needs to 
all of these things – 
needs to be more of 
an example list 
100 30 80 80 80 74 
       
Use/Analysis of 
outcomes data needs 
to be included (health 
informatics/quality 
improvement)  
90 70 90 80 80 82 
       
Scholarship – 




future roles for 
pharmacists 
85 80 80 80 100 85 
       
Systems-based 
Practice – first bullet 
– population 
health/public health 
80 60 80 80 30 66 
       
Quality care 
mentioned in several 
places but quality 
improvement is not 
explicated stated 
80 70 90 80 50 74 
       
Collaborator – bullet 
2 – "safe, high 
quality, and effective 
patient care" – comes 
through in several 
places – be consistent 
in document 
90 60 50 90 50 68 
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Should "evidence-
based" be added to 
bullet 1 on 
collaborator 
 
80 50 80 80 30 64 
       
Collaborator – bullet 
2 – "Must understand 
role of others on the 
team" – pharmacists 
need to be able to 
articulate their role 
on the team 
80 65 90 80 100 83 
       
Missing from CAPE:  
Innovator seems to be 
missing 
80 70 80 80 100 82 
       
Pharmacotherapeutics 
expert – central tenet 
– seems to have a 
very heavy clinical 
tenet – is there 
another term that can 
be used – maybe 
change to pharmacy 
expert  
100 70 70 100 0 68 
 
The final set of core roles after making the sixteen modifications and ensuring the 
sixteen strengths were kept is in Appendix D. The final core role proposal answered 
Research Question One:  What are the core professional roles pharmacy programs believe 
students should be able to demonstrate competency in upon graduation?  Upon 
completion of the NGT process, pharmacy expert became the central role of a 
pharmacist. The NGT process then defined a set of core roles students should be able to 
demonstrate competency in upon graduation to ensure they are ready for the central role 
of pharmacy expert. These core roles included knowledge, patient care skills, 
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professionalism, scholarship, systems-based practice, and collaborator. Further 
description of each core role provided direction on what specific knowledge and skills are 
needed to be considered competent in that particular role. The core roles developed 
during the NGT process will be used to answer Research Questions Two and Three:   
1. What is the alignment of the current pharmacy competencies and entrustable 
professional activities (EPAs) to the core professional roles?    
2. What level of entrustment should pharmacy graduates be expected to achieve for 
each EPA?    
In the second phase of this study, mapping the current pharmacy competencies and 
EPAs to the core roles developed during the NGT process and assignment of entrustment 
levels for the EPAs occurred. A modified Delphi process was used to determine 
consensus on the mapping to the core roles and levels of EPA entrustment. The answer to 
these two research questions will help determine gaps in the current pharmacy 
competencies/EPAs based on the core roles. 
Research Question Two 
Research Question Two was:  According to pharmacy practitioners, what is the 
alignment of the current pharmacy competencies and entrustable professional activities 
(EPAs) to the core professional roles? Usage of the Delphi technique to simultaneously 
collect quantitative and qualitative data (Delbecq et al., 1975) answered Research 
Question Two. Like the NGT process, the Delphi technique offered a framework for 
gathering stakeholder data on topics that call for aggregation of individual judgments. 
Therefore, Research Question Two addressed the extent to which there is broad 
consensus from different pharmacy practices on the competency/EPAs (Research 
Question Two) mapped to the core roles developed in Research Question One. 
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 In this research, the CAPE outcomes, along with the corresponding mapped 
EPAs, were used as the pharmacy competencies/EPAs to map to the roles created during 
Research Question One (ACPE, 2015; Pittegner et al., 2017). The initial mapping of the 
competencies/EPAs to the core roles are in Appendix E. The mapping document created 
the Delphi survey for round one. For example, participants were presented a role with a 
competency and its EPAs underneath. Participants were then asked to report their level of 
agreement with the alignment of that particular competency/EPA(s) as a group to the 
pharmacy roles on a four-point Likert scale (1 = Strongly Disagree to 4= Strongly Agree). 
Participants also could leave open-ended comments to explain their ratings. The 
knowledge role had one competency with five EPAs mapped. The patient care skills role 
had five competencies with 5-12 EPAs mapped depending on the competency. 
Professionalism had four competencies mapped with 3-4 EPAs for each competency. 
Scholarship had three competencies mapped with 2-6 EPAs under each competency. 
Systems-based practice/manager had four competencies mapped, each with 2-9 EPAs. 
Collaborator had four competencies mapped, each with 1-6 EPAs. Lastly, the 
advocate/health promoter had four competencies, each with 4-8 EPAs. Overall, 
participants were asked to review 25 different competency/EPA mappings during round 
one for the seven different roles. 
Delphi surveys typically use a 5-point Likert scale allowing participants to choose a 
neutral response (McMillian et al., 2016). The choice of a 4-point Likert scale was to 
force participants to agree or disagree, given the questions' nature. The use of a 4-point 
Likert scale is also in-line with other Delphi studies done in pharmacy education 
(Johnson & Traynor, 2018). Aggregation of the results from the selected-response (Likert 
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scale) questions into two categories occurred:  Category 1 - Strongly Agree/Agree and 
Category 2 – Disagree/ Strongly Disagree from each panelist's response to determine 
consensus achievement. Computation of the percent number of responses for each 
category then occurred for each question. For example, if 50 participants completed the 
survey with 30 indicating Strongly Agree and ten indicating Agree for a question, then the 
percent response for Category 1 (Strongly Agree/Agree) would be 80%. For there to be 
consensus on the competency/EPA alignment, there had to be a category score of ≥ 80% 
Strongly Agree/Agree for the question. Data from the literature states that cut-offs for 
consensus can range from 51-80% (Hasson et al., 2000). A cut-off of ≥ 80%  was chosen 
for this study to be conservative and in line with other pharmacy Delphi studies (Johnson 
& Traynor, 2018). A review of constructed-response comments occurred for any question 
that did not achieve consensus (<80% agreement) using structural coding via NiViVo 
software (NiViVo qualitative data analysis software, 2019). Once a mapping reached 
consensus (≥ 80% Strongly Agree/Agree), it was no longer included in subsequent round 
surveys. 
Panelists from the NGT group in Research Question One provided a list of people to 
participate in the Delphi survey via online Microsoft form. The form collected the Delphi 
participant's name, pharmacy degree, practice site, length of time in pharmacy practice, 
and email. NGT participants ensured that participants chosen came from various 
pharmacy disciplines and different years of experience. The initial Delphi participant list 
was a total of 63 people [University of Arkansas = 14 (22.2%); Sullivan University = 19 
(30.2%); University of North Carolina = 17 (27.0%); and University of Minnesota = 13 
(20.6%)]. All but one participant had a PharmD degree. The other participant had a Ph.D. 
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degree. Nine participants (14.3%) had >20 years of experience, 26 (41.3%) had 11-20 
years of experience, 22 (34.9%) had 5-10 years of experience, and six (9.5%) had <5 
years of experience. Twenty-three (36.5%) participants were male, and 40 (63.5%) were 
female. The Delphi participants' demographics represent the make-up of the pharmacy 
profession, which has more females than males. Forty-five (71.4%) practiced in urban 
locations, 15 (23.8%) practiced in rural sites, and 3 (4.8%) practice in mixed sites. 
Thirteen (20.6%) participants were acute care pharmacists, 18 (28.9%) were ambulatory 
care pharmacists, six (9.5%) were hospital pharmacists, 11 (17.5%) were community 
pharmacists, seven (11.1%) were in academia, three (4.8%) were in pharmacy 
management, and five (7.9%) were in other types of pharmacy practice. 
Round One. The first round Delphi survey had a total of 24 participants respond 
(38% response rate). Six (25%) of the respondents had >20 years of experience, 10 
(41.7%) had 11-20 years of experience, six (25%) had 5-10 years of experience, and two 
(8.3%) had <5 years of experience. Seven (29.2%) respondents were male, 15 (62.5%) 
were female, and two (8.3%) preferred not to answer. Seventeen (70.8%) had practice 
sites in urban locations, and seven (29.2%) had rural practice sites. Seven (29.2%) 
respondents were acute care pharmacists, eight (33.3%) were ambulatory care 
pharmacists, four (16.7%) were community pharmacists, three (12.5%) were in academia, 
and two (8.3%) were in other types of practice. 
As defined in Research Question One, the knowledge role was: "Pharmacists must be 
able to integrate knowledge of biomedical and psychosocial science principles of health 
and disease, and clinical science to design appropriate treatment plans for their patients. 
This knowledge includes understanding these principles across the life-span of the 
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patient. Pharmacists understand that they serve a unique role in the healthcare team. They 
are the "medication" experts and possess the most knowledge of how medications 
contribute to the patient's care." There was one competency with five EPAs mapped to 
the knowledge role. Consensus was achieved (≥80% Strongly Agree/Agree) for the 
mapping to this role, so this role's inclusion did not occur in the round two survey. The 
results are below in Table 7. The competency mapped under the knowledge role contains 
all of the knowledge elements defined by this role, but the EPAs are not specific. While 
participants felt the EPAs under this role were correct, the EPAs are general and leave the 
specific knowledge to be learned to be determined by the pharmacy school/college. 
Table 7 
Competencies/EPAs Mapped to Knowledge Role 








Learner:  Develop, integrate, 
and apply knowledge from the 
foundational sciences (i.e., 
pharmaceutical, 
social/behavioral/administrative, 
and clinical sciences) to 
evaluate the scientific literature, 
explain drug action, solve 
therapeutic problems, and 
advance population health and 

















goals and create 
















Collaborate as a 















The definition of patient care skills in Research Question One was: "Pharmacists 
must be able to perform basic patient care skills such as communication, collection and 
assessment of information to formulate and implement a treatment plan, and ability to 
monitor if a treatment is successful or not. Pharmacists need to ensure they take a 
patient's cultural, education level, and financial status into account when formulating a 
treatment plan to ensure a patient's plan can be adherent. Pharmacists also understand that 
part of patient care should include discussing the plan in a compassionate and empathetic 
manner with not only the patient but also their support system as needed." There were 
five competencies, each with various EPAs mapped to the Patient Care skills role. 
Consensus was achieved (≥80% Strongly Agree/Agree) on four of the five 
competencies/EPAs mapped to this role. The Educator competency was the one that did 
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not achieve consensus, with only 79.2% of respondents strongly agreeing/agreeing with 
this mapping. Comments from three respondents suggested that the EPAs related to 
implementation, identifying patients at risk, and immunizations did not fit here. Two 
respondents also suggested splitting Educator into a patient-focused competency and a 
health care professional focused competency. These suggestions were used to set-up the 
questions for the second-round survey. Overall, the competencies mapped under this role 
help to define the role of patient care skills. Except for some EPAs mapped under the 
Educator competency, the EPAs help define the actions needed to meet this role's 
competencies. While the competencies and EPAs mapped to this role are the same as 
ones mapped to later roles, in this case, they are specific to determine if a student was 
competent in this role. The issue is because these same competencies and EPAs occur in 
later roles, one would have a hard time determining which role was being assessed. There 
are also some competencies missing. There are no competencies related to the cultural 
and financial status of the patient. Table 8 shows the full results for this role. 
Table 8 
Competencies/EPAs Mapped to Patient Care Skills Role 









care (Caregiver):  
Provide patient-








EPA: Collect information to 
identify a patient's 
medication-related problems 
and health-related needs. 
EPA: Analyze information to 
determine the effects of 
medication therapy, identify 
medication-related problems, 
and prioritize health-related 
needs. 











centered goals and create a 
care plan for a patient in 
collaboration with the patient, 
caregiver(s), and other health 
professionals that are 
evidence-based and cost-
effective. 
EPA: Implement a care plan 
in collaboration with the 
patient, caregivers, and other 
health professionals. 
EPA: Follow-up and monitor 
a care plan. 
EPA: Maximize the 
appropriate use of 
medications in a population. 
EPA: Ensure that patients 


















EPA: Collect information to 
identify a patient's 
medication-related problems 
and health-related needs. 
EPA: Identify patients at risk 
for prevalent disease in a 
population. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the 
appropriate use of 
medications in a population. 
EPA: Ensure that patients 
have been immunized against 
vaccine-preventable diseases. 
 









EPA: Collect information to 
identify a patient's 
medication-related problems 
and health-related needs. 
EPA: Analyze information to 
determine the effects of 
medication therapy, identify 
medication-related problems, 




evaluate a viable 
solution. 
 
and prioritize health-related 
needs. 
EPA: Implement a care plan 
in collaboration with the 
patient, caregivers, and other 
health professionals. 
EPA: Collaborate as a 
member of an IPE team. 
EPA: Oversee the pharmacy 
operations for an assigned 
shift. 















EPA: Implement a care plan 
in collaboration with the 
patient, caregivers, and other 
health professionals. 
EPA: Identify patients at risk 
for prevalent disease in a 
population. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the 
appropriate use of 
medications in a population. 
EPA: Ensure that patients 
have been immunized against 
vaccine-preventable diseases. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate use 
of medication. 
 











EPA: Collect information to 
identify a patient's 
medication-related problems 
and health-related needs. 
EPA: Analyze information to 
determine the effects of 
medication therapy, identify 
medication-related problems, 
and prioritize health-related 
needs. 
83.3% 16.7% Yes 
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 EPA: Follow-up and monitor 
a care plan. 
EPA: Collaborate as a 
member of an IPE team. 
EPA: Identify patients at risk 
for prevalent disease in a 
population. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the 
appropriate use of 
medications in a population. 
EPA: Ensure that patients 
have been immunized against 
vaccine-preventable diseases. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate use 
of medication. 
EPA: Use evidence-based 
information to advance 
patient care. 
EPA: Oversee the pharmacy 
operations for an assigned 
shift. 
EPA: Full-fill a medication 
order. 
 
As defined from Research Question One, the Professionalism role was: "Pharmacists 
are committed to the health and well-being of their patients, society, and themselves. 
Demonstration of this role occurs through ethical practice, high standards of personal 
behavior, accountability to the profession and society, and maintenance of their own 
personal health. Pharmacists serve essential roles in the healthcare team and society. As 
such, professional identity is central. This tenet includes promotion of the public good, 
adherence to high ethical and moral standards. It recognizes that to provide good quality 
patient care, they must take care of themselves and others in their profession." There 
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were four competencies, each with three EPAs mapped to the professionalism role. 
Consensus was achieved (≥80% Strongly Agree/Agree) on all five competencies/EPAs 
mapped to this role. The inclusion of this role did not occur in the second-round survey. 
Table 9 shows the full results for this role. The competencies mapped to this role met 
some of the items covered in this role's definition. Competencies are missing related to 
ethics and maintenance of personal health. While participants did feel the EPAs mapped 
to this role were appropriate, they again are not explicitly written for this role, so it is 
hard to see how achieving them as written would mean you have achieved this role. For 
example, “Overseeing the pharmacy operations for an assigned shift” is not clearly 
defined for how it assesses the competency of self-awareness in the context of the 
professionalism role. To help schools/colleges of pharmacy better address this EPA, the 
EPA needs to be more explicit. 
Table 9 
Competencies/EPAs Mapped to Professionalism Role 








     
Self-awareness (Self-
aware): Examine and 




and emotions that 
could enhance or 
limit personal and 
professional growth. 
 
EPA:  Collaborate as a 
member of an IPE team. 
EPA: Oversee the 
pharmacy operations for 
an assigned shift. 








EPA: Collaborate as a 
member of an IPE team. 





goals, regardless of 
position. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate 
use of medication. 
EPA: Oversee the 
pharmacy operations for 






activities by using 
creative thinking to 
envision better ways 
of accomplishing 
professional goals. 
EPA: Collaborate as a 
member of an IPE team. 
EPA: Use evidence-based 
information to advance 
patient care. 
EPA: Oversee the 
pharmacy operations for 
an assigned shift. 
 




and values that are 
consistent with the 






EPA: Collaborate as a 
member of an IPE team. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate 
use of medication. 
EPA: Oversee the 
pharmacy operations for 
an assigned shift. 
EPA: Create a written plan 
for continuous 
professional development 
91.7% 8.3% Yes 
 
As defined in Research Question One, the scholarship role was: "Pharmacists are 
committed to excellence in their practice through life-long professional development, the 
teaching of others, developing new innovative practices that advance the profession, and 
use of evidence-based medicine. Pharmacists are committed to finding and promoting 
drug and other health information that is evidence-based and up-to-date. Pharmacists 
understand the importance of contributing to scholarship and evidence-based medical 
literature." There were three competencies mapped to the scholarship role. One 
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competency had six EPAs mapped to it, one had three, and one had two. Consensus was 
achieved (≥80% Strongly Agree/Agree) on all three competencies/EPAs mapped to this 
role. The inclusion of this role did not occur in the second-round survey. Table 10 shows 
the full results for this role. For the most part, the competencies mapped to this role cover 
all elements defined except for contributing to scholarship. There is no competency or 
EPA that discusses contributing to scholarship, only the use of it. Like the other roles, the 
competencies and EPAs mapped to this role are also not explicitly written for this role. 
Some tend to be very general, leaving it up to the school/college to determine how they 
would fit into this role. 
Table 10 
Competencies/EPAs Mapped to Scholarship Role 




















EPA: Implement a care plan in 
collaboration with the patient, 
caregivers, and other health 
professionals. 
EPA: Identify patients at risk 
for prevalent disease in a 
population. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the 
appropriate use of medications 
in a population. 
EPA: Ensure that patients 
have been immunized against 
vaccine-preventable diseases. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate use 
of medication. 
 















EPA: Educate patients and 
professional colleagues 
regarding the appropriate use 
of medication. 
EPA: Use evidence-based 
information to advance patient 
care. 
 














EPA: Collaborate as a member 
of an IPE team. 
EPA: Use evidence-based 
information to advance patient 
care. 
EPA: Oversee the pharmacy 
operations for an assigned 
shift. 
83.3% 16.7% Yes 
 
The systems-based practice/manager role, as defined from Research Question One 
was: "Pharmacists are committed to safety and quality in health care, professional 
advocacy, health insurance, health care economics, health outcomes, quality 
improvement, transitions of care, public health, and chronic care of patients. Pharmacists 
understand that they work as part of a larger "system" of health care and that to provide 
excellent, quality care, they need to be able to coordinate care within the systems, provide 
treatment recommendations that work with the patients' insurance, and be an advocate for 
optimal and quality patient care. Pharmacists also need to be an advocate for the 
profession on professional roles/responsibilities and the ability to bill for services." There 
were four competencies with a variety of EPAs mapped to the systems-based 
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practice/manager role. Consensus was achieved (≥80% Strongly Agree/Agree) on three of 
the four competencies/EPAs mapped to this role. Again, the Educator competency did not 
reach consensus, with only 79.2% of respondents Strongly Agreeing/Agreeing to the 
mapping to this role. Two respondents commented immunizations and identifying at-risk 
patients did not fit under this role. These suggestions were taken into account when the 
rewording of this mapping for the second-round survey. Table 11 shows the full results 
for this role. The competencies and EPAs mapped to this role are again very general. 
While they do fit under this role, they are not specific for the role, and some 
competencies are missing. For example, the Manager's competency is written to fit the 
broad healthcare system-based intent of this role. However, the EPAs underneath it is 
written to be at the patient level and not at the system level. The EPAs would need to be 
adjusted to assess competency for this role better. There are also competencies and EPAs 
missing. There are no competencies or EPAs related to professional advocacy (not 
advocating for the good of the patient but advocating for the good of the profession and 
its place in healthcare), health outcomes, quality improvement, transitions of care, and 
public health. 
Table 11 
Competencies/EPAs Mapped to Systems-based Practice/Manager Role 











(Manager):  Manage 
patient healthcare 
needs using human, 
financial, 
EPA: Collect information 
to identify a patient's 
medication-related 
problems and health-related 
needs. 
EPA: Establish patient-
centered goals and create a 





to optimize the 
safety and efficacy 
of medication use. 
 
care plan for a patient in 
collaboration with the 
patient, caregiver(s), and 
other health professionals 
that are evidence-based and 
cost-effective. 
EPA: Implement a care 
plan in collaboration with 
the patient, caregivers, and 
other health professionals. 
EPA: Follow-up and 
monitor a care plan.  
EPA: Identify patients at 
risk for prevalent disease in 
a population. 
EPA: Minimize adverse 
drug events and 
medications in a 
population. 
EPA: Maximize the 
appropriate use of 
medications in a 
population. 
EPA: Ensure that patients 
have been immunized 
against vaccine-preventable 
diseases. 
EPA: Oversee the 
pharmacy operations for an 
assigned shift. 





all audiences by 
determining the 
most effective and 





EPA: Identify patients at 
risk for prevalent disease in 
a population. 
EPA: Minimize adverse 
drug events and 
medications in a 
population. 
EPA: Maximize the 
appropriate use of 
medications in a 
population. 
EPA: Ensure that patients 
have been immunized 





EPA: Educate patients and 
professional colleagues 
regarding the appropriate 








interacting with an 
individual, group, or 
organization. 
EPA: Oversee the 
pharmacy operations for an 
assigned shift. 
EPA: Full-fill a medication 
order. 
 












EPA: Collaborate as a 
member of an IPE team. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate 
use of medication. 
EPA: Oversee the 









As defined in Research Question One, the collaborator role was: "Pharmacists work 
with other healthcare professionals to provide safe, high-quality, evidence-based, and 
patient-centered care. Pharmacists understand that being able to function effectively in an 
interprofessional team is necessary to provide safe, high-quality, and patient-centered 
care. Collaboration is also important with the patient and their support systems. 
Collaboration requires trust, respect, and shared decision-making. It also requires the 
sharing of knowledge, perspectives, responsibilities, and the willingness to learn from 
others. To effectively collaborate, one must understand the roles of others on the team, be 
able to articulate one's role on the team, be pursuing common goals, and be able to 
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manage conflict effectively." There were four competencies with a variety of EPAs 
mapped to the collaborator role. Consensus was achieved (≥80% Strongly Agree/Agree) 
on all four competencies/EPAs mapped to this role. This role did not need to be included 
in the second round Delphi survey. Table 12 shows the full results for this role. Overall 
the competencies under this role fit; however, just as with the other roles, the 
competencies/EPAs are general. The competencies and EPAs are not written to precisely 
match this role, and many of the EPAs fit under more than one competency. For example, 
if a student did not meet the EPA of “Collaborate as a member of an IPE team,” which 
competency is meeting it for, Problem Solver, Collaborator, or Communicator. There is 
also no competency or EPA related to conflict management. 
Table 12 
Competencies/EPAs Mapped to Collaborator Role 















and evaluate a viable 
solution. 
EPA: Collaborate as a 
member of an IPE team. 





determining the most 
effective and 





EPA: Implement a care 
plan in collaboration with 
the patient, caregivers, and 
other health professionals. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate 




















values to meet 
patient care needs. 
 
EPA: Follow-up and 
monitor a care plan. 
EPA: Collaborate as a 
member of an IPE team. 
EPA: Identify patients at 
risk for prevalent disease 
in a population. 
EPA: Minimize adverse 
drug events and 
medications in a 
population. 
EPA: Maximize the 
appropriate use of 
medications in a 
population. 
EPA: Ensure that patients 











interacting with an 
individual, group, or 
organization. 
EPA: Collaborate as a 
member of an IPE team. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate 
use of medication. 
95.8% 4.2% Yes 
 
The advocate/health promoter role, as defined in Research Question One, was: 
"Pharmacists are committed to using their expertise and influence to work with patient 
populations to improve health and wellness in communities. They work to understand the 
needs, speak on behalf of others, and seek to mobilize resources to effect change when 
needed. Pharmacists understand that improving health is not limited to treating illness but 
also includes disease prevention, health promotion, and health protection. They 
understand their unique place in the healthcare team, and society allows them access to 
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populations that others may not have. Pharmacists understand the need to work with 
patients to help them navigate complex medical situations to get the care they may need." 
There were four competencies with a variety of EPAs mapped to the advocate/health 
promoter role. Consensus was achieved (≥80% Strongly Agree/Agree) on all four 
competencies/EPAs mapped to this role. This role did not need to be included in the 
second round Delphi survey. Table 13 shows the full results for this role. The 
competencies mapped to this role are consistent with the intent of this role. However, just 
like the previous roles, the competencies and EPAs are not specific for this role, leaving 
it up to the schools/colleges of pharmacy to define the competency/EPAs' intent. 
Table 13 
Competencies/EPAs Mapped to Advocate/Health Promoter Role 
























EPA: Identify patients at risk 
for prevalent disease in a 
population. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the appropriate 
use of medications in a 
population. 
EPA: Ensure that patients have 
been immunized against 
vaccine-preventable diseases. 
 






EPA: Identify patients at risk 
for prevalent disease in a 
population. 










EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the appropriate 
use of medications in a 
population. 
EPA: Ensure that patients have 
been immunized against 
vaccine-preventable diseases. 
EPA: Educate patients and 
professional colleagues 











EPA: Establish patient-centered 
goals and create a care plan for 
a patient in collaboration with 
the patient, caregiver(s), and 
other health professionals that 
are evidence-based and cost-
effective. 
EPA: Collaborate as a member 
of an IPE team. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the appropriate 
use of medications in a 
population. 
EPA: Ensure that patients have 
been immunized against 
vaccine-preventable diseases. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate use of 
medication. 
 


















EPA: Collect information to 
identify a patient's medication-
related problems and health-
related needs. 
EPA: Establish patient-centered 
goals and create a care plan for 
a patient in collaboration with 
the patient, caregiver(s), and 
other health professionals that 
are evidence-based and cost-
effective. 
EPA: Identify patients at risk 
for prevalent disease in a 
population. 
EPA: Minimize adverse drug 
events and medications in a 
population. 
EPA: Maximize the appropriate 
use of medications in a 
population. 
EPA: Ensure that patients have 
been immunized against 
vaccine-preventable diseases. 
EPA: Educate patients and 
professional colleagues 
regarding the appropriate use of 
medication. 
EPA: Use evidence-based 











After round one of the Delphi survey, two of the roles, patient care skills and 
systems-based practice/manager, had competencies/EPAs that did not reach consensus (2 
competencies/EPA mappings out of 25 [8%]). For round two of the Delphi survey, 
participants were asked for consensus on updated mapping for these two roles. For 
patient care skills, splitting of the educator competency into two competencies occurred. 
One competency defined education for patients: "Educate patients and their caregivers by 
determining the most effective and enduring ways to impart information and assess 
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understanding." The other competency defined Healthcare professional education: 
"Educate healthcare providers by determining the most effective and enduring ways to 
impart information and assess understanding.". Both competencies had the same three 
EPAs mapped to them related to minimizing adverse effects, maximizing the appropriate 
use of medications, and providing education. For systems-based practice/manager, 
removing the EPAs related to immunizations and identifying patients at risk occurred, but 
rewording of the competency itself did not occur. These updated competency/EPA 
mappings, along with the changes made to the survey upon review of the data for 
Research Question Three, formed the round two Delphi survey. The same group of 
participants as round one received the updated survey.  
Round Two. The second round of the Delphi survey followed the same survey 
procedure as round one, except questions were only asked on items that did not meet 
consensus during round one (2 competencies/EPA mappings out of 25 [8%]). The same 
participant group was used as round one. The second round Delphi survey had a total of 
19 participants respond (30.2% response rate). Six (31.6%) of the respondents had >20 
years of experience, five (9%) had 11-20 years of experience, seven (36.8%) had 5-10 
years of experience, zero (80%) had <5 years of experience, and one preferred not to 
answer (5.3%). Six (31.6%) respondents were male, 11 (58.0%) were female, and two 
(10.5%) preferred not to answer. Fifteen (78.9%) had practice sites in urban locations, 
three (15.8%) had rural practice sites, and one (5.3%) preferred not to answer. One 
(5.3%) respondent was an acute care pharmacist, nine (47.4%%) were ambulatory care 
pharmacists, two (10.5%%) were community pharmacists, two (10.5%) were in 
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academia, two (10.5%) were hospital pharmacists, two (10.5%) were in management, and 
one (5.2%) preferred not to answer. 
Under the patient care skills role, the Educator competency did not meet consensus 
during round one. Comments from respondents suggested that the EPAs related to 
implementation, identifying patients at risk, and immunizations did not fit under this 
competency for this role. Removal of these EPAs occurred from the question for this 
round. Respondents also suggested splitting the Educator competency for this role into 
two competencies, one related to healthcare professionals and one for patients. For round 
two, the division of this competency into Patient Educator and Healthcare Professional 
Educator occurred. Patient Educator's definition was "educating patients and their 
caregivers by determining the most effective and enduring ways to impart information 
and assess understanding." This competency then had three EPAs mapped to it. The 
definition of Healthcare Professional Educator was "educating healthcare providers by 
determining the most effective and enduring ways to impart information and assess 
understanding." This competency also had three EPAs mapped to it. Consensus was 
achieved (≥80% Strongly Agree/Agree) for all the mapping to this role, so this role's 
inclusion in the round three survey did not occur. The results are below in Table 14. The 
changes made based on the participants' feedback after round one did not address the 
issues discussed related to this mapping after round one. The competencies and EPAs are 
still very general and map to multiple roles. Even with splitting the Educator competency 
into two parts, the patient educator's coverage occurs in multiple roles, and the EPAs 
mapped are still not specific for this particular role. There was also no suggestion to add 
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competencies related to the patient's cultural and financial status, which would be needed 
to assess this role adequately. 
Table 14 
Updated Competencies/EPAs Mapped to Patient Care Skills Role 











and their caregivers 
by determining the 
most effective and 





EPA: Minimize adverse 
drug events and medications 
in a population. 
EPA: Maximize the 
appropriate use of 
medications in a population. 
EPA: Educate patients and 
caregivers regarding the 
appropriate use of 
medication 
 








most effective and 




EPA: Minimize adverse 
drug events and medications 
in a population. 
EPA: Maximize the 
appropriate use of 
medications in a population. 
EPA: Educate professional 
colleagues regarding the 
appropriate use of 
medication. 
94.7% 5.3% Yes 
     
 
Systems-based practice/manager had one competency not meet consensus during 
round one. Respondents in round one did not feel immunizations and identifying at-risk 
patients fit under this role. For the round two survey questions related to this competency, 
removing the EPAs related to immunizations and identifying at-risk patients occurred. 
Consensus was achieved (≥80% Strongly Agree/Agree) for the mapping to this role, so 
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this role's inclusion did not occur in the round three survey. The results are below in 
Table 15. These changes still did not address the issues discussed after round one related 
to this role. The competencies and EPAs are still not written to match this role precisely 
and many of the EPAs fit under more than one competency. There is also still no 
competency or EPA related to conflict management. 
Table 15 
Updated Competencies/EPAs Mapped to Systems-based Practice/Manager Role 









Educate all audiences 
by determining the 
most effective and 





• EPA: Minimize 
adverse drug events 
and medications in a 
population. 
• EPA: Maximize the 
appropriate use of 
medications in a 
population. 




the appropriate use of 
medication. 
94.7% 5.3% Yes 
 
After round two of the Delphi survey, all competencies and EPAs mapped to the core 
roles developed in Research Question One met consensus. Since all competency and EPA 
mapping met consensus, there was no need for a round three survey for Research 
Question Two. Research Question Two asked the following:  According to pharmacy 
practitioners, what is the alignment of the current pharmacy competencies and entrustable 
professional activities (EPAs) to the core professional roles? Appendix F shows the 
alignment of the current pharmacy competencies and EPAs to the core professional roles 
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developed in Research Question One. The average number of competencies under each 
role was 4 (1-6), with the most in the patient care skills role. The average number of 
EPAs mapped to each role was 17 (5-36), with patient care skills having the most EPAs. 
The pharmacy roles developed in Research Question One are distinct and meant to stand 
alone. However, the competencies and EPAs mapped to these roles are duplicative across 
roles, as discussed previously. This duplication makes it hard for schools/colleges of 
pharmacy to know for sure which role a student is competent in just by meeting the 
competency/EPA as written. 
The core role of knowledge had one competency, Learner, mapped to it along with 
five EPAs. There were no missing competencies for this role. However, separation of the 
mapped competency into more specific competencies related to the role would help 
determine a student’s real areas of weakness. The patient care skills role had five 
competencies mapped to it:  Caregiver, Promoter, Problem Solver, Educator, and 
Communicator. One pharmacy competency change occurred with the mapping to this 
role. Delphi participants felt the Educator competency needed divided into patient 
education and healthcare professional education for this role, given the importance of 
education in patient care skills. The competencies had 3-12 EPAs mapped to them with 
Communicator having the most. Two competencies are missing related to the cultural and 
financial status of the patient for this role. 
The professionalism role had four competencies mapped to it:  Self-aware, Leader, 
Innovator, and Professional. Each competency has 3-4 EPAs mapped to it with 
Professional having the most. No competencies or EPAs were missing, but the 
competencies and EPAs are very general. Scholarship has three competencies mapped to 
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it:  Educator, Communication, and Innovator. Each competency has 2-6 EPAs mapped to 
it with Educator having the most. Competencies are missing for this role related to ethics 
and maintenance of personal health. Systems-based practice/manager had four 
competencies mapped:  Manager, Educator, Communicator, and Leader. Each 
competency had 3-10 EPAs mapped to them, with Manager having the most EPAs. The 
systems-based practice/manager role had several competencies missing. There are no 
competencies or EPAs related to professional advocacy (not advocating for the good of 
the patient but advocating for the good of the profession and its place in healthcare), 
health outcomes, quality improvement, transitions of care, and public health. 
Collaborator had four competencies mapped:  Problem Solver, Educator, 
Collaborator, and Communicator. Each competency had 1-6 EPAs mapped to it, with 
Collaborator having the most. The collaborator role was missing a competency and/or 
EPA(s) related to conflict management. Lastly, advocate/health promoter had four 
competencies mapped to it: Provider, Educator, Advocate, and Includer. Each 
competency had 4-8 EPAs mapped to it, with Includer having the most. No competencies 
were missing for this role.  
Mapping of all current pharmacy competencies and EPAs to the core roles from 
Research Question One occurred with no changes occurring in the wording of the EPAs 
or the addition of any EPAs (with exception of splitting one EPA for one competency). 
The lack of changes or additions to the already developed EPAs from AACP meant a 
baseline level of entrustment that could form the first Delphi survey for Research 
Question Three. The purpose of Research Question Three was to obtain a consensus on 
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the level of entrustment that students should achieve by graduation for each of the EPAs 
mapped to the pharmacy competencies. 
Research Question Three 
Research Question Three was:  According to pharmacy practitioners, what level 
of entrustment should pharmacy graduates be expected to achieve for each EPA? This 
research question used the same Delphi technique as research question two to 
simultaneously collect quantitative and qualitative data (Delbecq et al., 1975). Like the 
NGT process, the Delphi technique offered a framework for gathering stakeholder data 
on topics that call for aggregation of individual judgments such as Research Question 
Three. Research Question Three sought to examine if there was a broad consensus from 
different pharmacy practices on the entrustment level (Research Question Three) 
assigned to the EPAs from the mapping for Research Question Two. 
There were five levels of entrustment defined for this survey. Specifically, Level 1 
entrustment suggests a student can observe but not complete a task (e.g., a student may 
observe but not do a patient's medication history). Level 2 is execution with direct and 
proactive supervision (e.g., student will perform the medication history with the 
pharmacist in the room providing advice). Level 3 is performance with quickly available 
(reactive) supervision (e.g., the student will perform the medication history alone with the 
pharmacist in the next room should help be needed). Level 4 is execution with 
supervision from a distance or when asked for by the student (e.g., a student can be freely 
trusted to perform the history without any help). Level 5 is the ability to teach someone 
else the skill (ten Cate, 2013). 
Questions related to the levels of entrustment a student should achieve upon 
graduation were devised for each of the AACP EPA statements. The level of entrustment 
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chosen as the starting point for round one was a Level 3 (performance with quickly 
available [reactive] supervision). This level of entrustment was chosen to be in-line with 
the recommendations from the AACP Academic Affairs Standing Committee, who 
developed the EPAs (Jarrett et al., 2018). For example, participants were presented with 
an EPA with a level of entrustment: “Collect information to identify a patient’s 
medication-related problems and health-related needs (Level 3).”  Participants were then 
asked to report their level of agreement with the alignment of that level of entrustment for 
that EPA on a four-point Likert scale (1 = Strongly Disagree to 4= Strongly Agree) 
similar to Research Question Two. For round one, participants were also given a fifth 
option of choosing "depends on the role." The "depends on the role" would indicate that 
respondents felt the level of entrustment would change depending on the EPA's role 
mapping. Removal of this option occurred for rounds two and three. 
Round One. Just as for Research Question Two, aggregation of the results from the 
selected-response (Likert scale) questions into three categories occurred for Round One:  
Category 1 - Strongly Agree/Agree, Category 2 – Disagree/ Strongly Disagree, and 
Category 3 – “depends on the role” from each panelist's response to determine if 
consensus was achieved. Rounds two and three only used Category 1 and Category 2 for 
aggregation. Computation of the percent number of responses for each category then 
occurred for each question. For example, if 50 participants completed the survey with 30 
indicating Strongly Agree and ten indicating Agree for a question, then the percent 
response for Category 1 (Strongly Agree/Agree) would be 80%. For there to be consensus 
on the competency/EPA alignment, there had to be a category score of ≥ 80% Strongly 
Agree/Agree for the question. A review of constructed-response comments occurred for 
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any question that did not achieve consensus (≥ 80% agreement) using structural coding 
via NiViVo software (NiViVo qualitative data analysis software, 2019). Once a mapping 
reached consensus (≥ 80% Strongly Agree/Agree), it was no longer included in 
subsequent round surveys. 
The questions related to the EPA levels of entrustment were included in the same 
round one survey as Research Question Two. Participants did not have to complete both 
sections of the survey to have their data included. The first round Delphi survey for 
Research Question Three had a total of 21 participants respond (33.3% response rate). 
Five (23.8%) of the respondents had >20 years of experience, seven (33.3%) had 11-20 
years of experience, seven (33.3%) had 5-10 years of experience, and two (9.5%) had <5 
years of experience. Eight (38.1%) of respondents were male, and 13 (61.9%) were 
female. Fifteen (71.4%) of respondents have practice sites in urban settings and six (28.6) 
practice in rural settings. Five (23.8%) respondents were acute care pharmacists, eight 
(38.1%) were ambulatory care pharmacists, four (19.0%) were community pharmacists, 
two (9.5%) were in academia, and two (9.5%) were in other types of practice. 
Of the fifteen EPAs, only four achieved consensus for students to meet a Level 3 
(performance with quickly available [reactive] supervision) of entrustment upon 
graduation after the first round Delphi survey. Respondents did not feel the four EPAs 
that achieved consensus had a different level of entrustment depending on the role 
mapping. For the remaining eleven EPAs, respondents felt the level of entrustment would 
vary depending on the role mapping from Research Question Two (Appendix F). 
Respondents also felt that students should meet higher levels of entrustment for two of 
the EPAs upon graduation. These EPAs were "Collect information to identify a patient's 
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medication-related problems and health-related needs" and "Educate patients and 
professional colleagues regarding the appropriate use of medication." Respondents felt 
that students should meet a Level 4 (execution with supervision from a distance or when 
asked for by the student) for entrustment upon graduation for these EPAs. For six of the 
EPAs, respondents felt the level of entrustment should be less than 3 upon graduation. 
For these six EPAs, respondents felt students should only achieve a Level 2 (execution 
with direct and proactive supervision) upon graduation. Table 16 shows the full results. 
The other comment that was constant for all the EPAs is the respondents were not sure 
where in the curriculum students were being assessed. 
Table 16 











Collect information to identify a 
patient's medication-related problems 
and health-related needs. (Level 3) 
72.7% 4.5 22.7% No 
 
Analyze information to determine the 
effects of medication therapy, identify 
medication-related problem, and 














Establish patient-centered goals and 
create a care plan for a patient in 
collaboration with the patient, 
caregiver(s), and other health 
professionals that are evidence-based 
and cost-effective. (Level 3) 
 
71.4% 4.8% 23.8% No 
Implement a care plan in collaboration 
with the patient, caregivers, and other 
health professionals. (Level 3) 











Follow-up and monitor a care plan. 
(Level 3) 
 
81.0% 4.8% 14.3% Yes 
Collaborate as a member of an IPE 
team. (Level 3) 
 
81.0% 0% 19.0% Yes 
Identify patients at risk for prevalent 
disease in a population. (Level 3) 
 
85.7% 0% 14.3% Yes 
Minimize adverse drug events and 
medications in a population. (Level 3) 
 
71.4% 4.8% 23.8% No 
Maximize the appropriate use of 
medications in a population. (Level 3) 
 
76.2% 9.5% 14.3% No 
Ensure that patients have been 
immunized against vaccine-
preventable diseases. (Level 3) 
 
95.2% 0% 4.8% Yes 
Educate patients and professional 
colleagues regarding the appropriate 
use of medication. (Level 3) 
 
76.2% 0% 23.8% No 
Use evidence-based information to 
advance patient care. (Level 3) 
 
76.2% 0% 23.8% No 
Oversee the pharmacy operations for 
an assigned shift. (Level 3) 
 
38.1% 33.3% 28.6% No 
Full-fill a medication order. (Level 3) 
 
71.4% 9.5% 19.0% No 
Create a written plan for continuous 
professional development. (Level 3) 
76.2% 9.5% 14.3% No 
 
 Based on the first round of the Delphi survey for Research Question Three, 
respondents were unsure where in the curriculum students were being assessed and felt 
that most of the EPAs' level of entrustment depended on the role mapping. For the second 
round Delphi survey, directions to the respondents were made more explicit that 
entrustment levels are being assigned based on students at graduation (in their final 
rotation). The survey for round two asked respondents whether they agree with the EPAs' 
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levels of entrustment based on their role mapping. Levels of entrustment were also 
adjusted up or down based on participants’ comments. The combination of this updated 
survey and changes from Research Question Two was sent to the same group of 
participants as the round one survey.  
Round Two. The second round of the Delphi survey followed the same survey 
procedure as round one, except questions were only asked on items that did not meet 
consensus during round one (11/15 [73.3%] did not meet consensus). The same 
participant group was used as round one as well. The second round Delphi survey had a 
total of 18 participants respond (28.6% response rate). Six (33.3%%) of the respondents 
had >20 years of experience, five (27.8%) had 11-20 years of experience, seven (38.9%) 
had 5-10 years of experience, and zero (80%) had <5 years of experience. Six (33.3%%) 
respondents were male, 11 (61.1%) were female, and one (5.6%) preferred not to answer. 
Fifteen (83.3%) had practice sites in urban locations, and three (16.7%) had rural practice 
sites. One (5.6%) respondent was an acute care pharmacist, nine (50%) were ambulatory 
care pharmacists, two (11.1%) were community pharmacists, two (11.1%) were in 
academia, two (11.1%) were hospital pharmacists, and two (11.1%) were in management. 
Usage of the same five levels of entrustment occurred for this survey as in Round 
One. Level 1 entrustment suggests a student can observe but not complete a task (e.g., a 
student may observe but not do a medication history on a patient). Level 2 is execution 
with direct and proactive supervision (e.g., student will perform the medication history 
with the pharmacist in the room providing advice). Level 3 is performance with quickly 
available (reactive) supervision (e.g., the student will perform the medication history 
alone with the pharmacist in the next room should help be needed). Level 4 is execution 
158 
 
with supervision from a distance or when asked for by the student (e.g., a student can be 
freely trusted to perform the history without any help). Level 5 is the ability to teach 
someone else the skill (ten Cate, 2013). 
Per the results from round one, EPA mapping to the core roles with levels of 
entrustment provided by the participants’ comments occurred. The knowledge role had 
five EPAs mapped to it all with Level 3 entrustment (performance with quickly available 
[reactive] supervision). Consensus was achieved (>80% Strongly Agree/Agree) for the 
mapping to this role, so the inclusion of these EPAs was not needed in the round three 
survey. The results are below in Table 17. Participants felt that students should have the 
knowledge related to each of the EPA statements and should be trusted to discuss this 
knowledge with minor involvement of the preceptor. The only issue is that the EPAs 
listed under this role do not cover all the knowledge components required to be 
competent in this role adequately.  
Table 17 









EPA: Analyze information to determine the effects 
of medication therapy, identify medication-related 
problems, and prioritize health-related needs. 
(Level 3) 
 
88.9% 11.1% Yes 
EPA: Establish patient-centered goals and create a 
care plan for a patient in collaboration with the 
patient, caregiver(s), and other health 
professionals that are evidence-based and cost-
effective. (Level 3) 
 
94.4% 5.6% Yes 
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EPA: Educate patients and professional colleagues 
regarding the appropriate use of medication. 
(Level 3) 
 
88.9% 11.1% Yes 
EPA: Use evidence-based information to advance 
patient care. (Level 3) 
94.4% 5.6% Yes 
 
The patient care skills role has ten EPAs mapped to it. Nine of the ten EPAs achieved 
consensus (≥80% Strongly Agree/Agree) after round two. The inclusion of these nine 
EPAs did not occur in the round three Delphi survey. One EPA, “Implement a care plan 
in collaboration with the patient, caregivers, and other healthcare professionals,” did not 
achieve consensus at an entrustment level 2 (execution with direct and proactive 
supervision). Delphi participants felt this EPA should be at least a Level 3 (performance 
with quickly available [reactive] supervision) at graduation. Table 18 contains the survey 
results for this role. Participants felt that four of the EPAs related to analyzing 
information from patients, establishing patient-centered goals, full-filling medication 
orders, and using evidence-based information students should achieve a Level 3 
(performance with quickly available [reactive] supervision) at graduation. Participants 
felt that the ability to collect information from patients should be at a Level 4 (execution 
with supervision from a distance or asked for by the student). Lastly, three of the EPAs 
related to maximizing medication use in a population, minimizing adverse drug events, 
and overseeing pharmacy operations, participants felt students should achieve a Level 2 
(execution with direct and proactive supervision) upon graduation. Overall the EPAs 
mapped to this role match well with the competencies mapped and the role itself, except 
for Educator, which had EPAs which were not role-specific. The problem is that the 
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EPAs are not specific for only this role, so how is a school/college to know if the student 
is achieving this role when meeting the EPA or another role? 
Table 18 









EPA: Collect information to identify a patient’s 
medication-related problems and health-related 
needs. (Level 4) 
 
94.4% 5.6% Yes 
EPA: Analyze information to determine the 
effects of medication therapy, identify 
medication-related problems, and prioritize 





EPA: Establish patient-centered goals and create a 
care plan for a patient in collaboration with the 
patient, caregiver(s), and other health 
professionals that are evidence-based and cost-
effective. (Level 3) 
 
94.4% 5.6% Yes 
EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 2) 
 
66.7% 33.3% No 
EPA: Maximize the appropriate use of 
medications in a population. (Level 2) 
 
94.4% 5.6% Yes 
EPA: Minimize adverse drug events and 
medications in a population. (Level 2) 
 
94.4% 5.6% Yes 
EPA: Oversee the pharmacy operations for an 
assigned shift. (Level 2) 
 
100% 0% Yes 
EPA: Full-fill a medication order. (Level 3) 
 
88.9% 11.1% Yes 
EPA: Educate patients and professional 
colleagues regarding the appropriate use of 
medication. (Level 4) 
 




 The professionalism role has four EPAs mapped to it with levels of entrustment 
ranging from 2-4. All ten EPAs achieved consensus (≥80% Strongly Agree/Agree) after 
round two. The inclusion of these EPAs did not occur in round three of the Delphi 
survey. Table 19 contains the survey results for this role. Participants felt that students 
should achieve an entrustment level of 2 upon graduation (execution with direct and 
proactive supervision) for the EPA related to overseeing pharmacy operations. Students 
should achieve an entrustment level of 3 (performance with quickly available [reactive] 
supervision) for items related to developing plans for professional development and using 
evidence-based medicine. Lastly, students should achieve an entrustment level of 4 
(execution with supervision from a distance or when asked by the student) to educate 
patients and colleagues. The EPAs mapped to this role are not specific for the definitions 
and competencies mapped for this role. The lack of specificity means that 
schools/colleges will need to further define these for themselves to know if students are 
achieving this role. 
Table 19 
EPAs with Level of Entrustment for the Professionalism Role 
Use evidence-based information to advance 
patient care. (Level 3) 









EPA: Oversee the pharmacy operations for an 
assigned shift. (Level 2) 
 
100% 0% Yes 
EPA: Create a written plan for continuous 
professional development (Level 3) 
 




The scholarship role had six EPAs mapped to it with levels of entrustment ranging 
from 2-4. Four of the EPAs achieved consensus (≥80% Strongly Agree/Agree) after 
round two with entrustment levels from 2-4. The inclusion of these EPAs did not occur in 
round three of the Delphi survey. The two EPAs that met consensus were related to 
minimizing adverse drug events and maximizing medication use in the population. 
Participants felt that students should achieve an entrustment level of 2 (execution with 
direct and proactive supervision ) upon graduation. Two of the EPAs did not achieve 
consensus. The EPA “Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals” did not achieve consensus at a Level 2 (execution with 
direct and proactive supervision). Participants felt this EPA should be at least a Level 3 
(performance with quickly available [reactive] supervision). The EPA “Educate patients 
and professional colleagues regarding the appropriate use of medication” did not achieve 
consensus at a Level 4 (execution with supervision from a distance or when asked for by 
the student). Participants felt this EPA should be a Level 3 [performance with quickly 
available (reactive) supervision], a different level of attainment than in other roles. Some 
participants mentioned that maybe this EPA should not be under this role. The EPA was 
left, however, because it reached consensus under Research Question 2. The inclusion of 
these two EPAs occurred in the round three Delphi Survey. Table 20 contains the survey 
results. Just as discussed in previous roles, while these EPAs do somewhat fit this role, 
EPA: Educate patients and professional 
colleagues regarding the appropriate use of 
medication. (Level 4) 
 
83.3% 16.7% Yes 
EPA: Use evidence-based information to advance 
patient care. (Level 3) 
88.9% 11.1% Yes 
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they are not explicitly written for this role, making it hard to know which role the student 
is achieving. 
Table 20 
EPAs with Level of Entrustment for the Scholarship Role 
 
The systems-based/practice manager role had eight EPAs mapped to it with 
entrustment levels ranging from 2-4. All ten EPAs achieved consensus (≥80% Strongly 
Agree/Agree) after round two. The inclusion of these EPAs did not occur in round three 
of the Delphi survey. Table 21 contains the survey results for this role. Participants felt 
that students should achieve an entrustment level 2 (execution with direct and proactive 
supervision ) for EPAs to minimize adverse drug events, maximize the appropriate use of 
medications, and oversee pharmacy operations. Students should achieve an entrustment 









EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 2) 
 
61.1% 38.9% No 
EPA: Minimize adverse drug events and 
medications in a population. (Level 2) 
 
83.3% 16.7% Yes 
EPA: Maximize the appropriate use of 
medications in a population. (Level 2) 
 
83.3% 16.7% Yes 
EPA: Educate patients and professional colleagues 
regarding the appropriate use of medication. 
(Level 4) 
77.8% 22.2% No 
EPA: Use evidence-based information to advance 
patient care. (Level 3) 
 
88.9% 11.1% Yes 
EPA: Oversee the pharmacy operations for an 
assigned shift. (Level 2) 
88.9% 11.1% Yes 
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establishing patient-centered goals and care plans, implementing care plans, and full-
filling medication orders. Lastly, students should achieve an entrustment level of 4 
(execution with supervision from a distance or when asked by the student) for EPAs 
related to collecting patient information and educating patients and colleagues. These 
EPAs' entrustment levels are the same as those seen for previous roles for these EPAs. 
While these EPAs do fit under this role, they are written more at the patient level than at 
the broader systems-level leaving it to the school/college to define attainment for 
themselves. There are also no EPAs related to professional advocacy (not advocating for 
the good of the patient but advocating for the good of the profession and its place in 
healthcare), health outcomes, quality improvement, transitions of care, and public health. 
Table 21 









EPA: Collect information to identify a patient’s 
medication-related problems and health-related 
needs. (Level 4) 
 
94.4% 5.6% Yes 
EPA: Establish patient-centered goals and create a 
care plan for a patient in collaboration with the 
patient, caregiver(s), and other health 
professionals that are evidence-based and cost-
effective. (Level 3) 
 
88.9% 11.1% Yes 
EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 3) 
 
88.9% 11.1% Yes 
EPA: Minimize adverse drug events and 
medications in a population. (Level 2) 
 
94.4% 5.6% Yes 
EPA: Maximize the appropriate use of 
medications in a population. (Level 2) 




The collaborator role had four EPAs mapped to it with levels of entrustment ranging 
from 2-4. Three of the EPA achieved consensus (≥80% Strongly Agree/Agree) after 
round two with entrustment levels from 2-4. The inclusion of these EPAs did not occur in 
round three of the Delphi survey. Participants felt that students should achieve 
entrustment levels of 2 (execution with direct and proactive supervision) for EPAs related 
to minimizing adverse drug events and maximizing the appropriate use of medications. 
Students should achieve an entrustment level of 4 (execution with supervision from a 
distance or when asked for by the student) for the EPA related to educating patients. 
These entrustment levels are the same as other roles to which these EPAs are mapped. 
One of the EPAs did not achieve consensus: “Implement a care plan in collaboration with 
the patient, caregivers, and other health professionals” at a Level of 2 (execution with 
direct and proactive supervision). Participants felt this EPA should be at least a Level 3 
(performance with quickly available [reactive] supervision). The inclusion of this EPA 
did occur in the round three Delphi Survey. Table 22 contains the survey results and 
comments for this role. Like the other roles, the EPAs mapped to this role do fit, but they 
are not role-specific, leaving it up to schools/colleges of pharmacy to further define. 
There is also no EPA related to conflict management. 
Table 22 
 
EPA: Oversee the pharmacy operations for an 
assigned shift. (Level 2) 
 
100% 0% Yes 
EPA: Full-fill a medication order. (Level 3) 
 
83.3% 16.7% Yes 
EPA: Educate patients and professional colleagues 
regarding the appropriate use of medication. 
(Level 4) 
88.9% 11.1% Yes 
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EPAs with Level of Entrustment for the Collaborator Role 
The advocate/health promoter role has six EPAs mapped to it with entrustment levels 
ranging from 2-4. All six EPAs achieved consensus (≥80% Strongly agree/Agree) after 
round two. The inclusion of these EPAs did not occur in round three of the Delphi 
survey. Table 23 contains the survey results for this role. Participants felt that students 
should achieve an entrustment level of 2 (execution with direct and proactive 
supervision) for EPAs to minimize adverse drug events and maximize appropriate 
medication use. Students should achieve an entrustment Level 3 (performance with 
quickly available [reactive] supervision) for EPAs to establish patient-centered goals and 
use evidence-based medicine. Lastly, students should achieve an entrustment Level 4 
(execution with supervision from a distance or when asked by the student) for EPAs 
related to educating patients/colleagues and collecting patient information. These levels 
of entrustment are the same as recommended for previous roles to which these EPAs 
were mapped. Once again, these EPAs do fit under this role, but they are not role-









EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 2) 
 
72.2% 27.8% No 
EPA: Educate patients and professional colleagues 
regarding the appropriate use of medication. 
(Level 4) 
 
83.3% 16.7% Yes 
EPA: Minimize adverse drug events and 
medications in a population. (Level 2) 
 
94.4% 5.6% Yes 
EPA: Maximize the appropriate use of 
medications in a population. (Level 2) 




EPAs with Level of Entrustment for the Advocate/Health Promotor Role 
  
After round two, there were still four EPAs that had not met consensus for their 
level of entrustment for the roles they were mapped to in Research Question Two. These 
EPAs fell in patient care skills, scholarship, and collaborator role. The EPA not meeting 
consensus in the patient care skills role was increased to an entrustment level of 3 
(performance with quickly available [reactive] supervision). The two EPAs under the 
scholarship role were also increased to an entrustment level of 3 as was the one EPA 
under collaborator. The updated survey was sent to the same participants as rounds one 









EPA: Minimize adverse drug events and 
medications in a population. (Level 2)  
 
94.4% 5.6% Yes 
EPA: Maximize the appropriate use of 
medications in a population. (Level 2) 
 
94.4% 5.6% Yes 
EPA: Educate patients and professional 
colleagues regarding the appropriate  use of 
medication. (Level 4) 
 
88.9% 11.1% Yes 
EPA: Establish patient-centered goals and create 
a care plan for a patient in collaboration with the 
patient, caregiver(s), and other health 
professionals that are evidence-based and cost-
effective. (Level 3) 
 
88.9% 11.1% Yes 
EPA: Collect information to identify a patient’s 
medication-related problems and health-related 
needs. (Level 4) 
 
83.3% 16.7% Yes 
EPA: Use evidence-based information to advance 
patient care. (Level 3) 
88.9% 11.1% Yes 
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Round Three. The third round of the Delphi survey followed the same survey 
procedure as round one and two, except questions were only asked on items that did not 
meet consensus during round two (4/117 [3.4%] EPA mappings to the roles). The same 
participant group was used as round one as well. The second round Delphi survey had a 
total of 13 participants respond (20.6% response rate). Five (38.5%) of the respondents 
had >20 years of experience, two (15.4%) had 11-20 years of experience, four (30.8%) 
had 5-10 years of experience, and two (15.4%) had <5 years of experience. Three 
(23.1%) respondents were male, Nine (69.2%) were female, and one (7.7%) preferred not 
to answer. Nine (69.2%) had practice sites in urban locations and four (30.8%) had rural 
practice sites. One (7.7%) respondent was an academic pharmacist, six (46.2%) were 
ambulatory care pharmacists, two (15.4%) were community pharmacists, and four 
(30.8%) were hospital pharmacists. 
Usage of the same five levels of entrustment occurred for this survey as in rounds 
one and two. Level 1 entrustment suggests a student can observe but not complete a task 
(e.g., a student may observe but not do a medication history on a patient). Level 2 is 
execution with direct and proactive supervision (e.g., student will perform the medication 
history with the pharmacist in the room providing advice). Level 3 is performance with 
quickly available (reactive) supervision (e.g., the student will perform the medication 
history alone with the pharmacist in the next room should help be needed). Level 4 is 
execution with supervision from a distance or when asked for by the student (e.g., a 
student can be freely trusted to perform the history without any help). Level 5 is the 
ability to teach someone else the skill (ten Cate, 2013). 
169 
 
 Three roles, patient care skills, scholarship, and collaborator, had EPAs mapped 
to them that did not reach consensus regarding their level of entrustment during round 
two. After round three, the one EPA under patient care skills related to implementing a 
care plan and both EPAs under scholarship related to implementing a care plan and 
educating patients/colleagues met consensus (≥80% Strongly Agree/Agree). However, the 
EPA under collaborator did not meet consensus. The EPA that did not meet consensus 
under collaborator was “Implement a care plan in collaboration with the patient, 
caregivers, and other health professionals.”  Delphi participants felt assigning a level was 
difficult for this EPA as collaborating with other health care professionals requires time 
to build relationships, which is sometimes hard given the short time students are on 
rotation. Also, the ability to do this EPA is dependent on the complexity of the patient 
care plans. Table 24 shows the full results from the third round. 
Table 24 









Patient Care Skills 
EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 3) 
92.3% 7.7% Yes 
Scholarship 
EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 3) 
 
84.6% 15.4% Yes 
EPA: Educate patients and professional 
colleagues regarding the appropriate use of 
medication. (Level 3) 





The final overall competency and EPA with levels of entrustment mapping 
(Appendix F) answers Research Question 3:   What level of entrustment should pharmacy 
graduates be expected to achieve for each EPA? All but five of the EPA statements were 
determined to have levels of entrustment at Level 3. “Collect information to identify a 
patient’s medication-related problems and health-related needs” was given a Level 4 
(execution with supervision from a distance or when asked for by the student ) 
entrustment regardless of the role and competency mapping. “Maximize the appropriate 
use of medication in a population and “Minimize adverse drug events and medications in 
a population” were a Level 2 (execution with direct and proactive supervision) 
entrustment regardless of the role and competency mapping. “Oversee the pharmacy 
operation for an assigned shift” also had a Level 2 entrustment regardless of the role and 
competency mapping. 
The EPA, “Educate patients and professional colleagues regarding the appropriate 
use of medication,” was given different entrustment levels depending on the role 
mapping. The level of entrustment given was consistent within the role and did not 
depend on the competency it was mapped too. For the roles of knowledge and 
scholarship, the EPA had a Level 3 [performance with quickly available (reactive) 
supervision] entrustment. Whereas for patient care skills, professionalism, systems-based 
practice/manager, collaborator, and advocate/health promoter, a Level 4 entrustment was 
given.  
EPA: Implement a care plan in collaboration with 
the patient, caregivers, and other health 
professionals. (Level 3) 
76.9% 23.1% No 
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Only one EPA did not meet consensus for its entrustment level upon completion 
of the third Delphi round. This EPA was “Implement a care plan in collaboration with the 
patient, caregivers, and other health professionals, under the Collaborator role. This EPA, 
however, did meet consensus for a Level 3 [performance with quickly available (reactive) 
supervision] entrustment in other roles. This EPA will remain under the collaborator role 
in the mapping but will not be assigned a level of entrustment since there was no 
consensus on a level.  
Upon the conclusion of this study, all three research questions were answered. 
The final core role proposal in Appendix D answers Research Question One:  What are 
the core professional roles pharmacy programs believe students should be able to 
demonstrate competency in upon graduation?  Pharmacy expert became the central role 
of a pharmacist with several core roles defining it. The core roles included knowledge, 
patient care skills, professionalism, scholarship, systems-based practice, and collaborator. 
The core roles were then used to answer research questions two and three:   
1. What is the alignment of the current pharmacy competencies and entrustable 
professional activities (EPAs) to the core professional roles?    
2. What level of entrustment should pharmacy graduates be expected to achieve for 
each EPA?    
The alignment of the current pharmacy competencies and EPAs with their levels of 
entrustments developed during the Delphi process for Research Questions Two and Three 
is in Appendix F. Consensus occurred on all competency and EPA mappings. Consensus 
occurred on all but one of the EPA levels of entrustment under the collaborator role. 
Overall, the entrustment levels were consistent for all EPAs regardless of the role and 
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competency mapping except for the EPA related to education. The EPAs related to 
educating patients and colleagues did have a level of entrustment that varied depending 
on the role mapping. Once under a role, however, the EPA had the same level of 
entrustment regardless of the role's competency mapping. More research is needed to 
verify this pilot study's results and determine why the EPA related to implementation did 




CHAPTER 5: DISCUSSION             
In 2013, pharmacy programs developed and subsequently implemented pharmacy 
competencies (CAPE outcomes) and EPAs to mirror medicine to help define and assess 
the knowledge, skills, and attitudes needed by students upon graduation (Medina et al., 
2013; Pittenger et al., 2017). While the CAPE outcomes are required to be used by 
schools/colleges for accreditation, EPAs are not. EPAs also do not have an accreditation 
required defined level of entrustment, which allows pharmacy programs to set this for 
themselves. Consequently, this inconsistency means that students may be prepared 
differently for practice depending on where they graduate and may lead to graduates not 
being as prepared for safe and effective practice as seen in other professions (Frank et al., 
2017; Josiah Macy Jr. Foundation, 2017). Having a defined set of pharmacy roles with 
competency and EPA mapping along with a set level of entrustment based on progression 
through a professional’s career may be one way to help ensure minimal preparation for 
all graduates. The purpose of this project was to investigate the extent to which a 
consensus exists, if any, among pharmacy professionals regarding core practice-ready 
roles for graduates that then align to current pharmacy competencies and EPA statements, 
with levels of entrustment. In particular, the study addressed three research questions 
centered around the development of graduate core practice-ready roles aligned to 
competencies and EPAs with levels of entrustment using a two-phase embedded mixed-
method design.  
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This chapter discusses the implications of the results of this study with prior research 
presented in Chapter 2. The discussion will include analyzing how the core roles 
developed during this project compare with the current pharmacy competencies. It will 
also review the literature on current validity and definition of entrustment levels for the 
EPAs, evolving pharmacy practice, employer expectations, and other healthcare 
professions to determine any gaps in the new roles, competencies, and/or EPAs. Next, a 
discussion on how the roles and competency/EPA mapping can contribute to the 
development of school/college pedagogies and assessment to ensure all students are 
practice-ready upon graduation occurs. Lastly, study limitations, as well as future 
research and practice implications, are discussed.  
The current pharmacy competencies and EPAs are perceived as mapping to the 
core roles within this study, with some missing competencies. These missing 
competencies include transitions of care, role modeling, handling difficult conversations, 
handling difficult situations, conflict management, stress management, and areas related 
to patient privacy, sensitivity to patients, and ethics. This mapping also reveals that many 
of the pharmacy competencies map to multiple core roles and are not specific for the role. 
The lack of specificity regarding the competencies and EPAs makes assessing whether a 
student is competent for a particular role more difficult for schools/colleges of pharmacy. 
If a student masters the competency and EPAs related to Problem Solver, for example, 
are they competent for the role of patient care skills, collaborator, or both? Work is 
needed to review the current competencies and EPAs to ensure they are specific for the 
core role to which they are mapped. 
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In regards to the EPAs, the results from this study mirror the EPA face validity 
results seen in Haines et al. (2018) but are different than results seen in VanLangen et al. 
(2019) and Pittenger et al. (2019). Haines et al. reported greater than 75% agreement that 
the current 15 pharmacy EPA statements describe activities pertinent to pharmacy 
practice, which was echoed by the participants in the Delphi portion of this project. The 
difference between this study and the Haines et al. face validity study is Haines et al. just 
looked at the EPAs themselves, not how they mapped to the current pharmacy 
competencies. VanLangen et al. and Pittenger et al. both found different results regarding 
the usefulness of the EPAs in pharmacy practice. VanLangen et al. and Pittenger et al. 
found that the EPA related to identifying risk for prevalent diseases in a population was 
not an essential skill for students to have upon graduation. In contrast, this study found 
that all EPAs were essential and mapped to at least one competency. However, the EPA 
assessed did depend on the core role the competency mapped too. The results from this 
study add to the pharmacy literature by asking practitioners if they felt the current EPAs 
mapped correctly to the pharmacy competencies based on the roles the competency was 
mapped too. Correct mapping of the EPAs to the pharmacy competencies is vital to 
ensure the EPAs are adequately assessing whether students are ready to perform the core 
roles that define a pharmacist’s scope of practice. The next steps will be to conduct a 
more extensive face validity study that includes all stakeholders to ensure the core roles 
and mappings developed in this study are correct. 
Despite participants initially feeling the level of entrustment would depend on the 
role to which the EPA mapped, after this project, all but one of the EPAs had the same 
level of entrustment regardless of the role and competency mapping. There was one EPA 
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that participants felt did have a different level of entrustment based on the role to which it 
mapped. “Educate patients and professional colleagues regarding the appropriate use of 
medication,” was given a different level of entrustment depending on the role mapping. 
The level of entrustment given was consistent within the role and did not depend on the 
competency it was mapped too. For the roles of knowledge and scholarship, the EPA had 
a Level 3 entrustment, which is in line with the AACP recommendation (Jarrett et al., 
2018). Whereas for patient care skills, professionalism, systems-based practice/manager, 
collaborator, and advocate/health promoter, a Level 4 entrustment was given. Only one 
EPA did not meet consensus for its entrustment level upon completion of the third Delphi 
round. This EPA was “Implement a care plan in collaboration with the patient, 
caregivers, and other health professionals, under the Collaborator role. This EPA, 
however, did meet consensus for a Level 3 entrustment in other role mappings. These 
differences in the level of entrustment depending on the role mapping for certain EPAs 
needs researching further. Is there truly a different level of entrustment required for the 
EPA at the role, is the EPA maybe not worded correctly, or is pharmacy not defining 
levels of entrustment in a manner that works for pharmacy education since there is no 
residency requirement like medicine?    
Data from this study are similar to the medical literature data regarding student 
EPA entrustment attainment upon graduation. The medical literature suggests that 
medical students should reach the level of indirect supervision (EPA level 3=without a 
supervisor’s physical presence but quickly available) upon graduation from medical 
school (Lomis et al., 2017). This level of entrustment makes sense, given that medical 
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students are required to complete residency training before starting their careers. Data 
from the pharmacy literature is a little more conflicting. 
 Pharmacy faculty and students cannot agree on the level of entrustment necessary 
upon graduation. VanLangen et al. (2019) found that faulty agreed that 67% (10 out of 
the 15) of the EPAs had a level three entrustment upon graduation, which is similar in 
number to the results from this study [60% (nine out of 15)]. On the other hand, students 
felt they were a level 4 entrustment for all EPAs except collaborating on interprofessional 
teams and ensuring appropriate vaccinations for which they felt they were a Level 5 upon 
graduation. This study found the Delphi participants feel that students should achieve a 
lower level of entrustment attainment than students feel they can obtain upon graduation.  
Interestingly, students studied in Pittenger et al. (2019) did not feel as prepared 
for overseeing pharmacy operations despite saying they felt they were a Level 4 
entrustment. This unpreparedness feeling would match the Delphi participants’ thoughts 
on students only achieving a Level 2 entrustment upon graduation. Comparing the results 
of this study to the pharmacy literature indicates the need for more research in the area of 
EPAs for pharmacy education. As discussed previously, is there truly a different level of 
entrustment required for the EPA at the role mapped? The EPA may not be worded 
correctly for that role, or is pharmacy not defining entrustment levels in a manner that 
works for pharmacy education since there is no residency requirement like medicine? 
These are the next questions that need answering.   
Before reworking the current pharmacy competencies/EPAs to match the newly 
developed core roles, the literature on evolving pharmacy practice and employer 
expectations need reviewing to ensure these new roles cover all areas needed for 
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graduates to be practice-ready. Schools/colleges of pharmacy need to ensure they teach 
the knowledge and skills requested by employers to ensure students are employable upon 
graduation. Based on a review of the current literature, pharmacy employers are looking 
for graduates that have not only the CAPE outcomes but also have additional skills 
related to relationship building, adaptability, conflict resolution, time management, and 
curiosity (Alston et al., 2017; American College of Clinical Pharmacy, 2014; Augustine 
et al., 2018; Chanakit et al., 2015; Greinter & Knebel, 2003; Hester et al., 2014; Kennie-
Kaulbach et al., 2012; McLaughlin et al., 2017; O’Sullivan et al., 2017; Saseen et al., 
2017; Thompson et al., 2012; Vlasses et al., 2013). These missing skills requested by 
employers create a disconnect between what employers want and what they are getting. 
The core roles developed during this study encompass these additional skills that 
employers want students to have before graduation. Coverage of relationship-building 
occurs in patient care skills, collaborator, and advocate/health promoter. Coverage of 
adaptability, conflict resolution, and innovation occurs in the system-based 
practice/manager role. Curiosity coverage is under scholarship. The problem is that the 
current competencies and EPAs mapped to these core roles do not address these specific 
areas. The lack of specificity would mean that schools/colleges of pharmacy would not be 
designing pedagogies and assessments to address these areas, which employers consider 
necessary to hire someone upon graduation. Not only do the core roles contain the skills 
requested by employers, but they also contain the skills needed for students to be 
practice-ready for the current healthcare trends that are driving the transformation of the 
US healthcare system. These trends include changes in (a) technology (e.g., telehealth, 
telemedicine), (b) healthcare insurance (move to high deductible plans), (c) workforce, 
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(d) drug supply chains, and, lastly, (e) regulatory (Affordable Health Care Act; 
Vogenberg & Santilli, 2018).  
All the core roles developed during this study will help to prepare students for the 
healthcare trends of telehealth, telemedicine, and consumer wearables (Vogenberg & 
Santilli, 2018). Knowledge around the interpretation of healthcare data using technology 
is essential to allow pharmacists to take a more active role in patient treatment in the 
community setting leading to new and innovative pharmacy practice models (Vogenberg 
& Santilli, 2018). To develop these new innovative practice models, pharmacists will 
need to be continually learning and developing new skills through evidence-based 
medicine, which is in the scholarship role. The change in the drug delivery models also 
makes it challenging to ensure everyone has access to all the patient’s accurate medical 
records as patients are now receiving care and medications through multiple places 
(Vogenberg & Santilli, 2018). Pharmacists need to be part of the teams that look for ways 
to increase access to medical records needed to treat patients across transitions of care 
such as the hospital to community and community to the hospital while still maintaining a 
patient’s healthcare confidentiality (Vogenberg & Santilli, 2018). Patient care skills such 
as communication, collection and assessment of information, and the ability to monitor 
therapy along with the roles of collaborator and advocate/health promoter will be needed 
to help pharmacists develop cost-effective treatment plans using these new areas of 
technology (Vogenberg & Santilli, 2018). The core role definitions design is to ensure 
students would be prepared to design treatment plans and use technology. However, the 
competencies and EPAs that schools/colleges of pharmacy use to design pedagogies and 
assessments around these roles are not specific enough to ensure the same baseline 
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knowledge is provided to all students regardless of the school/college attended. Also, 
specific competencies related to contributing to scholarship and the evidence-based 
medicine literature are lacking. These missing competencies are a crucial oversight. The 
best way to ensure pharmacy can continue to increase its role on the healthcare team is to 
have people who are willing to publish and discuss the innovative practice models they 
are using to take care of patients.  
The core roles of knowledge and systems-based practice/manager help to prepare 
students for the trend of healthcare insurance moving to high deductibles. The knowledge 
role trains students to integrate the knowledge of biomedical and psychosocial science 
related to health and disease and clinical science to design patient treatment plans that are 
cost-effective (Vogenberg & Santilli, 2018). The system-based practice/manager role 
helps prepare pharmacists to work with both state and national stakeholders to provide 
pharmacists with ways to bill for patient care services. Billing will be necessary as 
pharmacy tries to develop innovative practices that take advantage of telehealth and 
telemedicine opportunities. This role also helps to prepare pharmacists that can work in 
the broader healthcare landscape to help physicians and other healthcare practitioners 
choose cost-effective treatments in broader healthcare system settings (Vogenberg & 
Santilli, 2018). The problem is that the competencies and EPAs listed under these roles 
occur under other roles, so how would a school/college know if a student was competent 
in this role categorically instead of one of the other roles. Care needs taking to ensure the 
competencies and EPAs listed under each of the roles are specific for that role to ensure 
schools/colleges understand what pedagogies and assessments are needed to ensure 
students are practice-ready for these healthcare trends. 
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Patient care skills such as communicating with multiple different entities 
(patients, caregivers, providers, and insurance companies) will be necessary as the 
workforce continues to contain a mix of younger and older workers, different races, and 
different cultures (Pew Research Center, 2016). Changes in the Affordable Care Act 
affect ways patient access care and how healthcare workers are getting paid for providing 
care. The changes in healthcare provider payments open the door for pharmacists to 
provide care to patients in the community setting, given their accessibility and potential 
to begin to bill for these services (Vogenberg & Santilli, 2018). Pharmacists will also 
need to watch for regulatory changes that will affect pharmacy (Vogenberg & Santilli, 
2018) and will also need to participate in advocating for regulatory changes that will 
allow pharmacists to bill for services outside of just dispensing a product. Also, similar to 
some of the other roles, the EPAs listed here are not specific for this role, so if 
schools/colleges are only using the EPAs listed to assess students, one would not know if 
a student was competent in this role. 
Pharmacists also need to be involved in the changes being made in drug supply 
chains (Vogenberg & Santilli, 2018) to ensure the safe and ethical delivery of 
medications occurs with the move to more delivery of medications straight to patient’s 
homes. While the competencies and EPAs mapped to the professionalism role would help 
ensure students are prepared for the professional aspects of practice, competencies and 
EPAs related to ethics and patient confidentiality are not explicitly stated. Many 
schools/colleges of pharmacy teach and assess these areas, but they do not occur as stand-
alone competencies and EPAs. This lack of standalone competencies/EPAs could mean 
that schools/colleges of pharmacy are not intentional about ensuring these concepts are 
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covered in curricula and assessments as they would be if the competencies/EPAs were 
listed. 
The core roles developed in this study cover the knowledge and skills needed to 
ensure students are ready for the healthcare trends occurring in the US healthcare system. 
However, as discussed, the competencies and EPAs used by schools/colleges of 
pharmacy to develop pedagogies and assessments related to these roles are not specific 
enough to ensure teaching and assessment of all aspects of the roles. This lack of 
specificity would mean that students may be prepared differently for practice depending 
on the school/college attended. For the core roles developed in this study to be useful 
updated competencies and EPAs would need to be developed. Before updating the 
competencies and EPAs, the healthcare literature needs to be reviewed as the last 
component to ensure all healthcare education areas occur in the core roles. 
Englander et al. (2013) conducted a review to extract a standard set of competencies 
for all health professions to aid in interprofessional education. The eight competency 
domains include patient care, knowledge for practice, practice-based learning and 
improvement, interpersonal and communication skills, professionalism, systems-based 
practice, interprofessional collaboration, and personal and professional development. 
During this study, the core roles developed include five out of the eight of these 
competency domains: patient care, knowledge, professionalism, systems-based practice, 
and collaboration. The Englander et al. domains of practice-based learning and 
improvement fall under the professionalism role in the pharmacy core roles as does 
personal and professional development. The weaving of communication skills occurs 
throughout the core roles as opposed to being a standalone competency domain. 
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Comparing the pharmacy competencies in this study to the Englander list shows most 
of the Englander competencies map just under different core roles (Englander et al., 
2013). However, there are some competencies still missing. One area is patient care, with 
competencies missing in transitions of care, patient privacy, and sensitivity to patients. 
Another area with missing competencies is attitudes such as providing role modeling, 
handling difficult conversations, handling difficult situations, conflict management, stress 
management, ethics, professional advocacy (not advocating for the good of the patient 
but advocating for the good of the profession and its place in healthcare), and personal 
health. The last area missing is systems-based care and includes missing competencies in 
health outcomes, quality improvement, and public health. Many of these are areas that 
many schools/colleges of pharmacy would say they cover within their curricula. 
However, explicit coverage does not occur in the competencies and EPAs despite being 
considered as part of the core roles needed for pharmacy students to be practice-ready 
upon graduation and being mentioned by employers as being necessary for practice. It 
will be essential to review the competencies Englander et al. (2013) created for inclusion 
in any competencies/EPA updates that would need to be done based on the core roles 
developed in this study. Having specific competencies in these areas would ensure that all 
students are practice-ready in all areas upon graduation regardless of the school/college to 
which they attend. 
 Another critical literature review is the dimensions of professional competence: 
cognitive, technical, integrative, relational, and affective/moral constructs. The newly 
developed pharmacy core roles cover all the professional competency dimensions. The 
cognitive dimension includes the core knowledge and skills needed to problem-solve 
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(knowledge and patient-care skills roles). The technical dimension consists of those skills 
that are hands-on and required for a specific type of pharmacy practice (patient-care skills 
roles). Integration includes the ability to link basic and clinical knowledge to other 
disciplines and manage uncertainty within the defined clinical setting and place in the 
pharmacist’s career (the central tenet of pharmacy expert and collaborator, systems-based 
practice/manager, and scholarship roles). The relationship domain includes the 
communication skills, teamwork, and conflict-management skills needed to form 
relationships within the healthcare domain as well as the patient and their families 
(patient-care skills and collaborator roles). The affective/moral domain includes 
emotional intelligence and ethics, consisting of the pharmacists’ ability to observe their 
emotional intelligence, curiosity, and willingness to acknowledge and correct errors 
(professionalism roles). These domains all work together to produce a pharmacist capable 
of functioning in the ever-changing healthcare world to manage ambiguous problems, 
tolerate uncertainty, and make decisions with sometimes limited knowledge (Epstein & 
Hundert, 2002).  
The last set of healthcare literature to review for comparison is the medical 
literature. This review is vital as pharmacy works very closely with medicine. It will be 
essential to ensure the core roles are defined clearly for pharmacy to avoid jurisdiction 
issues as these newly defined roles move pharmacy from just an advisory jurisdiction 
with physicians into more of a limited jurisdiction model (Abbott, 1986). The roles begin 
to assert that pharmacists can handle patients' medication therapy outside of just advising 
physicians but with a move into a more independent model. The move to an independent 
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model will require conversations to ensure that everyone feels comfortable and that a 
definition of the practice scope is evident.  
The jurisdictional issues arise as one looks at a pharmacy expert's roles and see 
how closely they align with those of a physician. Pharmacy’s scope of practice is a 
pharmacy expert. A pharmacy expert is one that “integrates knowledge, uses appropriate 
patient care skills, and is professional to provide safe, high-quality, evidence-based, and 
patient-centered” within a pharmacist’s limits of expertise. The pharmacy expert 
definition is very similar to the CanMEDs’ definition of a medical expert, which defines 
the physician scope of practice: “physicians integrate all of the roles, applying medical 
knowledge, clinical skills, and professional values in their provision of high-quality and 
safe patient-centered care” (Frank et al., 2015, p. 3). As conversations regarding 
jurisdiction start, one needs to keep in mind that a pharmacist’s area of expertise lies with 
the medication therapy management and public health areas related to medications and 
their use for the prevention and treatment of disease (Frenck et al., 2010; Isasi & Krofah, 
2015). Now that a set of core roles as been proposed for pharmacy, the conversations 
around jurisdiction can begin with a universal language. 
The development of core roles with mapping has helped to demonstrate some of 
the gaps in the current pharmacy competencies and EPAs that schools/colleges of 
pharmacy use to develop pedagogies and assessments. These gaps may be leading to 
students not be as prepared for practice as needed. Since the development of a core set of 
pharmacy roles has occurred, schools/colleges of pharmacy could use the medical model 
of competency and EPA development to ensure all areas of the roles are taught and 
assessed in schools/colleges of pharmacy.  
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The core medical roles played an essential part in the development of the 
medicine competency statements used to drive pedagogy and assessment for medical 
education. A person achieving all the competencies for a given role is said to be 
“competent” in that area. For example, CanMeds defines five critical competencies for 
the medical expert role. One of these competencies is “practice medicine within their 
defined scope of practice and expertise” (Frank et al., 2014, p. 10). The creation of 
assessments occurs from the enabling competencies that are under each of the five 
broader competencies. For example, under the competency just mentioned, there are six 
enabling competencies with one being “Integrate the CanMEDS Intrinsic Roles into their 
practice of medicine” (Frank et al., 2014, p. 10). With the development of a set of core 
roles, pharmacy can now work through a similar process. Mapping of competencies that 
cover all areas of the core roles would help to ensure that all students are prepared the 
same upon graduation regardless of the school/college of pharmacy from which they 
graduate. It would also allow the development of assessments to share among 
schools/colleges of pharmacy. 
Assessment planning is a critical step to determine if students are practice-ready. 
Medical school is ahead of pharmacy in the development of competencies and assessment 
of competence. Medicine has defined levels of competency depending on where a student 
is in their career. The competency levels in medical school are medical school 
fundamentals and early clinical activity. Competency levels for residency are transitions 
to discipline, foundations of the discipline, and core of the discipline. Lastly, competency 
levels for learning in practice are transitions to practice and continuing professional 
development (Frank et al., 2014). While pharmacy has created competencies and EPAs, it 
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has not defined entrustment levels based on students' progress through their career, nor 
does pharmacy agree on the level of entrustment upon graduation.   
For performance activities like entrustable professional activities to be useful, one 
needs to map the EPA's competencies and set the entrustment level required for each 
stage of training (Modi et al., 2015). Medicine has created such a mapping with their 
roles mapped to competencies to EPAs with defined entrustment levels for a particular 
time in a student’s learning career (medical school, residency). While pharmacy has 
created the competencies and EPAs, there is no set level of entrustment that all 
schools/colleges are using, nor is there a set entrustment level depending on a student’s 
stage of their career. The work done in this project continues to add to the literature 
showing there is work that pharmacy needs to do in the area of entrustment as one of the 
EPAs did not reach consensus. Also, some of the EPA levels of entrustment varied 
depending on the role to which it was mapped. The development of a set of core roles 
with mapping to the current pharmacy competencies and EPAs is the first step in 
pharmacy developing an education model similar to medicine.  
Study Limitations 
 Several limitations need discussing with this study. One limitation was the 
inability to find a time that worked best for all potential NGT groups to meet. The initial 
invited group contained six members, with only five members being able to participate. 
Even with this limitation, the NGT group was still a mix of four different pharmacy 
programs and different opinions related to pharmacists' roles. The small size of the NGT 
group, while planned, is another potential limitation of this study. While a small group 
was suitable for this pilot study, a broad consensus development process would need 
doing before these roles could be considered for implementation across the country. 
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Another potential limitation of NGT studies is the potential for one or more participants 
to dominate the conversation or push their views. This domination of conversation could 
have potentially been a big issue in this study, given the large pharmacy programs 
involved and the research interests of the participants. Everyone listened to the facilitator 
and answered one at a time during each round. Everyone provided thoughtful answers for 
both strengths and limitations and participated equally. There were no feelings of 
domination or pushing one set of views. Thus, the limitation of the potential domination 
of conversation in this study was avoided. 
Some of the Delphi method's disadvantages include the time it takes to do the 
process and the potential for a low response rate to the surveys (McMillan et al., 2016). 
The time it takes to do the Delphi method was one big negative to the use of this process, 
but combining the research questions into one Delphi survey helped limit some of the 
timetable. This project's timetable did get pushed back due to a pandemic situation that 
caused the surveys to go out later than was initially intended. Once the surveys started, 
though, the process flowed through the timeline as initially scheduled. The potential for a 
low response rate was also a limitation. The response rate for the surveys was around 30-
40%, which is relatively low. The responses, though, are representative of the pharmacy 
practice population. The samples chosen came from four diverse areas of the country 
(Arkansas, Kentucky, North Carolina, and Minnesota). Participants were also from varied 
backgrounds that are representative of the broad areas of current pharmacy practice. This 
study's number of responses should not be a problem as this study is a pilot study, and 
larger Delphi groups would be needed before this data could be widely used.  
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 Besides the limitations of the consensus processes chosen for this study, threats to 
internal and external validity also needed to be considered (Campbell & Stanley, 1963). 
Sample bias and reactive effects of arrangements are threats to external validity that were 
potential factors in this study (Campbell & Stanley, 1963). Reactive effects of 
arrangements refer to the inability to generalize to non-experimental settings because the 
experimental setting is artificial. Reactive effects of arrangements could have been 
potentially a problem in this study since no actual testing of the alignments and levels of 
entrustment happened; instead, results are from practitioners’ thoughts about the 
appropriate alignments and levels of entrustment achievement. Future studies will need to 
be conducted in real-world educational settings to determine if the entrustment levels are 
correct. The threat of reactive effects of arrangements is less of a validity threat as the 
consensus participants were active practitioners with various practice experience. They 
were capable of accurately determining what graduates need to perform upon graduation. 
Sample bias is the last threat to external validity. Sample bias occurs when there is a 
chance that the sample chosen for the study may not represent the population of interest. 
Sample bias was a potential threat in this study, given only a small number of 
pharmacists participated in the consensus development process, which may have led to a 
lack of diversity (i.e., race, age, rural/urban practice sites). Mitigation of sample bias 
occurred by using a non-randomized sample chosen by the NGT process members to 
ensure that the sample selected is a diverse mix of pharmacy practice types and levels of 
experience (Campbell & Stanley, 1963). 
Threats to internal validity also need to be considered. Internal validity threats 
that had be considered included (a) history, (b) maturation, (c) testing, (d) 
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instrumentation, and  (e) experimenter bias (Campbell & Stanley, 1963). History is when 
events occur during the study that may impact the results, which could be an issue 
between the Delphi rounds if participants were to change jobs or learn different 
information that may change the way they think about the alignments and levels of 
entrustments in between the rounds. Maturation could be a problem as processes with the 
participants (aging, experience) could impact the outcomes. Mitigation of history and 
maturation occurred by keeping the time between the rounds to no more than 2-3 weeks. 
Another potential internal threat is testing itself as results are affected when participants 
do multiple rounds of “testing.” Testing was mitigated by only using two to three rounds 
of the Delphi process. The last threat to internal validity is experimenter bias, which 
occurs when the experimenter’s expectations of the results may consciously or 
unconsciously affect the results. The experimenter’s thoughts regarding what the core 
roles should be along with the mapping and EPA levels could come through in the way 
the results are presented. The experimenter’s potential to influence the results were 
mitigated through the design of the NGT process for Research Question One and then 
through providing both the original as well as the changed mappings and levels of 
entrustment in each round of the Delphi process, thus allowing Delphi participants to 
serve as reviewers to ensure researcher bias was mitigated (Campbell & Stanley, 1963).  
Future Research/Practice Implications 
Results from this study will have an impact on pharmacy, pharmacy education, 
and pharmacy research methodologies in multiple ways. For pharmacy education, the 
development of the pharmacy roles is the first step to ensuring students are minimally 
prepared for all potential pharmacy practice areas both now and in the future. As 
education begins to train pharmacists in these new roles, professional jurisdiction 
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discussions will need to occur to ensure everyone understands what pharmacists are 
prepared to undertake and that these roles can help further advance the practice of other 
professions instead of limiting their practice (Abbott, 1986).  
 The development of core roles with the alignment of pharmacy competencies and 
EPAs will provide a roadmap for minimum competency (Lumina Foundation, 2014). The 
developed core roles also help describe what the pharmacy profession can do for other 
identities both inside and outside healthcare. The core roles will help propel the 
profession forward as they work to increase pharmacy’s professional identity and move 
to more cognitive practice instead of just dispensing of a product. While the core roles 
and competency/EPA mapping will be useful for schools/colleges of pharmacy, more 
research and consensus building will be needed before they are ready for incorporation 
into the accreditation standards. This is especially true for the levels of entrustment given 
that one of the EPAs did not reach consensus on a level. Another future research area will 
be what role do the pre-program requirements for pharmacy school play in students' 
development for these future pharmacy roles?  Should pharmacy consider requiring a 
degree before entry to allow students to start developing some of the necessary 
competencies before entry into a pharmacy program? 
 Lastly, this study further demonstrates how mixed-methods study techniques can 
be used in pharmacy educational research.  The nominal group technique conducted via 
video conferencing and the Delphi technique conducted via electronic survey can be 
beneficial methods in gathering a broader consensus on the development of pharmacy 
roles and other areas needing consensus.  These are research methods that are currently 
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gaining use in the pharmacy literature but could be used more often for research studies 
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Pharmacy CAPE Outcomes 
The 15 CAPE outcomes, with one-word descriptors, center around four large domains 
(Medina et al., 2013). The four broad domains include Foundational Knowledge 
(knowledge), Essentials for Practice and Care (skills), Approach to Practice and Care 
(skills), and Personal and Professional Development (attitudes; Medina et al., 2013). The 
CAPE design was to represent all areas of pharmacy and guide the curricular and 
assessment efforts of schools/colleges of pharmacy. The 15 CAPE outcomes include 
(Medina et al., 2013, p. 3-8): 
Domain 1:  Foundational Knowledge 
• 1.1 Learner:  Develop, integrate, and apply knowledge from the foundational 
sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical 
sciences) to evaluate the scientific literature, explain drug action, solve 
therapeutic problems, and advance population health and patient-centered care  
Domain 2:  Essentials for Practice and Care 
• 2.1 Patient-centered care (Caregiver):  Provide patient-centered care as the 
medication expert (collect and interpret evidence, prioritize, formulate 
assessments and recommendations, implement, monitor and adjust plans, and 
document activities).  
205 
 
• 2.2 Medication use systems management (Manager):  Manage patient healthcare 
needs using human, financial, technological, and physical resources to optimize 
the safety and efficacy of medication use. 
• 2.3 Health and wellness (Promoter):  Design prevention, intervention, and 
educational strategies for individuals and communities to manage chronic disease 
and improve health and wellness. 
• 2.4 Population-based care (Provider):  Describe how population-based care 
influences patient-centered care and influences the development of practice 
guidelines and evidence-based best practices. 
Domain 3:  Approach to Practice and Care 
• 3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize 
potential strategies, and design, implement, and evaluate a viable solution. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
• 3.3 Patient Advocacy (Advocate): Assure that patients’ best interests are 
represented. 
• 3.4 Interprofessional collaboration (Collaborator): Actively participate and engage 
as a healthcare team member by demonstrating mutual respect, understanding, 
and values to meet patient care needs. 
• 3.5 Cultural sensitivity (Includer): Recognize social determinants of health to 
diminish disparities and inequities in access to quality care. 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
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Domain 4:  Personnel and Professional Development 
• 4.1 Self-awareness (Self-aware): Examine and reflect on personal knowledge, 
skills, abilities, beliefs, biases, motivation, and emotions that could enhance or 
limit personal and professional growth. 
• 4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving 
shared goals, regardless of position. 
• 4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities 
by using creative thinking to envision better ways of accomplishing professional 
goals. 
• 4.4 Professionalism (Professional): Exhibit behaviors and values that are 
consistent with the trust given by the profession by patients, other healthcare 





Pharmacy Entrustable Professional Activities (EPAs) 
EPA creation for pharmacy started in 2015-16 with the Academic Affairs 
Standing Committee of AACP. The president charged this committee to identify EPAs 
for pharmacy graduates as they transition from completion of their advanced pharmacy 
practice experiences into professional practice and other postgraduate opportunities. This 
work continued with the 2016-17 Academic Affairs committee, which compiled 
comments and input from stakeholders regarding the draft EPAs and completing the final 
edits. The fifteen EPAs created by the Academic Affairs Committee are as follows 
(Haines et al., 2017, p. 3-4): 
Patient Care Provider Domain 
• Collect information to identify a patient’s medication-related problems and 
health-related needs. 
• Analyze information to determine the effects of medication therapy, identify 
medication-related problems, and prioritize health-related needs. 
• Establish patient-centered goals and create a care plan for a patient in 
collaboration with the patient, caregiver(s), and other health professionals that 
are evidence-based and cost-effective. 
• Implement a care plan in collaboration with the patient, caregivers, and other 
health professionals. 
• Follow-up and monitor a care plan. 
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IPE Team Member Domain 
• Collaborate as a member of an IPE team. 
Population Health Promoter Domain 
• Identify patients at risk for prevalent disease in a population. 
• Minimize adverse drug events and medications in a population. 
• Maximize the appropriate use of medications in a population. 
• Ensure that patients have been immunized against vaccine-preventable 
diseases. 
Information Master Domain 
• Educate patients and professional colleagues regarding the appropriate use of 
medication. 
• Use evidence-based information to advance patient care. 
Practice Manager Domain 
• Oversee the pharmacy operations for an assigned shift. 
• Full-fill a medication order. 
Self-Developer Domain 










Initial Core Pharmacist's Role Proposal 
Figure C.1:  Model of Initial Core Pharmacist's Role  
 
Figure C.1. Graphical depiction of the initial core pharmacist's role. Adapted from 
"ACGME common program Requirements [Web page]," by Accreditation Council for 
Graduate Medical Education., 2017,  Retrieved from 
https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_2017-07-
01.pdf; "CanMeds 2015 Physician Competency Framework", by J. R. Frank et al., 2015, 














capabilities framework," by General Medical Council, 2017, Retrieved from  www.gmc-
uk.org. 
Central Role:  Pharmacotherapeutics Expert 
• Pharmacotherapeutics experts integrate all the tenets such as knowledge, using 
appropriate patient care skills, and being professional to provide high-quality and 
safe patient-centered care. Being a pharmacotherapeutics expert is the central role 
of a pharmacist and defines the pharmacist's scope of practice. 
• A pharmacotherapeutics expert will draw upon their knowledge, skills, and 
attitudes to collect and interpret information, make clinical decisions, and make 
therapeutics interventions. This is done within their scope of practice and with the 
understanding of the limits of their expertise. Decision-making is informed by 
evidence-based medicine and considers the patient and their caregivers' 
preferences and the appropriate use of available resources. Their practice is up-to-
date, ethical, and conducted in collaboration with other members of the healthcare 
team as well as the patient and their caregivers.  
Core Roles Needed to Become The "Expert": 
• Knowledge 
o Pharmacists must integrate knowledge of biomedical, psychological, and 
social science principles of health and disease, and clinical science to 
design appropriate treatment plans for their patients. This knowledge 
includes understanding these principles across the life-span of the patient. 
o Pharmacists understand that they serve a unique role in the healthcare 
team. They are the "medication" experts and possess the most knowledge 
of how medications contribute to the patient's care. 
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• Patient Care Skills 
o Pharmacists must be able to perform basic patient care skills such as 
communication, collection, and assessment of information to formulate a 
treatment plan and ability to monitor if a treatment is successful or not. 
o Pharmacists need to ensure they take a patient's cultural, education level, 
and financial status into account when formulating a treatment plan to 
ensure a patient's plan can be adherent. Pharmacists also understand that 
part of patient care should include discussing the plan with the patient and 
their support system as needed.  
• Professionalism 
o Pharmacists are committed to the health and well-being of their patients, 
society, and themselves. This is demonstrated through ethical practice, 
high standards of personal behavior, accountability to the profession and 
society, and maintenance of their health. 
o Pharmacists serve essential roles in the healthcare team and society, as 
such, professional identity is central. This tenet includes promotion of the 
public good, adherence to high ethical and moral standards. It recognizes 
that to provide good quality patient care, they must take care of 
themselves and others in their profession.  
• Scholarship 
o Pharmacists are committed to excellence in their practice through life-long 
professional development, the teaching of others, the use of evidence-
based medicine, and contributing to scholarship. 
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• Systems-based Practice/Manager 
o Pharmacists are committed to safety and quality in health care, 
professional advocacy, health insurance, health care economics, transitions 
of care, and chronic care of patients.  
o Pharmacists understand that they work as part of a more extensive 
"system" of health care and that to provide good, quality care, they need to 
be able to coordinate care within the systems, provide treatment 
recommendations that work with the patient's insurance, and be an 
advocate for optimal and quality patient care. Pharmacists also need to be 
an advocate for the profession on professional roles/responsibilities and 
the ability to bill for services   
• Collaborator 
o Pharmacists work with other healthcare professionals to provide safe, 
high-quality, and patient-centered care. 
o Pharmacists understand that being able to function effectively in an 
interprofessional team is necessary to provide safe, high-quality, and 
effective patient care. Collaboration is also important with the patient and 
their support systems. Collaboration requires trust, respect, and shared 
decision-making. It also requires the sharing of knowledge, perspectives, 
responsibilities, and the willingness to learn from others. To collaborate 
effectively, one must understand others' roles on the team, be pursuing 
common goals, and manage conflict effectively. 
• Advocate/Health Promoter 
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o Pharmacists are committed to using their expertise and influence to work 
with patient populations to improve communities' health and wellness. 
They work to understand the needs, speak on behalf of others, and seek to 
mobilize resources to effect change when needed. 
o Pharmacists understand that improving health is not limited to treating 
illness but also includes disease prevention, health promotion, and health 
protection. They understand their unique place in the healthcare team, and 
society allows them access to populations that others may not have. 
Pharmacists understand the need to work with patients to navigate 







Final Core Pharmacist's Role Proposal 
Figure D.1. Model of Final Core Pharmacist's Roles 
 
Figure D.1. Graphical depiction of the initial core pharmacist's role. Adapted from 
"ACGME common program Requirements [Web page]," by Accreditation Council for 
Graduate Medical Education., 2017,  Retrieved from 
https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_2017-07-
01.pdf; "CanMeds 2015 Physician Competency Framework", by J. R. Frank et al., 2015, 















capabilities framework," by General Medical Council, 2017, Retrieved from  www.gmc-
uk.org. 
Central Role:  Pharmacy Expert 
• Pharmacy experts integrate all the tenets such as knowledge, using appropriate 
patient care skills, and being professional to provide safe, high-quality, evidence-
based, and patient-centered care. Being a pharmacy expert is the pharmacist's 
central role and defines the pharmacist's scope of practice. 
• A pharmacy expert will draw upon their knowledge, skills, and attitudes to collect 
and interpret information, make clinical decisions, make therapeutics 
interventions, and monitor the results of therapeutic interventions. This is done 
within their scope of practice and with the understanding of the limits of their 
expertise. A pharmacy expert also understands they work as part of a more 
extensive "system" of healthcare to coordinate and advocate optimal and quality 
patient care to improve health by treating illnesses, disease prevention, health 
promotion, and health protection. Decision-making is informed by evidence-based 
medicine and considers the patient and their caregivers' preferences and the 
appropriate use of available resources. Their practice is up-to-date, innovative, 
ethical, and is conducted in collaboration with other members of the healthcare 
team as well as the patient and their caregivers.  
Core Roles Needed To Become The "Expert": 
• Knowledge 
o Pharmacists must integrate knowledge of biomedical and psychosocial 




appropriate treatment plans for their patients. This knowledge includes 
understanding these principles across the life-span of the patient. 
o Pharmacists understand that they serve a unique role in the healthcare 
team. They are the "medication" experts and possess the most knowledge 
of how medications contribute to the patient's care. 
• Patient Care Skills 
o Pharmacists must be able to perform basic patient care skills such as 
communication, collection and assessment of information to formulate and 
implement a treatment plan, and the ability to monitor if a treatment is 
successful or not. 
o Pharmacists need to ensure they take a patient's cultural, education level, 
and financial status into account when formulating a treatment plan to 
ensure a patient's plan can be adherent. Pharmacists also understand that 
part of patient care should include discussing the plan in a compassionate 
and empathetic manner with the patient and their support system as 
needed.  
• Professionalism 
o Pharmacists are committed to the health and well-being of their patients, 
society, and themselves. This is demonstrated through ethical practice, 
high standards of personal behavior, accountability to the profession and 
society, and maintenance of their health. 
o Pharmacists serve essential roles in the healthcare team and society, as 




public good, adherence to high ethical and moral standards. It recognizes 
that to provide good quality patient care, they must take care of 
themselves and others in their profession.  
• Scholarship 
o Pharmacists are committed to excellence in their practice through life-long 
professional development, the teaching of others, developing new 
innovative practices that advance the profession, and the use of evidence-
based medicine. Pharmacists are committed to finding and promoting 
drugs and other health information that is evidence-based and up-to-date. 
o Pharmacists understand the importance of contributing to scholarship and 
evidence-based medical literature. 
• Systems-based Practice/Manager 
o Pharmacists are committed to safety and quality in health care, 
professional advocacy, health insurance, health care economics, health 
outcomes, quality improvement, transitions of care, public health, and 
patients' chronic care.  
o Pharmacists understand that they work as part of a more extensive 
"system" of health care and that to provide good, quality care, they need to 
be able to coordinate care within the systems, provide treatment 
recommendations that work with the patients' insurance, and be an 
advocate for optimal and quality patient care. Pharmacists also need to 
advocate for the profession on professional roles/responsibilities and the 





o Pharmacists work with other healthcare professionals to provide safe, 
high-quality, evidence-based, and patient-centered care. 
o Pharmacists understand that being able to function effectively in an 
interprofessional team is necessary to provide safe, high-quality, and 
patient-centered care. Collaboration is also important with the patient and 
their support systems. Collaboration requires trust, respect, and shared 
decision-making. It also requires the sharing of knowledge, perspectives, 
responsibilities, and the willingness to learn from others. To collaborate 
effectively, one must understand the roles of others on the team, articulate 
one's role on the team, be pursuing common goals, and manage conflict 
effectively. 
• Advocate/Health Promoter 
o Pharmacists are committed to using their expertise and influence to work 
with patient populations to improve communities' health and wellness. 
They work to understand the needs, speak on behalf of others, and seek to 
mobilize resources to effect change when needed. 
o Pharmacists understand that improving health is not limited to treating 
illness but also includes disease prevention, health promotion, and health 
protection. They understand their unique place in the healthcare team, and 
society allows them access to populations that others may not have. 
Pharmacists understand the need to work with patients to navigate 





Initial Roles/Competencies/EPA Mapping 
Role:  Knowledge 
Pharmacists must integrate knowledge of biomedical and psychosocial science 
principles of health and disease, and clinical science to design appropriate treatment plans 
for their patients. This knowledge includes understanding these principles across the life-
span of the patient. Pharmacists understand that they serve a unique role in the healthcare 
team. They are the "medication" experts and possess the most knowledge of how 
medications contribute to the patient's care. 
• 1.1 Learner:  Develop, integrate, and apply knowledge from the foundational 
sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical 
sciences) to evaluate the scientific literature, explain drug action, solve 
therapeutic problems, and advance population health and patient-centered care  
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Educate patients and professional colleagues regarding the 




o EPA: Use evidence-based information to advance patient care. 
Role:  Patient Care Skills 
Pharmacists must be able to perform basic patient care skills such as 
communication, collection and assessment of information to formulate and implement a 
treatment plan, and the ability to monitor if a treatment is successful or not. Pharmacists 
need to ensure they take a patient's cultural, education level, and financial status into 
account when formulating a treatment plan to ensure a patient's plan can be adherent. 
Pharmacists also understand that part of patient care should include discussing the plan in 
a compassionate and empathetic manner with the patient and their support system as 
needed.  
• 2.1 Patient-centered care (Caregiver):  Provide patient-centered care as the 
medication expert (collect and interpret evidence, prioritize, formulate 
assessments and recommendations, implement, monitor and adjust plans, and 
document activities).  
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. 
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 




o EPA: Follow-up and monitor a care plan. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
• 2.3 Health and wellness (Promoter):  Design prevention, intervention, and 
educational strategies for individuals and communities to manage chronic disease 
and improve health and wellness. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
• 3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize 
potential strategies, and design, implement, and evaluate a viable solution. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. 
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. 




o EPA: Oversee the pharmacy operations for an assigned shift. 
o EPA: Full-fill a medication order. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. 
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
o EPA: Follow-up and monitor a care plan. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Identify patients at risk for prevalent disease in a population. 




o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
o EPA: Use evidence-based information to advance patient care. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
o EPA: Full-fill a medication order. 
Role:  Professionalism 
Pharmacists are committed to the health and well-being of their patients, society, 
and themselves. This is demonstrated through ethical practice, high standards of personal 
behavior, accountability to the profession and society, and maintenance of their health. 
Pharmacists serve essential roles in the healthcare team and society, as such, professional 
identity is central. This tenet includes promotion of the public good, adherence to high 
ethical and moral standards. It recognizes that to provide good quality patient care, they 
must take care of themselves and others in their profession.  
• 4.1 Self-awareness (Self-aware): Examine and reflect on personal knowledge, 
skills, abilities, beliefs, biases, motivation, and emotions that could enhance or 
limit personal and professional growth. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Oversee the pharmacy operations for an assigned shift. 




• 4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving 
shared goals, regardless of position. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
• 4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities 
by using creative thinking to envision better ways of accomplishing professional 
goals. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Use evidence-based information to advance patient care. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
• 4.4 Professionalism (Professional): Exhibit behaviors and values that are 
consistent with the trust given by the profession by patients, other healthcare 
providers, and society. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
o EPA: Create a written plan for continuous professional development 
Role: Scholarship 
Pharmacists are committed to excellence in their practice through life-long 




that advance the profession, and the use of evidence-based medicine. Pharmacists are 
committed to finding and promoting drugs and other health information that is evidence-
based and up-to-date. Pharmacists understand the importance of contributing to 
scholarship and evidence-based medical literature. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
o EPA: Use evidence-based information to advance patient care. 
• 4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities 





o EPA: Collaborate as a member of an IPE team. 
o EPA: Use evidence-based information to advance patient care. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
Roles: Systems-based Practice/Manager 
Pharmacists are committed to safety and quality in health care, professional 
advocacy, health insurance, health care economics, health outcomes, quality 
improvement, transitions of care, public health, and patients' chronic care. Pharmacists 
understand that they work as part of a more extensive "system" of health care and that to 
provide good, quality care, they need to be able to coordinate care within the systems, 
provide treatment recommendations that work with the patients' insurance, and be an 
advocate for optimal and quality patient care. Pharmacists also need to advocate for the 
profession on professional roles/responsibilities and the ability to bill for services.  
• 2.2 Medication use systems management (Manager):  Manage patient healthcare 
needs using human, financial, technological, and physical resources to optimize 
the safety and efficacy of medication use. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. 




o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
o EPA: Full-fill a medication order. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
o EPA: Full-fill a medication order. 
• 4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving 
shared goals, regardless of position. 




o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
o EPA: Oversee the pharmacy operations for an assigned shift. 
Role: Collaborator 
Pharmacists work with other healthcare professionals to provide safe, high-
quality, evidence-based, and patient-centered care. Pharmacists understand that being 
able to function effectively in an interprofessional team is necessary to provide safe, 
high-quality, and patient-centered care. Collaboration is also important with the patient 
and their support systems. Collaboration requires trust, respect, and shared decision-
making. It also requires the sharing of knowledge, perspectives, responsibilities, and the 
willingness to learn from others. To collaborate effectively, one must understand the roles 
of others on the team, articulate one's role on the team, be pursuing common goals, and 
manage conflict effectively. 
• 3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize 
potential strategies, and design, implement, and evaluate a viable solution. 
o EPA: Collaborate as a member of an IPE team. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. 
o EPA: Educate patients and professional colleagues regarding the 




• 3.4 Interprofessional collaboration (Collaborator): Actively participate and engage 
as a healthcare team member by demonstrating mutual respect, understanding, 
and values to meet patient care needs. 
o EPA: Follow-up and monitor a care plan. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
Role: Advocate/Health Promoter 
Pharmacists are committed to using their expertise and influence to work with 
patient populations to improve communities' health and wellness. They work to 
understand the needs, speak on behalf of others, and seek to mobilize resources to effect 
change when needed. Pharmacists understand that improving health is not limited to 
treating illness but also includes disease prevention, health promotion, and health 




them access to populations that others may not have. Pharmacists understand the need to 
work with patients to navigate complex medical situations to get the care they may need. 
• 2.4 Population-based care (Provider):  Describe how population-based care 
influences patient-centered care and influences the development of practice 
guidelines and evidence-based best practices. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 





o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. 
o EPA: Collaborate as a member of an IPE team. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 
• 3.5 Cultural sensitivity (Includer): Recognize social determinants of health to 
diminish disparities and inequities in access to quality care. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. 
o EPA: Identify patients at risk for prevalent disease in a population. 
o EPA: Minimize adverse drug events and medications in a population. 
o EPA: Maximize the appropriate use of medications in a population. 





o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. 






Mapping of Competencies and EPAs With Levels of Entrustment to Core Roles 
Role:  Knowledge  
Pharmacists must integrate knowledge of biomedical and psychosocial science 
principles of health and disease, and clinical science to design appropriate treatment plans 
for their patients. This knowledge includes understanding these principles across the life-
span of the patient. Pharmacists understand that they serve a unique role in the healthcare 
team. They are the “medication” experts and possess the most knowledge of how 
medications contribute to the patient's care. 
• 1.1 Learner:  Develop, integrate, and apply knowledge from the foundational 
sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical 
sciences) to evaluate the scientific literature, explain drug action, solve 
therapeutic problems, and advance population health and patient-centered care  
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
(Level 3) 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. (Level 3) 




o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 3) 
o EPA: Use evidence-based information to advance patient care. (Level 3) 
Role:  Patient Care Skills  
Pharmacists must be able to perform basic patient care skills such as 
communication, collection and assessment of information to formulate and implement a 
treatment plan, and ability to monitor if a treatment is successful or not. Pharmacists need 
to ensure they take a patient’s cultural, education level, and financial status into account 
when formulating a treatment plan to ensure a patient's plan can be adherent. Pharmacists 
also understand that part of patient care should include discussing the plan in a 
compassionate and empathetic manner with the patient and their support system as 
needed.  
• 2.1 Patient-centered care (Caregiver):  Provide patient-centered care as the 
medication expert (collect and interpret evidence, prioritize, formulate 
assessments and recommendations, implement, monitor and adjust plans, and 
document activities).  
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. (Level 4) 
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
(Level 3) 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 




o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. (Level 3) 
o EPA: Follow-up and monitor a care plan. (Level 3) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
• 2.3 Health and wellness (Promoter):  Design prevention, intervention, and 
educational strategies for individuals and communities to manage chronic disease 
and improve health and wellness. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. (Level 4) 
o EPA: Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
• 3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize 




o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. (Level 4) 
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
(Level 3) 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. (Level 3) 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
o EPA: Full-fill a medication order. (Level 3) 
• 3.2a Patient Educator (Patient Educator): Educate patients and their caregivers by 
determining the most effective and enduring ways to impart information and 
assess understanding. 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
• 3.2b Healthcare Professional Educator (Healthcare Professional Educator): 
Educate healthcare providers by determining the most effective and enduring 




o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. (Level 4) 
o EPA: Analyze information to determine the effects of medication therapy, 
identify medication-related problems, and prioritize health-related needs. 
(Level 3) 
o EPA: Follow-up and monitor a care plan. (Level 3) 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-




o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
o EPA: Use evidence-based information to advance patient care. (Level 3) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
o EPA: Full-fill a medication order. (Level 3) 
Role:  Professionalism  
Pharmacists are committed to the health and well-being of their patients, society, 
and themselves. This is demonstrated through ethical practice, high standards of personal 
behavior, accountability to the profession and society, and maintenance of their own 
personal health. Pharmacists serve essential roles in the healthcare team and society, as 
such, professional identity is central. This tenet includes promotion of the public good, 
adherence to high ethical and moral standards. It recognizes that to provide good quality 
patient care, they must take care of themselves and others in their profession.  
• 4.1 Self-awareness (Self-aware): Examine and reflect on personal knowledge, 
skills, abilities, beliefs, biases, motivation, and emotions that could enhance or 
limit personal and professional growth. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
o EPA: Create a written plan for continuous professional development. 
(Level 3) 
• 4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving 
shared goals, regardless of position. 




o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
• 4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities 
by using creative thinking to envision better ways of accomplishing professional 
goals. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Use evidence-based information to advance patient care. (Level 3) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
• 4.4 Professionalism (Professional): Exhibit behaviors and values that are 
consistent with the trust given by the profession by patients, other healthcare 
providers, and society. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
o EPA: Create a written plan for continuous professional development. 
(Level 3) 
Role:  Scholarship  
Pharmacists are committed to excellence in their practice through life-long 
professional development, teaching others, developing new innovative practices that 
advance the profession, and using evidence-based medicine. Pharmacists are committed 




up-to-date. Pharmacists understand the importance of contributing to scholarship and 
evidence-based medical literature. 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. (Level 3) 
o EPA: Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 3) 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 3) 




• 4.3 Innovation and Entrepreneurship (Innovator): Engage in innovative activities 
by using creative thinking to envision better ways of accomplishing professional 
goals. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Use evidence-based information to advance patient care. (Level 3) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
Role:  Systems-based Practice/Manager  
Pharmacists are committed to safety and quality in health care, professional 
advocacy, health insurance, health care economics, health outcomes, quality 
improvement, transitions of care, public health, and patients' chronic care. Pharmacists 
understand that they work as part of a more extensive “system” of health care and that to 
provide good, quality care, they need to be able to coordinate care within the systems, 
provide treatment recommendations that work with the patients' insurance, and be an 
advocate for optimal and quality patient care. Pharmacists also need to advocate for the 
profession on professional roles/responsibilities and the ability to bill for services.  
• 2.2 Medication use systems management (Manager):  Manage patient healthcare 
needs using human, financial, technological, and physical resources to optimize 
the safety and efficacy of medication use. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. (Level 4) 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 




o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. (Level 3) 
o EPA: Follow-up and monitor a care plan. (Level 3) 
o EPA:  Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
o EPA: Full-fill a medication order. (Level 3) 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
• 3.6 Communication (Communicator): Effectively communicate verbally and 




o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
o EPA: Full-fill a medication order. (Level 3) 
• 4.2 Leadership (Leader): Demonstrate responsibility for creating and achieving 
shared goals, regardless of position. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
o EPA: Oversee the pharmacy operations for an assigned shift. (Level 2) 
Role: Collaborator  
Pharmacists work with other healthcare professionals to provide safe, high-
quality, evidence-based, and patient-centered care. Pharmacists understand that being 
able to function effectively in an interprofessional team is necessary to provide safe, 
high-quality, and patient-centered care. Collaboration is also important with the patient 
and their support systems. Collaboration requires trust, respect, and shared decision-
making. It also requires the sharing of knowledge, perspectives, responsibilities, and the 
willingness to learn from others. To collaborate effectively, one must understand the roles 
of others on the team, articulate one’s role on the team, be pursuing common goals, and 
manage conflict effectively. 
• 3.1 Problem Solving (Problem Solver): Identify problems, explore and prioritize 
potential strategies, and design, implement, and evaluate a viable solution. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 




o EPA: Implement a care plan in collaboration with the patient, caregivers, 
and other health professionals. (No level – no consensus) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
• 3.4 Interprofessional collaboration (Collaborator): Actively participate and engage 
as a healthcare team member by demonstrating mutual respect, understanding, 
and values to meet patient care needs. 
o EPA: Follow-up and monitor a care plan. (Level 3) 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
3) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
• 3.6 Communication (Communicator): Effectively communicate verbally and 
nonverbally when interacting with an individual, group, or organization. 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 




Pharmacists are committed to using their expertise and influence to work with 
patient populations to improve communities' health and wellness. They work to 
understand the needs, speak on behalf of others, and seek to mobilize resources to effect 
change when needed. Pharmacists understand that improving health is not limited to 
treating illness but also includes disease prevention, health promotion, and health 
protection. They understand their unique place in the healthcare team, and society allows 
them access to populations that others may not have. Pharmacists understand the need to 
work with patients to navigate complex medical situations to get the care they may need. 
• 2.4 Population-based care (Provider):  Describe how population-based care 
influences patient-centered care and influences the development of practice 
guidelines and evidence-based best practices. 
o EPA: Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
• 3.2 Educator (Educator): Educate all audiences by determining the most effective 
and enduring ways to impart information and assess understanding. 





o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
• 3.3 Patient Advocacy (Advocate): Assure that patients’ best interests are 
represented. 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. (Level 3) 
o EPA: Collaborate as a member of an IPE team. (Level 3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 




• 3.5 Cultural sensitivity (Includer): Recognize social determinants of health to 
diminish disparities and inequities in access to quality care. 
o EPA: Collect information to identify a patient’s medication-related 
problems and health-related needs. (Level 4) 
o EPA: Establish patient-centered goals and create a care plan for a patient 
in collaboration with the patient, caregiver(s), and other health 
professionals that are evidence-based and cost-effective. (Level 3) 
o EPA: Identify patients at risk for prevalent disease in a population. (Level 
3) 
o EPA: Minimize adverse drug events and medications in a population. 
(Level 2) 
o EPA: Maximize the appropriate use of medications in a population. (Level 
2) 
o EPA: Ensure that patients have been immunized against vaccine-
preventable diseases. (Level 3) 
o EPA: Educate patients and professional colleagues regarding the 
appropriate use of medication. (Level 4) 
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University of Louisville 
Louisville, KY 
University of Kentucky 
Lexington, Kentucky  
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Basic Life Support 
Louisville, Kentucky 
Board Certified Pharmacotherapy Specialists (BCPS) 
American College of Clinical Pharmacy. 
Physical Assessment in Patient Care Management  
Nova Southeastern University. Ft. Lauderdale, Florida 
The Cooper Clayton Method to Stop Smoking  
Kentucky Cancer Program. Lexington, Kentucky 
Pharmacy-Based Immunization Program  
University of Kentucky. Lexington, Kentucky 
Basic Life Support 
Louisville, Kentucky 
Dale Carnegie Training Course 
Advanced Cardiac Life Support 
Lexington, Kentucky 
Scholarship of Teaching and Learning Program 
University of Kentucky. Lexington, Kentucky 
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Pharmacy 
Louisville, KY 
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Department 
Sullivan University College of 
Pharmacy 
Louisville, KY 
Sullivan University College of 
Pharmacy 
Louisville, KY 
Ferris State University 
Grand Rapids, MI 
Ferris State University 
Grand Rapids, MI 
University of Kentucky Clinic 
Lexington, Kentucky 
University of Kentucky Chandler 
Medical Center 
Lexington, Kentucky 














Sullivan University College of Pharmacy and Health Sciences 
Lectures Course Academic Year 
VARK, Mindset, & Grit 
Results Overview 





PHR 5009:  Development of the 
Student Pharmacist 
2019-present 
How To Provide Good 
Evaluations and Do Self 
Evaluations 
PHR 6606 Professional Seminar 
Course 
2019-present 
Getting Ready for the 
NAPLEX 
PHR 6606 Professional Seminar 
Course 
2019-present 
Presentation I PHR 5204:  Communication and 
Collaborative Solutions 
2008-present 
Presentation II PHR 5204:  Communication and 
Collaborative Solutions (moved to 
PHR 6606 Professional Seminar 
Course in 2016-2017) 
2008-present 
Overview of Careers in 
Academia; Teaching 
Organizational Structure 
PHR 6814:  Learn to Teach 2013-2019 
Writing Learning 
Objectives and Review of 
Bloom’s Taxonomy 
PHR 6814:  Learn to Teach 2009-2019 
Teaching to Target 
Learning Styles 
PHR 6814:  Learn to Teach 2009-2019 
Generational Differences PHR 6814:  Learn to Teach 2009-2019 
Presentation Delivery PHR 6814:  Learn to Teach 2009-2019 
Peer Assessment; Self-
Assessment 
PHR 6814:  Learn to Teach 2013-2019 
Active Learning 
Techniques 
PHR 6814:  Learn to Teach 2013-2019 
Professionalism PHR 5000:  Introduction to 
Pharmacy 
2010-2015 
Overview of Public Health PCAS 519:  Public Health Issues 2012-2014 
True Experiments PCAS 523/531:  Research Design 
and Literature Evaluation I and II 
2008-2009 
Chapter 1:  Definition and 
Concepts 
PCAS 606:  Clinical Laboratory 2011-2015 
252 
Chapter 3:  Drug 
Interference with Test 
Results 
PCAS 606:  Clinical Laboratory 2011-2015 
Chapter 9:  Pulmonary 
Function Test 
PCAS 606:  Clinical Laboratory 2011-2013 
Chapter 17:  Rheumatic 
Diseases 
PCAS 606:  Clinical Laboratory 2011-2012 
IBS/IBD PCAS 609:  Pharmacotherapeutics I 2010-2012 
How to Write a 
Publishable Research 
Paper 
PCAS 617:  Pharmaceutical Debates 
on Recent Issues Affecting the 
Profession 
2009-2011 
Cerebrovascular Disease PCAS 622:  Pharmacotherapeutics II 2009-2010 
Glaucoma PCAS 633:  Pharmacotherapeutics 
IV 
2009-2010 
Urinary Incontinence PCAS 633:  Pharmacotherapeutics 
IV 
2009-2010 
Precepted students for 
student research project 
PCAS 700:  Research Project 2010-2013 
True Experiments PCAS 523/531:  Research Design 
and Literature Evaluation I and II 
2008-2009 
Course Coordination Academic Year 
PHR 6606:  Professional Seminar 2019-present 
PHR 5009:  Development of Student Pharmacist 2016-present 
PHR 5204:  Communications and Collaborative Solutions 2019-2020 
PHR 6814:  Learn to Teach (Elective) 2010-2019 
PCAS 519:  Public Health Issues 2012-2014 
PCAS 604:  Landmark Trials I (elective) 2011-2012 
PCAS 522:  CAM/Self-Care 2009-2010 
PCAS 536:  Applied Therapeutics Lab I 2009-2010 
PCAS 612:  Pharmacotherapeutics I 2009-2010 
PCAS 523/531:  Research Design and Literature Evaluation I 
and II 
2008-2009 
Sullivan University College of Pharmacy and Health Sciences Master’s in Physician 
Assistant 
Lectures Course Academic Year 




Grand Valley State University 
Lectures Course Academic Year 
Neuropharmacology PT 643:  Clinical Medicine III 2006-2007 
Neurology Pharmacology PAS 630:  Clinical Rotations:  
Pharmacology for GVSU 
Physician Assistant Studies 
Program 
2003-2004 
Western Michigan University 
Lectures Course Academic Year 
Pulmonary Pharmacology CTA 510:  Clinical Pharmacology 
in Drug Development 
2003-2004 
Inflammation and Immune 
Modulation 
CTA 510:  Clinical Pharmacology 
in Drug Development 
2003-2004 
Anti-inflammatory Drugs CTA 510:  Clinical Pharmacology 
in Drug Development 
2003-2004 
Ferris State University 
Lectures Course Academic Year 
Introduction/Ethics/Professionalism/ 
Evaluation 
PHPR 514:  Clinical 
Communication 
2004-2008 
Presentation Style PHPR 514:  Clinical 
Communication 
2004-2008 
Know Your Audience/Active 
Learning 
PHPR 514:  Clinical 
Communication 
2004-2008 
Medication Histories PHPR 514:  Clinical 
Communication 
2003-2008 
Health Professional Communication PHPR 514:  Clinical 
Communication 
2004-2005 
GERD/ Peptic Ulcer Disease/ Stress 
Ulcers 
PHPR 523/524:  
Pharmacotherapy 
2002-2004 
Drug-Induced GI Disease PHPR 523/524:  
Pharmacotherapy 
2002-2003 
Supportive Care for the Cancer 
Patient 
PHPR 523/524:  
Pharmacotherapy 
2002-2003 
Eye Products PHPR 521/522:  
Pharmacotherapy 
2002-2004 
Stroke PHPR 521/522:  
Pharmacotherapy 
2002-2004 
Student Patient Presentations PHPR 501:  Integrated Lab 2002-2004 
Cardiovascular Lab PHPR 501:  Integrated Lab 2003-2004 
Introduction to Basic Pharmacist 
Communication Skills 




Course Coordination Academic Year 
PHPR 602: Adult Ambulatory Care Medicine Clerkship 2002-2008 
PHPR 514:  Clinical Communication 2004-2008 
University of Kentucky 
Lectures Course Academic Year 
Small Group Facilitator: 
Dyslipidemia and 
Hypertension 
PHR 949:  Contemporary 
Aspects of Pharmacy Practice IV 
2001-2002 
Small Group Facilitator: 
Surgical Prophylaxis/ 
Parenterals/ Diabetes 
PHR 939:  Contemporary 
Aspects of Pharmacy Practice III 
2001-2002 
Small Group Facilitator:  
Thyroid and Substance Abuse 
PHR 929:  Contemporary 
Aspects of Pharmacy Practice II 
2000-2002 
Small Group Facilitator:  Otitis 
Media and UTIs 
PHR 919:  Contemporary 
Aspects of Pharmacy Practice I 
2000-2002 
Critical Care Clinical 
Pharmacology Group 
Facilitator 




Congestive Heart Failure PHR 895:  Ambulatory Care 
Elective 
2000-2001 
Ocular Infections and 
Glaucoma 





PHR 961:  Integrated 
Therapeutics II 
2001-2002 
Menopause PHR 961:  Integrated 
Therapeutics II 
2000-2001 
Smoking Cessation PHR 923:  Nutrition and Health 
Promotion 
2001-2002 
Top 200 Drug Review PHR 939:  Contemporary 
Aspects of Pharmacy Practice III 
2001-2002 
Ophthalmic Conditions PHR 916:  Non-Prescription 




“Interprofessional Curriculum for the Care of Older Adults (ICCOA) to 
APPE Students.  American Association of Colleges of Pharmacy Schools 
Poster.  (Author)  
Jul 2020 
255 
“Nailed it! Doctor of Pharmacy Students’ Self-Awareness of 
Performance on Objective Structured Clinical Examinations (OSCE).  
American Pharmacists Association Virtual Poster Session.  (Author) 
“Addressing Student Performance Concerns Through Effective 
Remediation Programs.” American Association of Colleges of Pharmacy 
Student Services Sig. Webinar. (Presenter) 
“Co-Curriculum Assessment Modalities Across Accredited Pharmacy 
Program.”  American Association of Colleges of Pharmacy Assessment 
Sig.  Webinar.  (Moderator) 
“Practicing Understanding:  Strategies to Orient Non-Practiced Faculty to 
the Pharmacy Profession and Professional Education”.  American 
Association of Colleges of Pharmacy Annual Meeting.  Platform 
Presentation. (Presenter) 
“Text Anxiety’s Effect on Performance:  Managing the Power of the 
Mind”.  American Association of Colleges of Pharmacy Annual 
Meeting.  Platform Presentation. (Presenter) 
“Bridging the Great Divide:  Characterizing Activities to Orient Non-
Practice Faculty to the Pharmacy Profession”.  American Association of 
Colleges of Pharmacy Annual Meeting.  Poster Presentation. (Author) 
“Bridging the Gap Between Didactic and Experiential 
Learning”.  American Association of Colleges of Pharmacy Annual 
Meeting.  Poster Presentation.  (Author) 
“Influence of Program Type, Curricular Delivery, and Demographics on 
Test Anxiety”.  American Association of Colleges of Pharmacy Annual 
Meeting.  Poster Presentation.  (Author) 
“A Qualitative Study of Evaluating Pharmacy Faculty Perceptions on 
Empathy in Education”.  American Association of Colleges of Pharmacy 
Annual Meeting.  Poster Presentation.  (Author) 
“How to support struggling students through effective remediation 
plans”.  American Association of Colleges of Pharmacy Webinar.  
(Author) 
“Assessing Reliability and Validity of Advanced Pharmacy Practice 
Experience (APPE) Evaluations from One College of Pharmacy in the 
United States.”  American Society of Health-Systems Pharmacist Annual 













“ExamSoft Use as a Curricular Assessment and Learning Analytics 
Tool.”  American Association of Colleges of Pharmacy Annual Meeting.  
Poster Presentation. (Author) 
“Student Perceptions of the PCOA – A Multi-institutional Sample”.  
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation.  (Author) 
“PCOA Opportunities and Challenges:  Two Sides of the Same Coin.”  
American Association of Colleges of Pharmacy Annual Meeting.  
Platform Presentation.  (Presenter) 
“Fostering a Culture of Collaboration Using the Four Frames Model.”  
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation.  (Author) 
“Pharmacy Expert Panel Webinar.”  ExamSoft Webinar.  (Author) 
“Predicting NAPLEX Success Utilizing Performance on Skills-based 
Assessment in the Patient Care Laboratory Setting.”  American College 
of Clinical Pharmacy Meeting.  Poster Presentation. (Author) 
“Using ExamSoft Data for Faculty Development.”  ExamSoft Webinar. 
(Author) 
“Standard 4.1 and a Professional Development and Advising Plan for 
Student Achievement of Educational Outcomes.”  Association of 
Colleges of Pharmacy Annual Meeting.  Poster presentation.  Nashville, 
TN.  (Author) 
“Chicken or the egg? Exploring the link between assessment resources 
and culture of assessment.” Association for the Assessment of Learning 
in Higher Education Annual Meeting.  Louisville, KY.  (Author) 
“Use of ExamSoft data to prepare for and ease the accreditation process.” 
ExamSoft Webinar.  (Author) 
“Understanding the structure, resources, and culture towards assessment 
in US schools of pharmacy.” Assessment Institute in Indianapolis 
Meeting.  Platform presentation.  Indianapolis, IN. (Author) 
“Predictors of NAPLEX Performance in an Accelerated Program.”  
American Association of Colleges of Pharmacy Annual Meeting.  Poster 














“Creating an Arms Race?  Examining School Costs and Motivations for 
Providing NAPLEX and PCOA Preparation.  American Association of 
Colleges of Pharmacy Annual Meeting.  Poster presentation.  Anaheim, 
CA. (Author) 
“Continuum of Student Development:  A 3 Tiered Approach in a 3 Year 
Program.”  American Association of Colleges of Pharmacy Annual 
Meeting.  Poster presentation.  Anaheim, CA. (Primary Author) 
“Mini-Session:  Preparation for NAPLEX and PCOA Exams:  results of a 
National Study.  American Association of Colleges of Pharmacy Annual 
Meeting.  Platform presentation.  Anaheim, CA. (Author) 
“Special Session:  More Than Just Numbers:  Providing Autonomy-
Supportive Feedback to large Student Populations.  American 
Association of Colleges of Pharmacy Annual Meeting.  Platform 
presentation.  Anaheim, CA. (Author) 
“Creation of Longitudinal Report Cards Using Assessment Data.”  
ExamSoft Annual Meeting.  Platform presentation.  Dallas, TX. (Co-
Author) 
“Successful Didactic Course Remediation in an Accelerated Program.”  
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation.  National Harbor, MD.  (Co-Author) 
“Impact of a Landmark Trials Elective on Pharmacy Curriculum 
Outcomes Assessment (PCOA) Student Scores.”  American Association 
of Colleges of Pharmacy Annual Meeting.  Poster Presentation.  National 
Harbor, MD.  (Co-Author) 
“Evaluation of student and faculty perceptions on implementation of 
electronic assessments in an accelerated Doctor of Pharmacy Program.”  
American Pharmacist Association.  Poster Presentation.  San Diego, CA. 
(Co-Author) 
“A Curriculum Committee Toolkit for Addressing the 2013 CAPE 
Outcomes.”  American Association of College of Pharmacy Webinar. 
Platform Presentation.  Web.  (Author) 
“Preparing Students for an Accelerated Pharm D Program At Sullivan 
University.”  American Association of Colleges of Pharmacy Annual 












“Success Rate of Exam Remediation in a 3-Year Accelerated Program.”  
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation.  Kissimmee, FL.  (Primary Author) 
“Use of NAPLEX to Validate SUCOP Benchmarking of Student 
Outcome Achievement.”  American Association of Colleges of Pharmacy 
Annual Meeting.  Poster Presentation.  Kissimmee, FL.  (Primary 
Author) 
“A Prospective Evaluation of Group Presentation and Peer Review in a 
Critical Care Elective Course.” American Association of Colleges of 
Pharmacy Annual Meeting.  Poster Presentation.  San Antonio, TX.  (Co-
Author) 
“Survey results for exam remediation at US Colleges of Pharmacy.” 
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation.  San Antonio, TX.  (Primary Author) 
“Do HSRT exam results predict how well students will do in pharmacy 
Therapeutic courses?” American Association of Colleges of Pharmacy 
Annual Meeting.  Poster Presentation.  San Antonio, TX.  (Primary 
Author) 
“Course action plan impact on course outcomes.” American Association 
of Colleges of Pharmacy Annual Meeting.  Poster Presentation.  San 
Antonio, TX.  (Co-Author) 
“Correlation of student self-assessment of program outcomes with course 
grade averages.” American Association of Colleges of Pharmacy Annual 
Meeting.  Poster Presentation.  San Antonio, TX.  (Primary Author) 
“Comparison of HSRT results between students with degrees prior to 
pharmacy school versus only pre-requisites.” American Association of 
Colleges of Pharmacy Annual Meeting.  Poster Presentation.  San 
Antonio, TX.  (Primary Author) 
“End of the Year Capstone Exam Descriptions”.  American Association 
of Colleges of Pharmacy Annual Meeting.  Poster Presentation.  San 
Antonio, TX.  (Primary Author) 
“Longitudinal Didactic Review Examinations During Advance Pharmacy 
Practice Experiences (APPE)”.  American Association of Colleges of 













“Experience with an Exam Remediation Procedure in a 3-Year 
Accelerated Program.”  American Association of Colleges of Pharmacy 
Annual Meeting. Poster Presentation. Seattle, WA (Primary Author) 
“Tracking Performance of Sullivan University College of Pharmacy 
Students Using Pharmacy Curricular Outcomes Assessment (PCOA).”  
American Association of Colleges of Pharmacy Annual Meeting. Poster 
Presentation. Seattle, WA. (Co-Author) 
“Quantitative Measurement of Student Attainment of Sullivan University 
College of Pharmacy Program-level ABOs.”  American Association of 
Colleges of Pharmacy Annual Meeting.  Poster Presentation. Seattle, 
WA. (Co-Author) 
“A Pilot Study to Evaluate Professionalism in a Pharmacy Curriculum.” 
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation. Boston, MA.  (Co-Author) 
“Does Examination Remediation Impact on Course Retention?” 
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation. Boston, MA.  (Co-Author) 
“Sullivan University College of Pharmacy Bridge Program:  IPPE to 
APPE.”  American Association of Colleges of Pharmacy Annual 
Meeting.  Poster Presentation. Boston, MA.  (Primary author) 
“Sullivan University College of Pharmacy NAPLEX and MPJE 
Preparation.”  American Association of Colleges of Pharmacy Annual 
Meeting.  Poster Presentation. Boston, MA.  (Primary author) 
“Faculty Satisfaction With the Student Self-Assessment of Program 
Outcomes Achievement System (RXOutcome) Process.” American 
Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation. Boston, MA.  (Primary author) 
“Student Self-Assessment of Program Outcomes Achievement.” 
American Association of Colleges of Pharmacy Annual Meeting.  Poster 
Presentation. Boston, MA.  (Co-Author) 
“An Innovative Approach to the Development, Delivery, and Assessment 
of Informatics Course for a Newly Established Doctor of Pharmacy 
Program.”  American Association of Colleges of Pharmacy Annual 












“Curricular Comparison of a New 3 Year Doctor of Pharmacy Degree 
Program vs Established Degree Programs.” American Association of 
Colleges of Pharmacy Annual Meeting. Poster Presentation. Chicago, IL. 
(Co-Author) 
“Public Health Opportunities at a New Doctor of Pharmacy Program.” 
American Association of Colleges of Pharmacy Annual Meeting. Poster 
Presentation. Chicago, IL. (Primary author) 
“Proton Pump Inhibitor Use by Hospital Inpatients as a Risk For 
Nosocomial Infection by Clostridum difficile.”  American College of 
Physicians Meeting. Platform Presentation. Philadelphia, Pennsylvania. 
(Co-Author) 
“Mentoring Junior Faculty.” American Association of College of 
Pharmacy Annual Meeting. Poster Presentation. Cincinnati, Ohio. 
(Primary author) 
“Type 2 Diabetes in Children and Adolescents: Who’s To Blame?” Live 
on-line Pharmacy CE. Continuing Education for Pharmacists 
presentation. ContinuingEducation.com. ACPE Continuing Education 
approved. (written by Joan Rider, presented by me as an encore 
presentation) 
“Non-adherence With Multiple Sclerosis Therapies.” American College 
of Clinical Pharmacy Meeting. Poster Presentation. Savannah, Georgia. 
(Primary author) 
“Topiramate Use In Essential Tremors.” American Society of Health-
System Pharmacists Midyear Clinical Meeting. Poster Presentation. New 
Orleans, Louisiana. (Primary author) 
“Idiopathic Paresthesia Reaction to Rofecoxib.” American Society of 
Health-System Pharmacists Annual Meeting. Poster Presentation. Los 
Angeles, California. (Primary author) 
“Pharmacist Intervention in the Management of Type 2 Diabetes: Does It 
Improve Glycosylated Hemoglobin and Blood Pressure Control?” 
American Association of Colleges of Pharmacy Annual Meeting. Poster 
Presentation. San Diego, California. (Primary author) 
“Why I Participated in the Novo-Nordisk Diabetes Project Grant 
Program.” American Association of Colleges of Pharmacy Annual 













“Pediatric Adaptation of Patient Education Leaflets for Anticonvulsant 
Medications.” Pediatric Advocacy Group Conference. Poster 
Presentation. Kiawah Island, South Carolina. (Primary author) 
Oct 1998 
Regional 
“Faculty Perceptions of Summative Assessments.”  IUPUI Assessment 
Institute.  Platform Presentation.  Indianapolis, IN.  (Primary Author) 
“Teaching Recommendation and Patient Counseling Skills in a Self-
Care Course to Allow Achievement of Competencies in Intermediate 
Pharmacy Practice Experiences.”  Nonprescription Medicines Academy 
Annual Conference.  Poster Presentation.  Cincinnati, OH.  (Co-Author)  
“Selecting Appropriate Classroom Assessment Techniques Based on 
Teaching Goals Inventory (TGI)”. IUPUI Assessment Institute. Poster 
Presentation. Indianapolis. (Co-Author)  
“Exploring Collaborations.” Kentucky Science and Technology 
Conference. Poster Presentation. Frankfort, KY. (Co-Author)  
“Pharmacy Professionals’ Status in Kentucky.” Kentucky Science and 
Technology Conference. Poster Presentation.  Frankfort, KY. (Co-
Author) 
“Facts and Fiction of Hormone Replacement Therapy.” Michigan 
Pharmacists Association Grand Escape 2007. Platform Presentation. 
Mackinac Island, Michigan. ACPE Continuing Education Approved. 
(Sole author) 
“Patient Assessment, Self Monitoring, and Management.” Michigan 
Pharmacists Association Diabetes Care Certificate Program in 
Pharmacy. Platform Presentation. Grand Blanc, Michigan. ACPE 
Continuing Education Approved. (Co-Author) 
“Hormone Replacement Therapy.” Michigan Pharmacists Association 
Education Vacation 2004. Platform Presentation. Traverse City, 
Michigan. ACPE Continuing Education Approved. (Sole author) 
“Asthma Treatment in the Adult.” Michigan Pharmacists Association 
2004 Annual Convention. Platform Presentation. Dearborn, Michigan. 











“Late Complications in a 48-year old Male After Ingestion of 
Brodifacoum (DeCon) in a Suicide Attempt.” American College of 
Physicians Michigan Chapter Scientific Meeting. Poster Presentation. 
Acme, Michigan. (Last author) 
Sep 2003 
“Non-adherence With Multiple Sclerosis Therapies.” Southeast Resident 
Conference. Research Presentation. Athens, Georgia. ACPE Continuing 
Education Approved. (Primary author) 
Apr 2002 
“Pharmacist Intervention in the Management of Type 2 Diabetes: Does 
It Improve Glycosylated Hemoglobin and Blood Pressure Control?” 
Southeast Resident Conference. Research Presentation. Athens, Georgia. 
ACPE Continuing Education Approved. (Primary author) 
Apr 2001 
Local 
“Planning for Engagement.”  Sullivan University Faculty Retreat.  
Breakout Session.  Louisville, KY. (Co-presenter) 
“What Effects Student Engagement and Why Should We Care?”  
Sullivan University Faculty Retreat.  Keynote Platform Presentation.  
Louisville, KY.  (Presenter) 
“Leadership for a Successful Merger.”  University of Louisville Spring 
Research Conference.  Platform Presentation.  Louisville, KY. 
(Presenter) 
“How to Present a Research Poster.”  Sullivan University College of 
Pharmacy Seminar Series.  Platform Presentation.  Louisville, KY.  
(Presenter) 
“Large Group Presentations.”  Sullivan University College of 
Pharmacy Teaching Certificate Seminar.  Platform Presentation.  
Louisville, KY.  (Presenter) 
“Question Writing.”  Sullivan University College of Pharmacy 
Teaching Certificate Seminar.  Platform Presentation.  Louisville, KY.  
(Presenter) 
“Learning Objectives and Active Learning.”  Sullivan University 
College of Pharmacy Teaching Certificate Seminar.  Platform 
Presentation.  Louisville, KY.  (Presenter) 
“Objectives and Writing Good Assessments.”  Sullivan University 
College of Pharmacy Teaching Certificate Seminar.  Platform 










“Learning Styles.”  Sullivan University College of Pharmacy Teaching 
Certificate Seminar.  Platform Presentation.  Louisville, KY.  
(Presenter) 
“Learning Objectives:  Making Sure it Links.”  Sullivan University 
Faculty Retreat.  Platform Presentation.  Florence, IN.  (Presenter) 
“Writing Objectives and Quality Examinations Questions.”  Kentucky 
Pharmacy Residency Network Summer Meeting.  Platform 
Presentation.  Louisville, KY.  (Co-presenter) 
“College of Pharmacy Takes Center Stage.”  Sullivan University 
Faculty Retreat.  Panel Discussion.  Florence, IN.  (Co-presenter) 
“Update on the Treatment of C. Diff.” Kentucky Society of Health-
System Pharmacy Spring Meeting.  Platform Presentation. Louisville, 
KY. (Presenter) 
“Pharmacy 101”.  Sullivan University Faculty Retreat.  Platform 
Presentation.  Florence, IN. (Co-presenter) 
“How to Start a Clinical Practice Site.” Sullivan University College of 
Pharmacy Faculty Development. Platform Presentation. Louisville, 
KY. (Co-presenter) 
“Teaching Philosophies, Writing Objectives, Teaching Dos and Don’ts, 
and Writing Test Questions.” Sullivan University College of Pharmacy 
Faculty Development. Platform Presentation. Louisville, KY. (Co-
presenter) 
“Pharmacy Practice.”  Marion County Area Technology Center 
Students.  Platform Presentation. Louisville, KY. (Co-presenter) 
“Small Group Teaching.” Ferris State University Resident Teaching 
Seminar. Platform Presentation (encore). Grand Rapids, MI. (Co-
presenter) 
“Backward Course Design.”  Ferris State University Resident Teaching 
Seminar.  Platform Presentation.  Grand Rapids MI. (Co-presenter) 
“Small Group Teaching.” Ferris State University Resident Teaching 















“Small Group Teaching.”Ferris State University Resident Teaching 
Seminar. Platform Presentation. Grand Rapids, MI. (Co-presenter) 
“Utilization of BMI in Diagnosing Obesity at an Outpatient Clinic.” 
GRMERC’s Community Health Research Day. Platform Presentation. 
Grand Rapids, Michigan. (Co-Author) 
“Proton Pump Inhibitor Use by Hospital Inpatients as a Risk For 
Nosocomial Infection by Clostridium difficile.”  GRMERC’s 
Community Health Research Day. Platform Presentation. Grand 
Rapids, Michigan. (Co-Author) 
“Non-adherence With Multiple Sclerosis Therapies.” University of 
Kentucky Chandler Medical Center. Southeastern Residency 






“Ziprasidone HCl In-service.” Eastern State Hospital. Nursing In-
service. Platform Presentation. Lexington, Kentucky. (Co-Author) 
“Non-adherence To Multiple Sclerosis Therapies.” University of 
Kentucky Chandler Medical Center. Pharmacy Grand Rounds. Platform 
Presentation. Lexington, Kentucky. ACPE Continuing Education 
Approved. (Primary author) 
Nov 2001 
Oct 2001 
“Patient Noncompliance With Interferon Beta-1a, Interferon Beta-1b, 
and Glatiramer Acetate.” University of Kentucky Chandler Medical 
Center. Research Presentation. Lexington, Kentucky. (Primary author) 
Oct 2001 
“Treatment of Vasomotor Symptoms of Menopause.” University of 
Kentucky Chandler Medical Center. Pharmacy Grand Rounds. 
Lexington, Kentucky. (Sole author) 
“Pharmacist Intervention in the Management of Type 2 Diabetes: Does 
It Improve Glycosylated Hemoglobin and Blood Pressure Control?” 
University of Kentucky Chandler Medical Center. Resident Seminar 
Series. Lexington, Kentucky. ACPE Continuing Education Approved. 
(Primary author) 
“Idiopathic Paresthesia Reaction Associated With Rofecoxib.” 
University of Kentucky Chandler Medical Center. Resident Report. 
Lexington, Kentucky. (Primary author) 
“Vancomycin Ototoxicity.” University of Kentucky Chandler Medical 






“Pharmacist Intervention in the Management of Type 2 Diabetes: Does 
It Improve Glycosylated Hemoglobin and Blood Pressure Control?” 
University of Kentucky Chandler Medical Center. Research 
Presentation. Lexington, Kentucky. (Primary author) 
“Cancer Pain Management.” University of Kentucky Chandler Medical 
Center. Medical In-service. Lexington, Kentucky. (Sole author) 
“Prevention of Post Operative Atrial Fibrillation.” University of 
Kentucky Chandler Medical Center. Pharmacy In-service. Lexington, 
Kentucky. (Sole author) 
“Smoking Cessation.” University of Kentucky Chandler Medical 
Center. Nursing In-service. Lexington, Kentucky. (Sole author) 
“Diabetes.” University of Kentucky College of Pharmacy. Robinson 
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Drug Information/IT Position Committee (member) 
 
Ferris State University College of Pharmacy 
 
Continuing Education Committee (member) 
Accreditation Committee (member) 
English in the Curriculum Subcommittee (member) 
Curriculum Committee (secretary-2002-Mar 2004) 
MBA/PharmD Subcommittee (member) 





AALHE:  Grand Challenges:  Using Assessment Findings to 
Direct Immediate Pedagogical Improvement Taskforce 
AAHLE Grand Challenges:  Change Over Time Taskforce 
AACP Assessment Sig Chair-elect, Chair, Past-Chair 
AACP Assessment Sig Research Sub-Committee (Co-Chair) 
AACP Assessment Sig Executive Council (member) 
AACP Assessment Sig Research Sub-Committee (Co-Chair) 
AACP Academic Affairs Committee (member) 
Kentucky Pharmacy Education and Research Foundation Advisory 
Council (member) 
AACP Council of Dean’s Conflict of Interest Policy and Practice 
Task Force 
AACP Curriculum Sig CAPE Paper Taskforce (member) 
KSHP Board (member) 
AACP Pharmacy Practice Section Pharmacy Leadership 
Development Task Force (member) 
AACP Pharmacy Practice Section Program Committee (member) 
AACP New Investigator Grant Task Force (member) 
Michigan Pharmacists Association Education  (member; Chair 
2005-2007) 
AACP Nominating Committee 








































University of Kentucky Residency 
 
Residency Program Secretary 
Pharmacy Grand Rounds (member)  
Medication Use Evaluation Subcommittee Of Pharmacy and 
Therapeutics (member) 












Residency Recruitment (1st year-member; 2nd year-co-chair) 
Kentucky Konnection (editor) 
 
University of Kentucky College of Pharmacy 
 










American Educational Research Association (AERA) 
Association for the Assessment of Learning in Higher Education 
(AALHE) 
Phi Lambda Sigma (PLS) 
Jefferson County Pharmacist Association (JCAP) 
Kentucky Pharmacists Association (KPhA) 
American Association of Colleges of Pharmacy (AACP) 
American College of Clinical Pharmacy (ACCP) 
Rho Chi 
Kentucky Society of Health-System Pharmacists (KSHP) 
American Pharmacists Association (APhA) 
Western Michigan Society of Health-System Pharmacists 
(WMSHP) 
Michigan Society of Health-System Pharmacists (MSHP) 
Michigan Pharmacists Association (MPA) 
American Society of Health-System Pharmacists  (ASHP) 
Kentucky Pharmacists Association (KPhA) 
Kentucky Society of Health-System Pharmacists (KSHP) 





















ACPE Self-Study Workshop 
 
Student Suicides and Suicide Threats for Colleges:  
Expectations, Risks, and Responses 
 
ACPE Standards 2007 Update Webinar 
 
ACPE Reviewer Training 
 





















AACP Teacher’s Seminar:  Inclusive Teaching – A Strategy to 
Reach ALL Learners. (attendee) 
 
AACP Scholarship of Teaching and Learning Institute (team 
leader) 
 
AACP Teacher’s Seminar:  Learning is NOT a Spectator Sport:  
Active Learning in Pharmacy Curricular. (attendee) 
 
AACP Teacher’s Seminar:  Beginning With the End in Mind:  
Developing the Self-Aware Pharmacist.  (attendee) 
 
AACP CAPE Institute.  Leesburg, VA. (Team Leader) 
 
Exam Soft.  “Making the Most From Reporting for Students and 
Institutions.”   Webinar.  (attendee) 
 
Exam Soft Training. Sullivan University College of Pharmacy.  
(attendee) 
 
Faculty Retreat.  Sullivan University. (attendee) 
 
Faculty Development:  Curriculum Mapping 101. (Presenter) 
 
Faculty Development:  Panopto Usage and other IT Questions.  
(attendee) 
 
Faculty Development:  Portal to Portal:  Library/DIC Resources 
for You. (attendee) 
 
Faculty Retreat.  Sullivan University.  (presenter and attendee) 
 
Spring 2012 KACCS Education Conference.  Sullivan University 
Lexington Campus.  (attendee) 
 
Faculty Retreat.  Sullivan University. (attendee) 
 
Faculty Development:  How to Write Great Test Questions;  
Sullivan University College of Pharmacy.  (attendee) 
 
Web Seminar:  Competency Based Education and Performance 

















































Education Scholar: Teaching Excellence and Scholarship 
Development Resources for Health Professions Educators 
Modules (7 modules) 
 
Faculty Retreat;  Sullivan University (attendee and presenter) 
 
Faculty Development:  Promotion Dossiers; Sullivan University 
College of Pharmacy.  (attendee) 
 
Faculty Development:  How to Not Get Sued; Sullivan University 
College of Pharmacy.  (attendee) 
 
Faculty Retreat; Sullivan University (attendee and presenter) 
 
Faculty Development:  How to Start a Clinical Practice Site; 
Sullivan University. (Co-leader) 
 
Faculty Development: Teaching Philosophies, Writing Objectives, 
Teaching Dos and Don’ts, and Writing Test Questions; Sullivan 
University. (Co-leader) 
 
Faculty Advance: Experiential Learning; Sullivan University 
(attendee) 
 
Faculty Development: Student Advising; Sullivan University 
College of Pharmacy (co-leader) 
 
Faculty Development: Basic Pedagogy and Assessment (Part II); 
Sullivan University (attendee) 
 
Faculty Development: Basic Pedagogy and Assessment (Part I); 
Sullivan University (attendee) 
 
Faculty Advance: Active Learning; Sullivan University (attendee) 
American Association of Colleges of Pharmacy Teaching Seminar 
(attendee) 
 
American Association of College of Pharmacy Teaching Seminar 
(attendee) 
 
American Association of College of Pharmacy Teaching Seminar 
(attendee) 
 


















































American Association of Colleges of Pharmacy Teaching Seminar 
(attendee) 
Holding a Cat by the Tail: Active Learning and Assessment in 
Pharmacy Practice: American College of Clinical Pharmacy 
(attendee) 
American Association of Colleges of Pharmacy Teaching Seminar 
(attendee) 
Education Scholar: Teaching Excellence and Scholarship 
Development Resources for Health Professions Educators 
Modules (6 modules) 
American Association of Colleges of Pharmacy Teaching Seminar 
(attendee) 
Introduction to Pharmaceutical Education Workshop 
(Coordinator/Moderator) 
Butler University College of Pharmacy and Health Sciences 
Primer in Pharmaceutical Education Workshop (attendee) 
Jul 2005 
Apr 2005 
Jul 2004 
Jun 2004 
Jul 2003 
Jan 2003 
Aug 2002 
